Quarterlytics / Basic Materials / Chemicals - Specialty / Sensient

Sensient

sxt · NYSE Basic Materials
Claim this profile
Ticker sxt
Exchange NYSE
Sector Basic Materials
Industry Chemicals - Specialty
Employees 1001-5000
← All annual reports
FY2018 Annual Report · Sensient
Sign in to download
Loading PDF…
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-K/A
Amendment No. 1

☒ ANNUAL REPORT PURSUANT TO  
SECTION 13 OR 15(d) OF THE  
SECURITIES EXCHANGE ACT OF 1934
For the Fiscal Year Ended December 31, 2018

OR

☐ TRANSITION REPORT PURSUANT 

TO SECTION 13 OR 15(d) OF THE 
SECURITIES EXCHANGE ACT OF 1934

     Commission File Number 1-7626

Sensient Technologies Corporation 

WISCONSIN
(State of Incorporation)

39-0561070
(IRS Employer Identification Number)

777 EAST WISCONSIN AVENUE
MILWAUKEE, WISCONSIN  53202-5304
(414) 271-6755
(Address of Principal Executive Offices)

SECURITIES REGISTERED PURSUANT  
TO SECTION 12(b) OF THE ACT:

TITLE OF EACH CLASS
Common Stock, $0.10 par value

NAME OF EACH EXCHANGE
ON WHICH REGISTERED
New York Stock Exchange, Inc.

Indicate by check mark if the registrant is a well-known  
seasoned issuer, as defined in Rule 405 of the Securities Act.   
Yes ☒   No ☐

Indicate by check mark if the registrant is not required to file 
reports pursuant to Section 13 or Section 15(d) of the Act.    
Yes ☐   No ☒

Indicate by check mark whether the Registrant (1) has filed all 
reports required to be filed by Section 13 or 15(d) of the Securities 
Exchange Act of 1934 during the preceding 12 months (or such 
shorter period that the Registrant was required to file such reports), 
and (2) has been subject to such filing requirements for at least the 
past 90 days.   Yes ☒   No ☐

Indicate by check mark whether the registrant is a large accelerated 
filer, an accelerated filer, a non-accelerated filer, or a smaller report-
ing company. See the definitions of “large accelerated filer,” “accel-
erated  filer,”  “smaller  reporting  company”  and  “emerging  growth 
company” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer ☒ 
Accelerated filer ☐ 
Non-accelerated filer ☐ 

Smaller Reporting Company  ☐ 
Emerging Growth Company ☐

If an emerging growth company, indicate by check mark if the  
registrant has elected not to use the extended transition period for 
complying with any new or revised financial accounting standards 
provided pursuant to Section 13(a) of the Exchange Act.   ☐

Indicate by check mark whether the registrant has submitted 
electronically every Interactive Data File required to be 
submitted pursuant to Rule 405 of Regulation S-T (§232.405  
of this chapter) during the preceding 12 months (or for such 
shorter period that the registrant was required to submit  
such files).   Yes ☒   No ☐

Indicate by check mark if disclosure of delinquent filers 
pursuant to Item 405 of Regulation S-K is not contained  
herein, and will not be contained, to the best of Registrant’s 
knowledge, in definitive proxy or information statements 
incorporated by reference in Part III of this Form 10-K or  
any amendment to this Form 10-K.   ☒

Indicate by check mark if the registrant is a shell company (as 
defined in Rule 12b-2 of the Exchange Act).   Yes ☐   No ☒

The aggregate market value of the voting Common Stock held  
by non-affiliates of the Registrant as of June 30, 2018, was 
$2,989,108,418. For purposes of this computation only, the 
Registrant’s directors and executive officers were considered to  
be affiliates of the Registrant. Such characterization shall not  
be construed to be an admission or determination for any other 
purpose that such persons are affiliates of the Registrant.

There were 42,293,718 shares of Common Stock outstanding  
as of February 15, 2019.

DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Company’s 2019 Annual Meeting Proxy Statement 
which will be filed with the Securities and Exchange Commission with-
in 120 days after December 31, 2018 (see Part III of this Form 10-K).

 
 
 
 
 
 
 
 
 
 
SENSIENT TECHNOLOGIES CORPORATION— 
FORM 10-K FOR YEAR ENDED DECEMBER 31, 2018 INDEX

PART I

Item 1. Business
General
Description of Business
Flavors & Fragrances Group
Color Group
Asia Pacific Group
Corporate
Research and Development/Quality Assurance
Products and Application Activities
Raw Materials
Competition
Foreign Operations
Patents, Formulae and Trademarks
Employees
Regulation

Item 1A.  Risk Factors
Item 1B.  Unresolved Staff Comments
Item 2.  Properties
Item 3.  Legal Proceedings
Item 4.  Mine Safety Disclosure
Executive Officers of the Registrant

PART II

Item 5.   Market for the Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases of 

Equity Securities
Item 6.  Selected Financial Data
Item 7.  Management’s Discussion and Analysis of Financial Condition and Results of Operation
Item 7A.  Quantitative and Qualitative Disclosures about Market Risk
Item 8.  Financial Statements and Supplementary Data
Item 9.  Changes in and Disagreements with Accountants on Accounting and Financial Disclosure
Item 9A. Controls and Procedures
Item 9B. Other Information

PART III

Item 10.  Directors, Executive Officers of the Registrant, and Corporate Governance
Item 11.  Executive Compensation
Item 12.  Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
Item 13.  Certain Relationships and Related Transactions and Director Independence
Item 14.  Principal Accountant Fees and Services

PART IV

Item 15.  Exhibits and Financial Statement Schedules

Financial Statements
Financial Statement Schedule
Schedule II – Valuation and Qualifying Accounts

Item 16.  Form 10-K Summary

EXHIBIT INDEX
SIGNATURES

2
2
 2
2
 3
 3
4
 4
4
 4
 4
5
 5
 5
 5
 5
 5
 10
10
10
11
11
12
 12

13
16
27
27
27
27
28
28
28
28
28
28
29
29
29
29
29
29
29
 E-1
S-1

 
 
 
 
 
 
 
 
 
 
FORWARD-LOOKI NG  S TATE ME N T S

This document contains forward-looking statements that 
reflect management’s current assumptions and estimates of 
future economic circumstances, industry conditions, 
Company performance, and financial results. Forward-
looking statements include statements in the future tense, 
statements referring to any period after December 31, 2018, 
and statements including the terms “expect,” “believe,” 
“anticipate,” and other similar terms that express 
expectations as to future events or conditions. The Private 
Securities Litigation Reform Act of 1995 provides a safe 
harbor for such forward-looking statements. Such forward-
looking statements are not guarantees of future performance 
and involve known and unknown risks, uncertainties, and 
other factors that could cause actual events to differ 
materially from those expressed in those statements. A 
variety of factors could cause the Company’s actual results 
and experience to differ materially from the anticipated 
results. These factors and assumptions include the pace and 
nature of new product introductions by the Company and the 
Company’s customers; our ability to anticipate and respond 
to changing consumer preferences and changing 
technologies; the Company’s ability to successfully 

NO N-GAAP  FI NANCIAL  MEA S U R E S

Within this document, the Company reports certain non-
GAAP financial measures, including: (1) adjusted operating 
income, adjusted net earnings, and adjusted diluted EPS 
from continuing operations (which exclude restructuring 
and other costs and the impacts of the Tax Cuts and Jobs 
Act (“2017 Tax Legislation”)) and (2) percentage changes 
in revenue, operating income, diluted EPS, adjusted 
operating income, and adjusted diluted EPS on a local 
currency basis (which eliminate the effects that result from 
translating its international operations into U.S. dollars). The 
Company has included each of these non-GAAP measures 
in order to provide additional information regarding our 
underlying operating results and comparable year-over-
year performance. Such information is supplemental to 
information presented in accordance with GAAP and is 
not intended to represent a presentation in accordance with 
GAAP. These non-GAAP measures should not be considered 
in isolation. Rather, they should be considered together with 
GAAP measures and the rest of the information included 
in this report. Management internally reviews each of 

implement its growth strategies; the outcome of the 
Company’s various productivity-improvement and cost-
reduction efforts and acquisition and divestiture activities; 
the effectiveness of the Company’s past restructuring 
activities; changes in costs of raw materials, including 
energy; industry, regulatory, legal, and economic factors 
related to the Company’s domestic and international 
business; growth in markets for products in which the 
Company competes; industry and customer acceptance of 
price increases; actions by competitors; currency exchange 
rate fluctuations; and the matters discussed below under the 
heading “Risk Factors” and under Part II, including the 
critical accounting policies set forth under the heading 
“CRITICAL ACCOUNTING POLICIES” within 
“Management’s Discussion and Analysis of Financial 
Condition and Results of Operation.” Except to the extent 
required by applicable law, the Company does not undertake 
to publicly update or revise its forward-looking statements 
even if experience or future changes make it clear that any 
projected results expressed or implied therein will not be 
realized.

these non-GAAP measures to evaluate performance on a 
comparative period-to-period basis and to gain additional 
insight into underlying operating and performance trends. 
The Company believes this information can be beneficial 
to investors for these same purposes. These non-GAAP 
measures may not be comparable to similarly titled measures 
used by other companies.

Additional information related to the Company’s use of non-
GAAP financial measures and the restructuring and other 
costs as well as the impacts from the 2017 Tax Legislation 
that have been excluded from the non-GAAP financial 
measures in 2018, 2017, and 2016 and reconciliations of 
non-GAAP financial measures to the most comparable 
GAAP financial measures are available below in Item 
7 under the sections titled “NON-GAAP FINANCIAL 
MEASURES.”

1

PA RT  I

Item 1. Business

General
Sensient Technologies Corporation (the “Company”) was 
incorporated in 1882 in Wisconsin. Its principal executive 
offices are located at 777 East Wisconsin Avenue, Suite 
1100, Milwaukee, Wisconsin 53202-5304, telephone (414) 
271-6755.

The Company is subject to the informational and report-
ing requirements of the Securities Exchange Act of 1934, 
as amended (the “Exchange Act”). In accordance with 
the Exchange Act, the Company files annual, quarterly 
and current reports, proxy statements, and other infor-
mation with the Securities and Exchange Commission 
(the “Commission”). These reports and other informa-
tion may be accessed from the website maintained by the 
Commission at http://www.sec.gov.

The Company’s common stock is listed on the New 
York Stock Exchange under the ticker symbol “SXT.” 
Information about the Company may be obtained at the 
offices of the New York Stock Exchange, 20 Broad Street, 
New York, New York 10005.

The Company can also be reached at its website at www.
sensient.com. The Company’s web address is provided as 
an inactive textual reference only, and the contents of that 
website are not incorporated in or otherwise to be regarded 
as part of this report. The Company makes available free of 
charge on its website its proxy statement, its annual report 
on Form 10-K, quarterly reports on Form 10-Q, current 
reports on Form 8-K, and amendments to these reports 
filed or furnished pursuant to Section 13(a) or 15(d) of 
the Exchange Act as soon as reasonably practicable after 
such documents are electronically filed with or furnished 
to the Commission. Charters for the Audit, Compensation 
and Development, Nominating and Corporate Governance, 
Finance, and Executive Committees of the Company’s 
Board of Directors, as well as the Company’s Code of 
Conduct, Corporate Governance Guidelines, Policy on 
Recovery of Incentive Compensation From Executives, 
and Directors and Officers Stock Ownership Guidelines 
are also available on the Company’s website. These docu-
ments are also available in print to any shareholder, free 
of charge, upon request. If there are any amendments to 
the Code of Conduct, or if waivers from it are granted for 
executive officers or directors, those amendments or waiv-
ers also will be posted on the Company’s website.

2

Description of Business
The Company is a leading global manufacturer and mar-
keter of colors, flavors, and fragrances. The Company uses 
advanced technologies at facilities around the world to 
develop specialty food and beverage systems; cosmetic, 
fragrance, pharmaceutical, and nutraceutical ingredients 
and systems; specialty inks and colors; and other specialty 
and fine chemicals. The Company’s customers include 
major international manufacturers representing some of the 
world’s best-known brands.

The Company’s principal products include:

•  flavors, flavor enhancers, ingredients, extracts, and 

bionutrients;

•  fragrances, aroma chemicals, and essential oils;

•  natural ingredients, including dehydrated vegetables and 

other food ingredients;

•  natural and synthetic food and beverage colors;

•  cosmetic colors and ingredients;

•  pharmaceutical and nutraceutical excipients and 

ingredients; and

•  technical colors, specialty inks and colors, and specialty 

dyes and pigments.

The Company’s three reportable segments are the Flavors 
& Fragrances Group and the Color Group, which are 
managed on a product basis, and the Asia Pacific Group, 
which is managed on a geographic basis. The Company’s 
corporate expenses and restructuring and certain other 
costs are included in the “Corporate & Other” category as 
described in this report. Financial information regarding the 
Company’s three reportable segments and the operations 
included within Corporate & Other is set forth in Note 
11, Segment and Geographic Information, in the Notes to 
Consolidated Financial Statements included in this report.

In July 2018, the Company completed the acquisition of 
Mazza Innovation Limited (now known as Sensient Natural 
Extraction Inc.). This acquisition provides the Company 
with an umbrella technology, which supports applications 
for both the Flavors & Fragrances and Color segments.
The Company is in the process of integrating this business, 
and therefore, the Company has included its results in 
Corporate & Other.

Flavors & Fragrances Group
The Company is a global developer, manufacturer, and 
supplier of flavor and fragrance systems for the food, 
beverage, personal care, and household-products industries. 
The Company’s flavor formulations are used in many of 
the world’s best-known consumer products. Under the 
unified brand names of Sensient Flavors, Sensient Natural 
Ingredients, and Sensient Fragrances, the Group is a 
supplier to multinational and regional companies.

The Flavors & Fragrances Group produces flavor and 
fragrance products that impart a desired taste, texture, 
aroma, and/or other characteristics to a broad range of 
consumer and other products. This Group includes the 
Company’s natural ingredients business, which produces 
ingredients for food processors. The main products of the 
Group are systems products, including flavor-delivery 
systems, and compounded and blended products. In 
addition, the Group has strong positions in selected 
ingredient products such as essential oils, natural and 
synthetic flavors, natural extracts, and aroma chemicals. 
The Group serves food and non-food industries. In food 
industries, markets include savory, beverage, and sweet 
flavors, as well as certain bioingredients. In non-food 
industries, the Group supplies fragrance products to the 
personal, home-care, and bioingredients markets.

Operating through its Sensient Natural Ingredients business, 
the Company believes it is the second largest producer 
(by sales) of dehydrated onion and garlic products in the 
United States. The Company is also one of the largest 
producers and distributors of chili powder, paprika, chili 
pepper, and dehydrated vegetables such as parsley, celery, 
and spinach. The Company sells dehydrated products to 
food manufacturers for use as ingredients and also for 
repackaging under private labels for sale to the retail market 
and to the food service industry. Advanced dehydration 
technologies utilized by Sensient Natural Ingredients permit 
fast and effective rehydration of ingredients used in many of 
today’s popular convenience foods.

As of December 31, 2018, the Group’s principal 
manufacturing plants are located in California, Illinois, 
Michigan, Wisconsin, Belgium, China, Costa Rica, Mexico, 
Spain, and the United Kingdom.

Color Group
The Company is a developer, manufacturer, and supplier of 
colors for businesses worldwide. The Company provides 
natural and synthetic color systems for use in foods, 
beverages, pharmaceuticals, and nutraceuticals; colors and 
other ingredients for cosmetics, such as active ingredients, 
solubilizers, and surface treated pigments; pharmaceutical 
and nutraceutical excipients, such as colors, flavors, 
coatings, and nutraceutical ingredients; specialty inks; and 
technical colors for industrial applications.

The Company believes that it is one of the world’s largest 
producers (by sales) of synthetic and natural colors, and 
that it is the world’s largest manufacturer (by sales) of 
certified food colors. The Company sells its synthetic and 
natural colors to domestic and international producers of 
beverages, bakery products, processed foods, confections, 
pet foods, cosmetics, and pharmaceuticals. The Company 
also makes industrial colors, specialty inks, and other dyes 
and pigments used in a variety of non-food applications.

As of December 31, 2018, the Group’s principal 
manufacturing plants are located in Missouri, New Jersey, 
Brazil, Canada, China, France, Germany, Italy, Mexico, 
Peru, Switzerland, and the United Kingdom.

The Color Group operates under the following trade names:

•  Sensient Food Colors (food and beverage colors);

•  Sensient Pharmaceutical Coating Systems 

(pharmaceutical and nutraceutical colors and coatings);

•  Sensient Cosmetic Technologies (cosmetic colors, 

ingredients, and systems);

•  Sensient Imaging Technologies/Sensient Inks  

(specialty inks); and

•  Sensient Industrial Colors (paper colors; and industrial 
colors for plastics, leather, wood stains, antifreeze, 
landscaping, and other uses).

The Company believes that its advanced process technology, 
state-of-the-art laboratory facilities and equipment, world 
class application chemists, and a complete range of synthetic 
and natural color products constitute the basis for its market 
leadership position.

3

  
Asia Pacific Group
The Asia Pacific Group focuses on marketing the 
Company’s diverse product lines in the Pacific Rim under 
the Sensient name. Through these operations, the Company 
offers a full range of products from its Flavors & Fragrances 
Group and Color Group, as well as products developed by 
regional technical teams to appeal to local preferences.

Sales, marketing, and technical functions are managed 
through the Asia Pacific Group’s headquarters, which is 
located in Singapore. Manufacturing operations are located 
in Australia, China, India, Japan, New Zealand, and the 
Philippines. The Asia Pacific Group maintains offices for 
local technical support, as well as sales, in China, India, 
Indonesia, and Thailand, and for research and development 
in Singapore.

Corporate
Corporate provides management, administrative, and 
support services to the Company from its headquarters 
in Milwaukee, Wisconsin. The Company’s corporate 
expenses, restructuring and other costs, and the results of 
Mazza Innovation Limited (now known as Sensient Natural 
Extraction Inc.) are included in the “Corporate & Other” 
category.

Research and Development/Quality Assurance
The development of specialized products and services is 
a complex technical process calling upon the combined 
knowledge and talents of the Company’s research, 
development, and quality assurance personnel. The 
Company believes that its competitive advantage lies in its 
ability to work with its customers to develop and deliver 
high-performance products that address the distinct needs 
of those customers.

The Company’s research, development, and quality 
assurance personnel support the Company’s efforts to 
improve existing products and develop new products 
tailored to customer needs, while providing on-going 
technical support and know-how to the Company’s 
manufacturing activities. The Company employed 769 
people in research and development, quality assurance, 
quality control, and lab technician positions as of 
December 31, 2018.

As part of its commitment to quality as a competitive 
advantage, the Company’s production facilities hold 
various certifications, such as those under the International 
Organization for Standardization (ISO) and those 
recognized by the Global Food Safety Initiative (GFSI), 
including the Safe Quality Food Program (SQF), British 
Retail Consortium (BRC), and Food Safety System 
Certification (FSSC 22000), for certifying the safety and 
quality of its products and production processes.

4

Products and Application Activities
The Company’s strategic focus is on the manufacture and 
marketing of high-performance components that bring life 
to products. Accordingly, the Company devotes considerable 
attention and resources to the development of product 
applications and processing improvements to support its 
customers’ numerous new and reformulated products. The 
majority of the proprietary processes and formulae developed 
by the Company are maintained as trade secrets and protected 
through confidentiality agreements with customers.

Within the Flavors & Fragrances Group, development 
activity is focused on ingredients, flavors, natural extracts, 
and fragrances as well as flavor and fragrance systems 
that are responsive to consumer trends and the processing 
needs of our food and beverage customers. These activities 
include the development of functional ingredient systems for 
foods and beverages, savory flavors, and ingredient systems 
for prepared foods and flavors and ingredients for dairy, 
confectionery, and other applications. The Company believes 
that the development of yeast derivatives and other specialty 
ingredients also provides growth opportunities in bionutrients 
and biotechnology markets, such as probiotics and fermented 
ingredients, including enzymes, vitamins, and amino acids.

Within the Color Group, development activity for food and 
beverage product lines is focused on value-added products 
derived from synthetic dyes and pigments, natural food 
and beverage colors, and color systems. The Company 
also produces a diverse line of colors and ingredients for 
cosmetics, pharmaceutical, and nutraceutical applications, 
specialty inks, and technical colors for industrial applications.

Raw Materials
The Company uses a wide range of raw materials in 
producing its products. Chemicals used to produce 
certified colors are obtained from several domestic and 
foreign suppliers. Raw materials for natural colors, 
such as carmine, beta-carotene, annatto, and turmeric, 
are purchased from overseas and U.S. sources. As of 
March 2018, the Company owns a natural food colorings 
business in Lima, Peru, and has vertically integrated 
production and processing capacity in annatto, carmine, 
and other natural color products.

In the production of flavors and fragrances, the principal 
raw materials include essential oils, aroma chemicals, 
botanicals, fruits, and juices. These raw materials are 
obtained from domestic and foreign suppliers. Flavor 
enhancers and secondary flavors are produced from 
brewers’ yeast and vegetable materials such as corn and 
soybeans. Chili peppers, onion, garlic, and other vegetables 
are acquired under annual contracts with numerous growers 
in the western United States and China.

The Company believes that its ability to reformulate its 
products and the general availability of alternate sources 
of materials would generally enable it to maintain its 
competitive position in the event of an interruption in  
the supply of raw materials from a single supplier.

Foreign Operations
Additional information regarding the Company’s foreign 
operations is set forth in Note 11, Segment and Geographic 
Information in the Notes to Consolidated Financial 
Statements included in this report.

Competition
All Company products are sold in highly competitive markets. 
While no single factor is determinative, the Company’s 
competitive position is based principally on process and 
applications expertise, quality, technological advances 
resulting from its research and development, and customer 
service and support. Because of its highly differentiated 
products, the Company competes with only a few companies 
across multiple product lines, and generally encounters 
different competitors in different product lines.

•   Flavors & Fragrances. Competition in the flavors and 

fragrances industries continues to have an ever increasing 
global nature. Most of the Company’s customers do 
not buy their entire flavor and/or fragrance products 
from a single supplier and the Company does not 
compete with a single supplier in all product categories. 
Competition for the supply of flavors and fragrances 
is based on the development of customized ingredients 
for new and reformulated customer products, as well as 
on quality, customer service, and price. Competition to 
supply dehydrated vegetable products is present through 
several large and small domestic competitors, as well as 
competitors from other countries. Competition for the 
supply of dehydrated vegetables is based principally on 
product quality, customer service, and price. 

•   Color. Competition in the color market is diverse, with 
the majority of the Company’s competitors specializing 
in either synthetic dyes and pigments or natural colors or 
coloring foodstuffs (in Europe). The Company believes 
that it gains a competitive advantage as the only major 
basic manufacturer of a full range of color products, 
including synthetic dyes and pigments as well as natural 
colors. Competition in the supply of cosmetic colors 
and ingredients, specialty inks, and pharmaceutical and 
nutraceutical ingredients and excipients is based on the 
development of customized products and solutions as well 
as quality, customer service, and price. The Company 
believes that its reputation and capacity as a color producer 
as well as its product development and applications 
expertise give it a competitive advantage in these markets.

•    Asia Pacific. The Company offers a broad array of 

products to customers through the Asia Pacific Group. 
Competition is based upon reliability in product quality, 
service, and price as well as technical support available 
to customers.

Patents, Formulae and Trademarks
The Company owns or controls many patents, formulae, 
and trademarks related to its businesses. The businesses 
are not materially dependent upon any particular patent or 
trademark; however, trademarks, patents, and formulae are 
important to the business of the Company.

Employees
As of December 31, 2018, the Company employed 4,113 
persons worldwide.

Regulation
Compliance with government rules regulating discharges 
into the environment, or otherwise relating to the protection 
of the environment, did not have a material adverse effect on 
the Company’s operations for the year covered by this report. 
Current compliance is not expected to have a material adverse 
effect in the next two years. The production, packaging, 
labeling, and distribution of certain of the products of the 
Company in the U.S. are subject to the regulations of various 
federal, state, and local governmental agencies, in particular 
the U.S. Food and Drug Administration. The Company is 
subject to similar regulations in many international markets, 
particularly Europe.

Item 1A. Risk Factors.

As with any business, the Company’s business and 
operations involve risks and uncertainties. In addition to 
the other discussions in this report, particularly those under 
the headings “Management’s Discussion and Analysis 
of Financial Condition and Results of Operation” below 
and “Forward-Looking Statements” above, the following 
factors should be considered:

•   Our recent restructurings may not be as effective as we 
anticipated and we may fail to realize the expected cost 
savings.

From 2014-2017, the Company executed a restructuring 
plan aimed at eliminating underperforming operations, 
consolidating manufacturing facilities, and improving 
efficiencies within the Company. These activities required 
the devotion of significant resources and management 
attention and may pose significant risks. Our ability to 
realize anticipated cost savings may be affected by a 

5

number of factors, including our ability to effectively 
reduce overhead, rationalize manufacturing capacity, and 
effectively produce products at the consolidated facilities. 
Furthermore, our restructurings may not be as effective as 
we anticipated, and we may fail to realize the cost savings 
we expected from these restructurings.

•  The impact of currency exchange rate fluctuation may 

negatively affect our results. 

We report the results of our foreign operations in the 
applicable local currency and then translate those results 
into U.S. dollars at applicable exchange rates. The 
applicable exchange rates between and among foreign 
currencies and the U.S. dollar have fluctuated and will 
continue to do so in the future. These fluctuations have 
impacted our results of operations in recent periods 
as discussed below in more detail under the headings 
“Management’s Discussion and Analysis of Financial 
Condition and Results of Operation.” Such currency 
exchange rate volatility may also adversely impact 
our financial condition or liquidity. While we may 
use forward exchange contracts and foreign currency 
denominated debt to manage our exposure to foreign 
exchange risk, such risk management strategies may 
not be effective and our results of operations could be 
adversely affected.

•  Changes to LIBOR may negatively impact us.

LIBOR, the London interbank offered rate, is the basic rate 
of interest used in lending between banks on the London 
interbank market and is widely used as a reference for 
setting the interest rate on loans globally. We have used 
LIBOR as a reference rate in our revolving loans, term 
loans, asset securitization program, and uncommitted credit 
facilities such that the interest due to our creditors pursuant 
to these loans is calculated using LIBOR. 

LIBOR, in its current form, is currently scheduled to 
disappear in 2021. Before LIBOR ceases to exist, we 
may need to renegotiate our credit agreements that utilize 
LIBOR as a factor in determining the interest rate to 
replace LIBOR with a new standard, which has yet to 
be established. The consequences of these developments 
cannot be entirely predicted, but could result in an 
increase in the cost of our variable rate debt which is 
approximately 40-45% of our total debt. While our policy 
is to manage our interest rate risk by entering into both 
fixed and variable rate debt arrangements, we cannot 
provide assurance that future interest rate changes will not 
have a material negative impact on our business, financial 
position, or operating results.

6

•  In some product lines, most of our sales are made to 

a relatively small number of customers; if we lose any 
of those customers, sales and operating results could 
decline.

In some of our product lines, our sales are concentrated to 
a small number of customers. While we do not currently 
have any single customer that we consider to be significant 
to us as a whole, the loss of a significant customer for a 
particular product line could substantially affect the sales 
and profitability of that line or the business unit that sells 
that product line, which may cause us to re-evaluate that 
line. Those developments could affect our results. In 
addition, the financial condition of our customers may 
adversely affect their ability to buy from us, or to pay for 
products that they have already purchased.

•  Many of our products are used in items for human 

consumption and contact. We may be subject to product 
liability claims and product recalls, which could 
negatively impact our profitability and corporate image.

We sell flavors, fragrances, and colors that are used 
in foods, beverages, pharmaceuticals, cosmetics, 
nutraceuticals, and other items for human consumption 
or contact. These products involve risks such as product 
contamination or spoilage, product tampering, product 
defects, and other adulteration. We may be subject to 
liability if the consumption or use of our products cause 
product damage, injury, illness, or death. In addition, we 
or our customers may need to recall products in the event 
of contamination or product defects.

A significant product defect, product recall, or product 
liability judgment may negatively impact our profitability 
for a period of time depending on publicity, product 
availability, scope, competitive reaction, and consumer 
attitudes. Even if a product liability claim is unsuccessful 
or is not fully pursued, the negative publicity surrounding 
any assertion that our products caused illness, injury, or 
death could adversely affect our reputation with existing 
and potential customers and our corporate image.

•  Consolidation has resulted in customers with increased 

buying power, which can affect our profitability.

Many of our customers have consolidated in recent years 
and we expect the combination trend to continue in many 
business lines. These consolidations have often produced 
large, sophisticated customers with increased buying power 
who are more capable of resisting price increases. If the 
larger size or greater buying power of those customers 
results in additional negotiating strength, the prices we 
are able to charge could be negatively affected and our 
profitability could decline.

•  Intense competition may result in reduced sales and 

profitability.

The industries and markets in which we operate are highly 
competitive. That competition can reduce both our sales 
and the prices at which we are able to sell our products, 
which can negatively affect our profitability.

•  Our sales and profitability are affected by changing 

consumer preferences, changing technologies, and our 
customers’ ability to make and sell to consumers in highly 
competitive markets. 

Although we do not generally make or sell proprietary 
consumer products, many of our products are sold to 
companies that develop and market consumer products. 
Sales of flavors, fragrances, colors, inks, cosmetic 
ingredients, pharmaceutical and nutraceutical excipients 
and ingredients, and many of our other products depend in 
part upon our customers’ ability to create and sell products 
to consumers in highly competitive markets, all of which 
are beyond our control. Our sales could also be affected 
by changing technologies that could impact consumer 
demand for products that contain our products. Therefore, 
we depend upon our customers’ ability to create markets 
for the consumer products that incorporate the products 
that we manufacture. In addition, if we cannot adequately 
anticipate and respond to the needs of our customers as 
they evolve in response to changing consumer preferences 
and new technologies, our results of operations could be 
adversely affected.

•  If we do not maintain an efficient cost structure, our 

profitability could decrease.

Our success depends in part on our ability to maintain 
an efficient cost structure. We regularly initiate cost-
reduction measures that could impact our manufacturing, 
sales, operations, and information systems functions. If we 
do not continue to manage costs and achieve additional 
efficiencies, or we do not successfully implement related 
strategies, our competitiveness and our profits could 
decrease.

•  Commodity, energy, and transportation price volatility 
and increases or material shortages may reduce our 
profits.

We use many different commodities as raw ingredients. 
We also use raw materials whose production is energy 
intensive. In addition, various energy sources are used in 
our production and distribution processes. Commodity and 
energy prices are subject to significant volatility caused 
by market fluctuations, supply and demand, currency 
fluctuation, production and transportation disruption, 
world events, and changes in governmental regulations. 

Commodity and energy price increases will raise both our 
raw material costs and operating costs. We may not be 
able to increase our product prices enough to offset these 
increased costs. Increasing our prices also may reduce sales 
volume and related profitability.

In addition, we obtain some raw materials from a single 
supplier or a limited number of suppliers. Problems 
with those suppliers could affect the availability of 
those materials. Even if there are multiple suppliers of a 
particular raw material, there are occasionally shortages. 
An unavailability or shortage of a raw material could 
negatively affect our operations using that raw material and 
thus adversely affect our results.

•   There are an enormous number of laws and regulations 

applicable to us, our suppliers, and our customers across 
all of our business lines. Compliance with these legal 
requirements is costly to us and can affect our operations 
as well as those of our suppliers and customers. Failure 
to comply could also be costly and disruptive.

Our facilities and products are subject to many laws 
and regulations relating to the environment, health, 
safety, and the content, processing, packaging, storage, 
distribution, quality, and safety of food, drugs, cosmetics, 
other consumer products, specialty inks, and industrial 
colors. These laws and regulations are administered in the 
United States by the Department of Agriculture, the Food 
and Drug Administration, the Environmental Protection 
Agency, the Department of Labor, and other federal and 
state governmental agencies. We, our suppliers, and our 
customers are subject to similar governmental regulation 
and oversight abroad. Compliance with these laws and 
regulations can be complex and costly and affect our, our 
suppliers’ and our customers’ operations. Also, if we, our 
suppliers, or our customers, fail to comply with applicable 
laws and regulations, we could be subject to administrative 
penalties and injunctive relief, civil and criminal remedies, 
fines, and recalls of products. Regulatory action against a 
supplier or customer can create risk for us and negatively 
affect our operations.  

•  Environmental compliance may be costly to us.

Our operations are subject to extensive and stringent 
laws and regulations which pertain to the discharge of 
materials into the environment, handling of materials, 
and disposition of wastes and air emissions. These rules 
operate or will operate at both the federal and state levels 
in the United States, and there are analogous laws at most 
of our overseas locations. Environmental regulations, and 
the potential failure to comply with them, can have serious 
consequences, including the costs of compliance and 
defense; interference with our operations or the ability to 
obtain required permits; civil, criminal, and administrative 
penalties; and negative publicity.

7

 
•  Operating in foreign countries and emerging markets 
exposes us to increased risks, including economic, 
political, and international operation risks. 

We operate, manufacture, and sell our products and obtain 
raw materials in many foreign countries and emerging 
markets. This subjects us to risks that could materially impact 
our operating results, including: difficulties in staffing and 
managing foreign personnel in diverse cultures; transportation 
delays or interruptions; sometimes unpredictable 
regulatory changes; and the effects of international political 
developments and political and economic instability. In 
addition, changes in policies by the United States or foreign 
governments could negatively affect our operating results 
due to changes in duties, tariffs, trade regulations, taxes, 
or limitations on currency or fund transfers. For example, 
changes in the trade relationship between the U.S. and 
China as well as potential regulatory actions by the Chinese 
government may affect the cost of our raw materials and 
products originating in China, the demand for as well as the 
supply of our products manufactured in China or containing 
raw materials from China, and the demand from Chinese 
customers for our products.

•  Brexit may adversely impact the Company’s revenue 

and profits in the short term and long term.

In 2016, the United Kingdom (U.K.) held a referendum in 
which voters approved an exit from the European Union, 
commonly referred to as “Brexit.” The British government 
and the European Union are negotiating the terms of 
the U.K.’s future relationship with the European Union. 
The final terms of the relationship and its impacts on the 
Company remain unclear. The U.K.’s pending exit from the 
European Union, currently scheduled for March 29, 2019, 
has resulted in currency exchange rate fluctuations and 
volatility. Because the Company has production facilities, 
customers, and suppliers in the U.K., the final terms of the 
agreement on the U.K.’s break with the European Union, or 
the absence of such an agreement, could have a significant 
impact on the Company. 

The Company has revenue related to sales of products 
between the U.K. and the European Union or its trade 
agreement partners, and costs related to raw materials 
purchases between the U.K. and the European Union or its 
trade agreement partners.  

Any agreement, or the absence of an agreement related 
to Brexit, could result in an increase in tariffs on all raw 
materials and finished goods moving between the U.K. 
and the European Union. Similarly, any agreement, or the 
absence of an agreement, could result in the U.K. losing 
the benefit of existing trade agreements between the 
European Union and other non-European Union countries, 
thereby increasing tariffs on all raw materials and finished 
goods moving between the U.K. and those non-European 

8

Union countries. An increase in tariffs could increase the 
cost to produce and sell the Company’s products, reduce 
the supply of and demand for the Company’s products, and 
reduce the Company’s revenue and profit. In both the short 
and long term, increased costs could make the Company 
less competitive with companies not impacted by post-
Brexit tariffs and, given the nature of our industry, could 
result in the short term and long term loss of customers that 
choose to introduce new products or reformulate existing 
products with our lower-cost competitors. 

A new border between the U.K. and the European Union 
could also impose increased cost, complexity, and delays 
(perhaps lengthy, particularly in the second and third quarters 
of 2019) related to the shipping and transportation of raw 
materials and finished products into and out of the U.K. 
These delays will complicate the Company’s production 
and distribution planning and, like increased tariffs, could 
adversely affect the Company’s revenue and profit, supply 
and demand for the Company’s products, and customer 
retention and acquisition in both the long term and short term.

Additionally, post-Brexit, new chemical regulations could 
be imposed within the U.K. to replace existing European 
Union regulations such as REACH. Similarly, because 
the U.K. will no longer be part of the European Union, 
the Company may be subject to new REACH registration 
requirements for products produced in the U.K. The costs 
related to compliance with these regulatory changes could 
affect the Company’s costs, revenue, profit, supply of and 
demand for the Company’s products, and the acquisition 
and retention of customers. 

Next, there could be new restrictions on travel and immigration 
that result from Brexit that could impose additional costs on 
the Company. In each of the Company’s three U.K. production 
facilities, a significant portion of the work forces are not 
U.K. nationals. Complying with new immigration regimes 
could result in increased costs to the Company.

Finally, while the Company will take steps to mitigate the 
effects of Brexit, these efforts may not be as successful as 
intended and the Company may not be able to avoid the 
costs and complications described above.

•  We depend on certain key personnel, and the loss of  

these persons may harm our business.

Our success depends in large part on the continued service 
and availability of our key management and technical 
personnel, and on our ability to attract and retain qualified 
new personnel. The competition for these individuals can 
be significant, and the loss of key employees could harm 
our business. In addition, we need to provide for smooth 
transitions when replacing key management and technical 
personnel positions. Our operations and results may be 
negatively affected if we are not able to do so.

•  We may not successfully complete and integrate past  
and future acquisitions, which could adversely affect  
our operating results.

We have acquired many companies and operations in the past 
and may continue growth by acquisition in the future. Our 
future growth through acquisitions could involve significant 
risks that may have a material adverse effect on us. We may 
also be at risk for factors associated with acquisitions that the 
Company has made in the past. Acquired companies may also 
have significant latent liabilities that may not be discovered 
before an acquisition or fully reflected in the price we pay.

We may also need to finance future acquisitions, and the 
terms of any financing, and the need to ultimately repay 
or refinance any indebtedness, may have negative effects 
on us. Acquisitions also could have a dilutive effect on our 
financial results. Acquisitions also generally result in good-
will, which would need to be written off against earnings in 
the future if it becomes impaired.

•  Our ability to successfully maintain and upgrade our 

information technology systems, and to effectively respond 
to failures, disruptions, compromises, or breaches of 
our information technology systems, may affect our 
competitiveness and our profits could decrease.

Our success depends in part on our ability to maintain a 
current information technology platform for our businesses 
to operate effectively, reliably, and securely. We routinely 
review and upgrade our information technology and 
cybersecurity systems in order to better manage, report, 
and protect the information related to our formulas, 
research and development, manufacturing processes, 
trade secrets, sales, products, customers, personnel, and 
other operations. If we do not continue to maintain our 
information technology and cybersecurity platforms and 
successfully implement upgrades to systems to protect our 
vital information, our competitiveness and profits could 
decrease. Because of the nature of our business, and the 
importance of our proprietary information, we face threats 
not only from hackers’ intent on theft and disruption, but 
also from malicious insiders that may attempt to steal 
Company information. Furthermore, our information 
technology systems may be susceptible to failures, 
disruptions, breaches, theft, and other similar cybersecurity 
events. The impact of any such event and the effectiveness 
of our response thereto may adversely affect our operations 
and subject us to increased operating costs, regulatory 
consequences, and reputational harm. While we take 
substantial steps to protect our information and systems 
through cyber security systems, monitoring, auditing, and 
training, these efforts may not always be successful.  

•  World events and natural disasters are beyond our 

control and could affect our results. 

World events can adversely affect national, international, 
and local economies. Economies can also be affected by 
conflicts, natural disasters, epidemics, or other catastrophic 
events. Such events and conditions, as well as uncertainty in 
or impairment of financial markets, have adversely affected 
and could continue to affect our revenues and profitability, 
particularly if they occur in locations in which we or our 
customers have significant operations. In addition, while we 
have manufacturing facilities throughout the world, certain of 
our facilities are the sole manufacturer of a specific product 
and a disruption in manufacturing could lead to increased 
costs of relocating or replacing the production of a product, 
or reformulating a product, which could have an adverse 
effect on our results.

•  Our ability to efficiently manage inventory may not be as 
effective as we anticipate and may adversely impact our 
performance.  

Efficient inventory management is essential to our 
performance. We must maintain appropriate inventory levels 
and product mix to meet customer demand, without incurring 
costs related to storing and holding excess inventory. If 
our inventory management decisions do not accurately 
predict demand or otherwise result in excess inventory, our 
financial results may be adversely impacted by markdowns, 
impairment charges, or other costs related to disposal of 
excess or obsolete inventory. 

•  We could be adversely affected by violations of anti-
bribery and anti-corruption laws and regulations.

Our business is subject to the U.S. Foreign Corrupt Practices 
Act, the United Kingdom Bribery Act, and similar anti-
bribery and anti-corruption laws and regulations in other 
countries where we operate. While the Company maintains 
robust policies to prevent violations of these laws and to 
monitor third party risks, investigating and resolving actual 
or alleged violations of anti-bribery and anti-corruption 
laws is expensive and could negatively impact our results 
of operations or financial condition. Under these laws 
companies may be held liable for the corrupt actions taken 
by their directors, officers, employees, agents, or other 
representatives. We could be subject to substantial civil 
and/or criminal fines and penalties if we or any of our 
representatives fail to comply with these laws, which could 
have a material adverse effect on our business and reputation.  

9

 
•  Our ability to protect our intellectual property rights is 

Asia Pacific:

key to our performance.

U.S. – None.

We protect our intellectual property rights as trade secrets, 
through patents, under confidentiality agreements, and 
through internal and external cyber security systems. We 
could incur significant costs in asserting our intellectual 
property rights or defending ourselves from third party 
intellectual property claims. The laws of some of the 
countries in which we operate do not protect intellectual 
property rights to the same extent as the laws of the United 
States. If other parties were to infringe on our intellectual 
property rights, or if a third party successfully asserted that 
we had infringed on their intellectual property rights, it 
could have an adverse impact on our business. 

Item 1B. Unresolved Staff Comments.

None.

Item 2. Properties.

We lease our corporate headquarters offices, which are 
located at 777 East Wisconsin Avenue, Milwaukee, 
Wisconsin. We own our Color Group headquarters offices 
located in St. Louis, Missouri. We lease our Asia Pacific 
Group headquarters offices located in Singapore. We own 
a part, and lease a part, of our Flavors & Fragrances Group 
headquarters offices located in Hoffman Estates, Illinois. 
As of December 31, 2018, the locations of our production 
properties by reportable segment are as follows:

Color Group:

U.S. – St. Louis, Missouri; and South Plainfield, 
New Jersey*.

International – Jundiai, Brazil*; Kingston, Ontario, 
Canada; Saint Ouen L’Aumone, France; Geesthacht, 
Germany; Reggio Emilia, Italy; Lerma, Mexico; 
Lima, Peru*; Johannesburg, South Africa; Morges, 
Switzerland; and Kings Lynn, United Kingdom.

International – Keysborough, Australia; Guangzhou, 
China*; Mumbai, India*; Hitachi, Japan; Auckland, 
New Zealand; Manila, Philippines*; and Bangkok, 
Thailand*.

* Indicates a leased property at the location.

All properties are owned except as otherwise indicated 
above. All facilities are considered to be in good condition 
(ordinary wear and tear excepted) and suitable and 
adequate for the Company’s requirements.

Item 3. Legal Proceedings.

People of the State of Illinois v. Sensient Flavors LLC

On June 7, 2018, the Attorney General of the State of Illinois 
Office, on her own motion and at the request of the Illinois 
Environmental Protection Agency, filed a Complaint in the 
Lee County Circuit Court against Sensient Flavors LLC 
(“Sensient Flavors”). The Complaint alleges that Sensient 
Flavors’ Amboy, Illinois facility improperly discharged 
wastewater to the City of Amboy’s wastewater treatment 
plant in late 2015 and early 2016, causing the City to violate 
its discharge permit. The Complaint alleged two counts 
against Sensient Flavors for violations of Illinois state law. 

The Company believes the facility’s discharges in question 
were done with the consent of the City of Amboy and in 
compliance with Illinois state law, and that Sensient Flavors 
complied with its wastewater permit, City of Amboy 
ordinances, and applicable Illinois state laws. The Company 
notes that at all times relevant to the matters at issue in the 
Complaint, the City of Amboy accepted Sensient Flavors’ 
wastewater and, in fact, charged Sensient Flavors for 
treating Sensient Flavors’ wastewater. The parties reached 
a settlement agreement in which Sensient Flavors agreed 
to pay a $100,000 fine and enter into a consent decree with 
the State of Illinois. On February 20, 2019, the Lee County 
Circuit Court approved the parties’ settlement agreement.

Flavors & Fragrances Group:

Other Claims and Litigation

U.S. – Livingston and Turlock, California; Amboy, 
Illinois; Harbor Beach, Michigan; and Juneau, 
Wisconsin.

International – Heverlee, Belgium; Qingdao, 
China*; San Jose, Costa Rica*; Celaya and 
Tlalnepantla, Mexico; Granada, Spain; and Wales 
and Milton Keynes, United Kingdom.

10

The Company is subject to various claims and litigation 
arising in the normal course of business. The Company 
establishes reserves for claims and proceedings when it is 
probable that liabilities exist and reasonable estimates of 
loss can be made. While it is not possible to predict the 
outcome of these matters, based on our assessment of the 
facts and circumstances now known, we do not believe that 
these matters, individually or in the aggregate, will have a 
material adverse effect on our financial position. However, 
actual outcomes may be different from those expected and 
could have a material effect on our results of operations or 
cash flows in a particular period.

 
Item 4. Mine Safety Disclosure.

Not applicable.

Executive Officers of the Registrant
The executive officers of the Company and their ages as of February 18, 2019, are as follows:

Name

Paul Manning

Amy M. Agallar

Michael C. Geraghty

Amy Schmidt Jones

John J. Manning

E. Craig Mitchell

Stephen J. Rolfs

Tobin Tornehl

Age

Position

44

41

57

49

50

54

54

45

Chairman, President and Chief Executive Officer

Vice President and Treasurer

President, Color Group 

Vice President, Human Resources and Senior Counsel

Vice President, General Counsel and Secretary

President, Flavors and Fragrances Group

Senior Vice President and Chief Financial Officer

Vice President, Controller and Chief Accounting Officer

The Company has employed all of the individuals named 
above, in substantively their current positions, for at least 
the past five years except as follows: 

•   Mr. Paul Manning has held his present office since April 
21, 2016, and previously served as President and Chief 
Executive Officer (2014 – April 2016).  

•   Ms. Agallar has held her present office since January 
9, 2019. Prior to joining the Company, Ms. Agallar 
was Director – Business Development CIS of Modine 
Manufacturing (June 2018 – December 2018), and 
Director – Global Treasury Operations of Modine 
Manufacturing (2011– June 2018).  

•   Mr. Mitchell has held his present office since September 
17, 2018. Prior to joining the Company, Mr. Mitchell 
served as President and Chief Operating Officer of 
Sekisui Specialty Chemical America, LLC (April 2016 – 
September 2018), and Vice President of Sales, Americas 
of Celanese Corporation (2013 – April 2016).  

•   Mr. Rolfs has held his present position since February 

7, 2015, and previously served as Senior Vice President, 
Administration (July 2013 – February 2015).  

•   Mr. Tornehl has held his present office since November 
10, 2018, and previously served as Director, Finance 
(2008 – November 2018).

•   Ms. Jones has held her present office since April 2, 2018. 
Prior to joining the Company, Ms. Jones was a partner of 
Michael Best & Friedrich LLP (1998 – March 2018).  

Mr. Paul Manning (Chairman, President and Chief 
Executive Officer) and Mr. John J. Manning (Vice 
President, General Counsel and Secretary) are brothers.

•   Mr. John J. Manning has held his present office since 

April 21, 2016, and previously served as Vice President 
and Assistant General Counsel (2013 – April 2016).  

11

PA RT  I I

Item 5. Market for the Registrant’s Common Equity, Related Stockholder Matters, and Issuer Purchases  
of Equity Securities.

The Company’s common stock is listed on the New York 
Stock Exchange under the ticker symbol “SXT.” The only 
market in which the common stock of the Company is listed 
is the New York Stock Exchange.

This graph compares the cumulative total shareholder return 
for the Company’s common stock over the last five years to 
the total returns on the Standard & Poor’s Midcap Specialty 

Chemicals Index (the “S&P Midcap Specialty Chemicals 
Index”), the Standard & Poor’s Midcap Food Products Index 
(the “S&P Midcap Food Products Index”), and the Standard 
& Poor’s 500 Stock Index (the “S&P 500 Index”). The graph 
assumes a $100 investment made on December 31, 2013, 
and reinvestment of dividends. The stock performance shown 
on the graph is not necessarily indicative of future price 
performance.

$250

$200

$150

$100

$50

Sensient  
Technologies 
Corporation

S&P Midcap  
Specialty Chemicals 
Index

S&P Midcap Food 
Products Index

S&P 500 Index

2013  

2014 

2015 

2016 

2017 

2018

Sensient Technologies Corporation
S&P Midcap Specialty Chemicals Index
S&P Midcap Food Products Index
S&P 500 Index

2013
$  100 
100
100
100

2014
$  127
115
146
114

2015
$  134
111
153
115

2016
$  170
139
186
129

2017
$  161
149
195
157

2018
$  126
141
182
150

  Standard & Poor’s and S&P are registered trademarks of Standard & Poor’s Financial Services, LLC.

On August 21, 2014, the Board of Directors authorized the 
repurchase of up to five million shares (2014 Authorization). 
On October 19, 2017, the Board of Directors authorized the 
repurchase of up to three million shares (2017 Authorization). 
As of February 18, 2019, all five million shares had been 
repurchased under the 2014 Authorization and 774,974 
shares had been repurchased under the 2017 Authorization. 
There were no repurchases of shares by the Company during 
the fourth quarter of 2018 and a total of 1,060,000 shares 
repurchased during 2018, which were purchased under the 
2017 and 2014 Authorizations. There is no expiration date 
for the 2017 Authorization. The 2017 Authorization may 

12

be modified, suspended, or discontinued by the Board of 
Directors at any time. As of December 31, 2018, the maxi-
mum number of shares that may be purchased under publicly 
announced plans is 2,225,026. 

The number of shareholders of record on February 15, 2019, 
was 2,282.

Information regarding the Company’s equity compensation 
plans is incorporated by reference into Item 11 of Part III  
of this report.

 
Item 6. Selected Financial Data.

The following selected financial data is derived from our consolidated financial statements. This data should be read in 
conjunction with the consolidated financial statements and notes thereto, and with Item 7, Management’s Discussion and 
Analysis of Financial Condition and Results of Operations. 

Quarterly Data

(in thousands except per share amounts) 
(unaudited)

First
Quarter

Second
Quarter

Third
Quarter

Fourth
Quarter

Full
Year

2018

Revenue
Gross profit
Net earnings
Earnings per basic share
Earnings per diluted share

2017

Revenue
Gross profit
Net earnings
Earnings per basic share
Earnings per diluted share

$356,477
123,071
38,194
0.89 
0.89

$341,397
120,945
13,192
0.30 
0.30

$363,041
121,470
39,123
0.93
0.92

$338,475
119,225
30,774
0.70
0.69

$342,734
115,573
47,193
1.12
1.12

$353,519
122,735
32,213
0.74
0.73

$324,563
106,015
32,850
0.78
0.78

$328,874
112,585
13,421
0.31
0.31

$1,386,815
466,129
157,360
3.71
3.70

$1,362,265
475,490
89,600
2.05
2.03

13

Five Year Review

(in thousands except percentages, employee and per share data)

Years ended December 31,
Summary of Operations
Revenue
Cost of products sold
Selling and administrative expenses
Operating income
Interest expense
Earnings before income taxes 
Income taxes
Earnings from continuing operations 
Gain (loss) from discontinued operations, net of tax
Net earnings
Earnings per basic share:
  Continuing operations
  Discontinued operations
  Earnings per basic share
Earnings per diluted share:
  Continuing operations
  Discontinued operations
  Earnings per diluted share
Other Related Data
Dividends per share, declared and paid
Average common shares outstanding:

  Basic
  Diluted

Book value per common share
Price range per common share
Share price at December 31
Capital expenditures
Depreciation
Amortization
Total assets
Long-term debt
Total debt
Shareholders’ equity
Return on average shareholders’ equity
Total debt to total capital 
Employees

2018

$1,386,815
920,686
262,751
203,378
21,853
181,525
24,165
157,360
              –
$   157,360

$        3.71
        –
$        3.71

$        3.70
       –
$        3.70

$        1.35

42,404
42,499
$      20.34
51.93 - 78.40
55.85
50,740
50,950
2,294
1,824,940
689,553
709,599
859,947

18.8%
45.2%
4,113

100.0%
66.4
18.9
14.7%

2017

$1,362,265
886,775
307,684
167,806
19,383
148,423
58,823
89,600
              –
$     89,600

$        2.05
       –
$        2.05

$        2.03
       –
$        2.03

$        1.23

43,780
44,031
$      19.70
71.21 - 84.98
73.15
56,344
46,956
1,562
1,724,340
604,159
624,289
852,301

10.3%
42.3%
4,023

100.0%
65.1
22.6
12.3%

100.0%

65.6

21.0

13.4%

100.0%

67.0

20.9

12.1%

100.0%

66.3

24.7

9.0%

2016

$1,383,210

907,783

289,818

185,609

18,324

167,285

44,372

122,913

3,343

$   126,256

$        2.76

        0.08

$        2.84

$        2.74

        0.07

$        2.82

$        1.11

44,523

44,843

$      18.83

52.69 - 83.38

78.58

81,216

45,714

1,305

1,667,860

582,780

603,358

835,741

14.7%

41.9%

4,083

2015

$1,375,964

921,531

288,092

166,341

16,945

149,396

42,149

107,247

(462)

$   106,785

$        2.34

  (0.01)

$        2.33

$        2.32

  (0.01)

$        2.31

$        1.04

45,910

46,204

$      18.78

56.71 - 70.53

62.82

79,941

46,694

1,245

1,703,732

613,502

634,157

845,127

11.6%

42.9%

4,032

2014

$1,447,821

959,311

357,845

130,665

16,067

114,598

32,827

81,771

(8,125)

$     73,646

$        1.69

  (0.17)

$        1.52

$        1.67

(0.17)

$        1.51

$        0.98

48,525

48,819

$      21.94

46.08 - 63.35

60.34

79,398

50,225

1,231

1,772,039

450,548

466,436

1,046,935

6.4%

30.8%

4,053

The 2018 results include $6.6 million ($0.16 per share) of tax benefit related to the finalization of provisional estimates made 
during 2017 as a result of the 2017 enactment of the Tax Cuts and Jobs Act (2017 Tax Legislation).  

The 2017 results include charges of $48.1 million ($42.5 million after tax, or $0.96 per share) related to the restructuring and other 
divestiture costs, as well as $18.4 million of tax expense ($0.42 per share) related to the enactment of the 2017 Tax Legislation 
in the fourth quarter of 2017. The restructuring costs pertain to the Company’s now completed 2014 Restructuring Plan related 
to the sale and/or elimination of underperforming operations, consolidation of manufacturing facilities, and efforts to improve 
efficiencies within the Company. The other costs pertain to the sale of a facility and certain related business lines within the 
Flavors & Fragrances segment in Strasbourg, France, which was completed in January 2017.

The 2016 results include charges of $26.1 million ($21.1 million after tax, or $0.47 per share) related to the restructuring and other 
divestiture costs. The restructuring costs pertain to the 2014 Restructuring Plan related to eliminating underperforming operations, 

14

 
 
100.0%

66.4

18.9

14.7%

100.0%

65.1

22.6

12.3%

Five Year Review

(in thousands except percentages, employee and per share data)

Gain (loss) from discontinued operations, net of tax

Years ended December 31,

Summary of Operations

Revenue

Cost of products sold

Selling and administrative expenses

Operating income

Interest expense

Earnings before income taxes 

Income taxes

Earnings from continuing operations 

Net earnings

Earnings per basic share:

  Continuing operations

  Discontinued operations

  Earnings per basic share

Earnings per diluted share:

  Continuing operations

  Discontinued operations

  Earnings per diluted share

Other Related Data

Dividends per share, declared and paid

Average common shares outstanding:

  Basic

  Diluted

Book value per common share

Price range per common share

Share price at December 31

Capital expenditures

Depreciation

Amortization

Total assets

Long-term debt

Total debt

Shareholders’ equity

Return on average shareholders’ equity

Total debt to total capital 

Employees

2018

$1,386,815

920,686

262,751

203,378

21,853

181,525

24,165

157,360

              –

$   157,360

$        3.71

        –

$        3.71

$        3.70

       –

$        3.70

$        1.35

42,404

42,499

$      20.34

51.93 - 78.40

55.85

50,740

50,950

2,294

1,824,940

689,553

709,599

859,947

18.8%

45.2%

4,113

2017

$1,362,265

886,775

307,684

167,806

19,383

148,423

58,823

89,600

              –

$     89,600

$        2.05

       –

$        2.05

$        2.03

       –

$        2.03

$        1.23

43,780

44,031

$      19.70

71.21 - 84.98

73.15

56,344

46,956

1,562

1,724,340

604,159

624,289

852,301

10.3%

42.3%

4,023

100.0%
67.0
20.9
12.1%

100.0%
65.6
21.0
13.4%

2016

$1,383,210
907,783
289,818
185,609
18,324
167,285
44,372
122,913
3,343
$   126,256

$        2.76
        0.08
$        2.84

$        2.74
        0.07
$        2.82

$        1.11

44,523
44,843
$      18.83
52.69 - 83.38
78.58
81,216
45,714
1,305
1,667,860
582,780
603,358
835,741

14.7%
41.9%
4,083

2015

$1,375,964
921,531
288,092
166,341
16,945
149,396
42,149
107,247
(462)
$   106,785

$        2.34
  (0.01)
$        2.33

$        2.32
  (0.01)
$        2.31

$        1.04

45,910
46,204
$      18.78
56.71 - 70.53
62.82
79,941
46,694
1,245
1,703,732
613,502
634,157
845,127

11.6%
42.9%
4,032

100.0%
66.3
24.7
9.0%

2014

$1,447,821
959,311
357,845
130,665
16,067
114,598
32,827
81,771
(8,125)
$     73,646

$        1.69
  (0.17)
$        1.52

$        1.67
(0.17)
$        1.51

$        0.98

48,525
48,819
$      21.94
46.08 - 63.35
60.34
79,398
50,225
1,231
1,772,039
450,548
466,436
1,046,935

6.4%
30.8%
4,053

consolidating manufacturing facilities, and improving efficiencies within the Company, and the other costs pertain to the 
Company’s divestiture in Strasbourg, France.

The 2015 results include charges of $43.6 million ($33.6 million after tax, or $0.73 per share) related to the restructuring and other 
acquisition related costs. The restructuring costs pertain to the 2014 Restructuring Plan related to eliminating underperforming 
operations, consolidating manufacturing facilities, and improving efficiencies within the Company, and the other costs 
pertain to acquisition related costs.

The 2014 results include charges of $90.6 million ($65.5 million after tax, or $1.34 per share) related to the restructuring 
and other proxy contest costs. The restructuring costs pertain to the 2014 Restructuring Plan related to eliminating 
underperforming operations, consolidating manufacturing facilities, and improving efficiencies within the Company,  
and the other costs pertain to proxy contest costs.

15

 
 
Item 7. Management’s Discussion and Analysis of 
Financial Condition and Results of Operations.

RESULTS OF CONTINUING OPERATIONS
2018 vs. 2017

OVERVIEW
Sensient Technologies Corporation (the Company or 
Sensient) is a global developer, manufacturer, and supplier 
of flavor and fragrance systems for the food, beverage, 
personal care, and household-products industries. The 
Company is also a leading developer, manufacturer, and 
supplier of colors for businesses worldwide. The Company 
provides natural and synthetic color systems for use in 
foods, beverages, pharmaceuticals and nutraceuticals; 
colors, inks, and other ingredients for cosmetics, 
pharmaceuticals, nutraceuticals and digital printing; and 
technical colors for industrial applications. The Company’s 
three reportable segments are the Flavors & Fragrances 
Group and the Color Group, which are managed on 
a product basis, and the Asia Pacific Group, which is 
managed on a geographic basis. The Company’s corporate 
expenses and restructuring and other costs are included in 
the “Corporate & Other” category.

In July 2018, the Company completed the acquisition of 
Mazza Innovation Limited (now known as Sensient Natural 
Extraction Inc.). This acquisition provides the Company 
with an umbrella technology, which supports applications 
for both the Flavors & Fragrances and Color segments. 
The Company is in the process of integrating this business, 
and therefore, the Company has included its results in 
Corporate & Other.

The Company’s diluted earnings per share from continuing 
operations were $3.70 in 2018 and $2.03 in 2017. Included 
in the 2017 results were $48.1 million, or $0.96 per share 
net of tax, of restructuring and other costs. There were no 
restructuring or other costs in 2018. Included in the 2018 
and 2017 results, were $6.6 million of a benefit and $18.4 
million of expense, respectively, related to the enactment of 
the Tax Cuts and Jobs Act (Act or 2017 Tax Legislation), 
equating to an impact of a 16 cents per share benefit and 42 
cents per share of expense, respectively. Adjusted diluted 
earnings per share, which exclude these restructuring and 
other costs as well as the impact of the 2017 Tax Legislation, 
were $3.55 in 2018 and $3.42 in 2017 (see discussion below 
regarding non-GAAP financial measures and the Company’s 
restructuring activities, divestiture and income taxes).

Since 1962, the Company has paid, without interruption, 
a quarterly cash dividend. In the fourth quarter of 2018, 
the Company increased the quarterly dividend by 3 cents 
per share from 33 cents to 36 cents per share, or $1.44 per 
share on an annualized basis. In addition, the Company 
repurchased $76.7 million of Company stock in 2018, which 
is in addition to the $87.2 million repurchased in 2017.

Additional information on the results is included below.

16

Revenue
Sensient’s revenue was approximately $1.4 billion in 2018 
and 2017. 

Gross Profit
The Company’s gross margin was 33.6% in 2018 and 
34.9% in 2017. Included in the cost of products sold are 
$2.9 million of restructuring costs for 2017. The decrease 
in gross margin is primarily a result of higher raw material 
costs and the unfavorable impact of product mix, partially 
offset by higher selling prices. Restructuring costs reduced 
gross margin by 20 basis points in 2017.

Selling and Administrative Expenses
Selling and administrative expense as a percent of revenue 
was 18.9% in 2018 and 22.6% in 2017, respectively. 
Restructuring and other costs of $45.2 million in 2017 were 
included in selling and administrative expense. Selling and 
administrative expense as a percent of revenue was lower 
in 2018 than in 2017 primarily as a result of the 2017 
restructuring and other costs and lower performance based 
executive compensation in 2018. Restructuring and other 
costs increased selling and administrative expense as a 
percent of revenue by 330 basis points in 2017.

Operating Income
Operating income was $203.4 million in 2018 and $167.8 
million in 2017. Operating margins were 14.7% in 2018 
and 12.3% in 2017. Restructuring and other costs reduced 
operating margins by 350 basis points in 2017.

Additional information on segment results can be found in 
the Segment Information section.

Interest Expense
Interest expense was $21.9 million in 2018 and $19.4 million 
in 2017. The increase in expense was primarily due to the 
increase in average debt outstanding.

Income Taxes 
The effective income tax rate was 13.3% in 2018 and 39.6% 
in 2017. The effective tax rates in both 2018 and 2017 
were impacted by changes in estimates associated with the 
finalization of prior year foreign and domestic tax items, 
audit settlements, adjustments to valuation allowances and 
mix of foreign earnings. The effective tax rate in 2018 was 
also favorably impacted by U.S. tax accounting method 
changes that were filed with the IRS in the second quarter 
of 2018 and generation of foreign tax credits during 2018. 
The 2017 effective tax rate was impacted by the limited tax 
deductibility of losses, the result of the cumulative foreign 
currency effect related to certain repatriation transactions,  
and restructuring and other activities.

On December 22, 2017, the U.S. enacted the 2017 Tax 
Legislation. The Act significantly changed U.S. corporate 
income tax laws by reducing the U.S. corporate income 
tax rate to 21% beginning in 2018 and creating a territorial 
tax system with a one-time mandatory tax on previously 
deferred foreign earnings of U.S. subsidiaries. As a result, 
the Company recorded a provisional net tax expense of 
$18.4 million during the fourth quarter of 2017. This amount 
consists of reevaluating the U.S. deferred tax assets 
and liabilities based on the lower corporate income tax 
rate, adjustments to the Company’s foreign tax credit 
carryover, and the one-time mandatory tax on previously 
deferred foreign earnings of U.S. subsidiaries. In 2018, 
the Company finalized its provisional estimates related to 
the Act resulting in an income tax benefit of $6.6 million. 
Sensient considers $11.8 million to be the final net tax 
expense related to the Act.

Rate before 2017 Tax Legislation,  
  restructuring and discrete items
2017 Tax Legislation
Restructuring impact
Discrete items
Reported effective tax rate

2018

20.7%

(3.7%)
–
  (3.7%)
13.3%

2017

24.5%

12.4%
3.9%
  (1.2%)
39.6%

The 2019 effective income tax rate is estimated to be 
between 22.0% and 23.0%, before any discrete items.

Acquisitions
On July 10, 2018, the Company completed the acquisition of  
Mazza Innovation Limited, a botanical extraction business 
with patented solvent-free extraction processes, located in 
Vancouver, Canada. The Company paid $19.8 million of 
cash for this acquisition. The assets acquired and liabilities 
assumed were recorded at their estimated fair values as of 
the acquisition date. The Company acquired net assets of 
$4.0 million and identified intangible assets, principally 
technological know-how, of $6.9 million. The remaining 
$8.9 million was allocated to goodwill. This acquisition 
provides the Company with an umbrella technology, which 
supports applications for both the Flavors & Fragrances 
and Color segments. The Company is still in the process of 
integrating this business, and therefore, the Company has 
included its results in Corporate & Other. 

On March 9, 2018, the Company completed the acquisition 
of certain net assets and the natural color business of Glo- 
beNatural, a natural color company based in Lima, Peru. The  
Company paid $10.8 million of cash for this acquisition. The 
Company acquired net assets of $1.4 million and identified 
intangible assets, principally customer relationships of $2.0 
million, and allocated the remaining $7.4 million to good-
will. These operations are included in the Color segment. 

Restructuring
Between March 2014 and 2017, the Company executed a 
restructuring plan (2014 Restructuring Plan) to eliminate 
underperforming operations, consolidate manufacturing 
facilities, and improve efficiencies within the Company. In 
accordance with GAAP, the Company recorded total restruc-
turing costs of $36.5 million for the year ended December 
31, 2017. No restructuring costs were recorded for the year 
ended December 31, 2018.

Divestiture
In 2016, the Company’s Board of Directors authorized 
management to explore strategic alternatives for a facility 
and certain related business lines within the Flavors & 
Fragrances segment in Strasbourg, France. In 2016, the 
Company recorded a non-cash impairment charge of $10.8 
million, in selling and administrative expense, and incurred 
$0.7 million of outside professional fees and other related 
costs in 2016, as a result of the then anticipated divestiture.

In January 2017, the Company completed this divestiture 
for approximately $12.5 million. The Company recognized 
an additional non-cash loss of $11.6 million in 2017. 

NON-GAAP FINANCIAL MEASURES
Within the following tables, the Company reports certain non-
GAAP financial measures, including: (1) adjusted operating 
income, adjusted net earnings, and adjusted diluted EPS from 
continuing operations (which exclude restructuring and other 
costs as well as the impact of the 2017 Tax Legislation) and 
(2) percentage changes in revenue, operating income, diluted 
EPS, adjusted operating income, and adjusted diluted EPS 
on a local currency basis (which eliminate the effects that 
result from translating its international operations into U.S. 
dollars). The other costs in 2017 are divestiture related costs, 
discussed under “Divestiture” above. 

The Company has included each of these non-GAAP 
measures in order to provide additional information regarding 
our underlying operating results and comparable year-
over-year performance. Such information is supplemental 
to information presented in accordance with GAAP and is 
not intended to represent a presentation in accordance with 
GAAP. These non-GAAP measures should not be considered 
in isolation. Rather, they should be considered together with 
GAAP measures and the rest of the information included in 
this report. Management internally reviews each of these non-
GAAP measures to evaluate performance on a comparative 
period-to-period basis and to gain additional insight into 
underlying operating and performance trends. The Company 
believes that this information can be beneficial to investors 
for the same purposes. These non-GAAP measures may not 
be comparable to similarly titled measures used by other 
companies.

17

(in thousands except per share amounts)
Operating Income from continuing operations (GAAP)
Restructuring – Cost of products sold
Restructuring – Selling and administrative
Other – Selling and administrative (1)
Adjusted operating income

Net Earnings from continuing operations (GAAP) 
Restructuring & other, before tax
Tax impact of restructuring & other
2017 Tax Legislation
Adjusted net earnings

Diluted EPS from continuing operations (GAAP) 
Restructuring & other, net of tax
2017 Tax Legislation
Adjusted diluted EPS

(1)  The other costs are for the divestiture related costs discussed under “Divestiture” above. 

Note: Earnings per share calculations may not foot due to rounding differences.

Twelve Months Ended December 31,

2018

$ 203,378
–
–
–
$ 203,378

$ 157,360
   –
–
(6,634)
$ 150,726

$      3.70
       –
(0.16)
$      3.55

2017

% Change

$ 167,806
2,889
33,627
11,555
$ 215,877

$   89,600
   48,071
   (5,602)
18,446
$ 150,515

$      2.03
       0.96
0.42
$      3.42

21.2%

(5.8%)

75.6%

0.1%

82.3%

   3.8%

The following table summarizes the percentage change in the 2018 results compared to the 2017 results in the respective 
financial measures.

Twelve Months Ended December 31, 2018

Revenue

Flavors & Fragrances 
Color
Asia Pacific
Total Revenue

Operating Income From Continuing Operations

Flavors & Fragrances
Color
Asia Pacific
Corporate & Other
Operating Income from continuing operations
Diluted EPS from continuing operations 

Adjusted operating income(1)
Adjusted diluted EPS(1)

(1) Refer to table above for a reconciliation of these non-GAAP measures.

18

Total

0.0%
5.2%
0.0%
1.8%

(15.7%)
1.4%
0.4%
(64.3%)
21.2%
82.3%

(5.8%)
3.8%

Foreign  
Exchange Rates

Local Currency

1.1%
0.4%
(0.1%)
0.7%

0.0%
1.1%
1.3%
1.4%
0.2%
0.0%

0.7%
0.6%

(1.1%)
4.8%
0.1%
1.1%

(15.7%)
0.3%
(0.9%)
(65.7%)
21.0%
82.3%

(6.5%)
3.2%

SEGMENT INFORMATION
The Company determines its operating segments based on 
information utilized by its chief operating decision maker 
to allocate resources and assess performance. Segment 
performance is evaluated on operating income before any 
applicable restructuring and other costs (which are reported 
in Corporate & Other), interest expense, and income taxes.

In July 2018, the Company completed the acquisition 
of Mazza Innovation Limited (See Acquisitions above 
for further information). This acquisition provides the 
Company with an umbrella technology, which supports 
applications for both the Flavors & Fragrances and Color 
segments. The Company is in the process of integrating  
this business, and therefore, the Company has included its 
results in Corporate & Other.

The Company’s discussion below regarding its operating 
segments has been updated to reflect the Company’s 
disaggregation of revenue, which was adopted in the first 
quarter of 2018, as summarized in Part IV, Item I, Note 11, 
Segment and Geographic Information, of this report.

The Company’s reportable segments consist of the Flavors 
& Fragrances, Color, and Asia Pacific segments.

Flavors & Fragrances
Flavors & Fragrances segment revenue was $746.9 million 
in both 2018 and 2017. Foreign exchange rates increased 
segment revenue by approximately 1% in 2018. Segment 
revenue was consistent with the prior year due to higher 
revenue in Fragrances and Natural Ingredients, mostly 
offset by lower revenue in Flavors. The higher revenue in 
Fragrances is primarily a result of higher selling prices, 
favorable volumes, and favorable exchange rates. The 
higher revenue in Natural Ingredients is primarily a result 
of favorable volumes, partially offset by lower selling 
prices and the impact of the 2017 sale of the European 
Natural Ingredients business as part of the Company’s prior 
restructuring activities. The lower revenue in Flavors was 
primarily a result of lower volumes, partially offset by the 
favorable impact of exchange rates and higher selling prices.

Flavors & Fragrances segment operating income was $96.4 
million in 2018 and $114.3 million in 2017, a decrease 
of approximately 16%. Foreign exchange rates had a 
minimal impact on segment operating income. The lower 
segment operating income was primarily a result of lower 
operating income in Flavors and Natural Ingredients. The 
lower operating income in Flavors was primarily a result of 
lower volumes (primarily at the production site affected by 
last year’s plant consolidation) and product mix, partially 
offset by higher selling prices, lower manufacturing and 
other costs, and lower raw material costs. The lower 
operating income in Natural Ingredients was primarily due 
to higher raw material costs, primarily onion, and lower 

selling prices, partially offset by higher volumes and lower 
manufacturing and other costs. Segment operating income 
as a percent of revenue was 12.9% and 15.3% for 2018 and 
2017, respectively.

Color
Segment revenue for the Color segment was $553.5 
million in 2018 and $526.4 million in 2017, an increase 
of approximately 5%. Foreign exchange rates had a 
minimal impact on segment revenue. The higher segment 
revenue was primarily a result of higher revenue in Food 
& Beverage Colors and Cosmetics. The higher revenue in 
Food & Beverage Colors was primarily a result of higher 
volumes, the impact of the GlobeNatural acquisition 
(approximately 1%), favorable exchange rates, and higher 
selling prices. The higher revenue in Cosmetics was 
primarily a result of higher volumes.

Segment operating income for the Color segment was 
$114.9 million in 2018 and $113.4 million in 2017, 
an increase of approximately 1%. The higher segment 
operating income was primarily a result of higher operating 
income in Cosmetics, partially offset by unfavorable 
product mix and higher raw material costs in Food 
& Beverage Colors. The higher operating income in 
Cosmetics was primarily a result of higher volumes and 
selling prices, favorable product mix, lower raw material 
costs, and the favorable impact of exchange rates, partially 
offset by higher manufacturing and other costs. Foreign 
exchange rates increased segment operating income by 
approximately 1%. Segment operating income as a percent 
of revenue was 20.8% in 2018 compared to 21.5% in 2017.

Asia Pacific
Segment revenue for the Asia Pacific segment was $123.2 
million for both 2018 and 2017. Foreign exchange rates 
had a minimal impact on segment revenues. Segment 
revenue was consistent with the prior year as higher selling 
prices were mostly offset by lower volumes.

Segment operating income for the Asia Pacific segment 
was $20.9 million in 2018 and $20.8 million in 2017, a 
slight increase over the prior year. The slight increase in 
segment operating income was a result of higher selling 
prices, favorable product mix, and favorable exchange 
rates, mostly offset by higher manufacturing and other 
costs. Foreign exchange rates increased segment operating 
income by approximately 1%. Segment operating income 
as a percent of revenue was 16.9% in both 2018 and 2017.

Corporate & Other
The Corporate & Other operating loss was $28.8 million 
in 2018 and $80.7 million in 2017. The lower operating 
loss was primarily a result of the absence in 2018 of the 
restructuring and other costs that were incurred in 2017 and 
lower performance based executive compensation incurred 

19

in 2018. Restructuring and other costs were $48.1 million 
in 2017. There were no restructuring and other costs 
incurred in 2018.

RESULTS OF CONTINUING OPERATIONS

2017 vs. 2016

Revenue
Sensient’s revenue was approximately $1.4 billion in both 
2017 and 2016. 

Gross Profit
The Company’s gross margin was 34.9% in 2017 and 
34.4% in 2016. Included in the cost of products sold are 
$2.9 million and $2.1 million of restructuring costs for 
2017 and 2016, respectively. The increase in the gross 
margin was primarily a result of higher selling prices 
and the favorable impact of a divestiture (See Note 13, 
Restructuring Charges, and Note 15, Divestiture), partially 
offset by higher raw material and manufacturing costs. 
Restructuring costs reduced gross margin by 20 basis  
points and 10 basis points in 2017 and 2016, respectively.

Selling and Administrative Expense
Selling and administrative expense as a percent of revenue 
was 22.6% in 2017 and 21.0% in 2016. Restructuring and 
other costs of $45.2 million and $24.0 million for 2017 and 
2016, respectively, were included in selling and administrative 
expense. Selling and administrative expense as a percent 
of revenue was higher in 2017 than in 2016 primarily as a 
result of higher restructuring and other costs, partially offset 
by lower performance based executive compensation and 
professional fees. Restructuring and other costs increased 
selling and administrative expense as a percent of revenue 
by 330 basis points and 180 basis points in 2017 and 2016, 
respectively.

Operating Income
Operating income was $167.8 million in 2017 and $185.6 
million in 2016. Operating margins were 12.3% in 2017 
and 13.4% in 2016. Restructuring and other costs reduced 
operating margins by 350 basis points and 190 basis points in 
2017 and 2016, respectively.

Additional information on segment results can be found in 
the Segment Information section.

Interest Expense
Interest expense was $19.4 million in 2017 and $18.3 
million in 2016. The increase in expense was primarily 
due to the increase in average debt outstanding.

Income Taxes
The effective income tax rate was 39.6% in 2017 and 
26.5% in 2016. The effective tax rates in both 2017 and 
2016 were impacted by restructuring and other activities, 
changes in estimates associated with the finalization 

20

of prior year foreign and domestic tax items, audit 
settlements, adjustments to valuation allowances, and 
mix of foreign earnings. The effective tax rate in 2017 
was also impacted by the limited tax deductibility of 
losses and the result of the cumulative foreign currency 
effect related to certain repatriation transactions.

On December 22, 2017, the U.S. enacted the 2017 Tax 
Legislation. The Act significantly changed U.S. corporate 
income tax laws by reducing the U.S. corporate income 
tax rate to 21% beginning in 2018 and creating a territorial 
tax system with a one-time mandatory tax on previously 
deferred foreign earnings of U.S. subsidiaries. As a result, the 
Company recorded a net charge of $18.4 million during the 
fourth quarter of 2017. This amount consisted of reassessing 
the U.S. deferred tax assets and liabilities based on the lower 
corporate income tax rate, adjustments to the Company’s 
foreign tax credit carryover, and the one-time mandatory tax 
on previously deferred foreign earnings of U.S. subsidiaries.

Although the Company believed that $18.4 million was 
a reasonable estimate of the 2017 Tax Legislation, it was 
considered a provisional estimate. The Company received 
additional guidance on the 2017 Tax Legislation in 2018, and 
adjusted this provisional estimate during the third and fourth 
quarters of 2018 (See Note 10, Income Taxes). 

Rate before restructuring  
   and discrete items
2017 Tax Legislation
Restructuring impact
Discrete items
Reported effective tax rate

2017
24.5%

12.4%
3.9%
(1.2%)
39.6%

2016
27.7%

–
1.0%
(2.2%)
26.5%

Restructuring
Between March 2014 and 2017, the Company executed a 
restructuring plan to eliminate underperforming operations, 
consolidate manufacturing facilities, and improve 
efficiencies within the Company. In accordance with 
GAAP, the Company recorded total restructuring costs 
of $36.5 million and $11.1 million for the years ended 
December 31, 2017 and 2016, respectively.

Divestiture
In 2016, the Company’s Board of Directors authorized 
management to explore strategic alternatives for a facility 
and certain related business lines within the Flavors & 
Fragrances segment in Strasbourg, France. In 2016, the 
Company recorded a non-cash impairment charge of $10.8 
million, in selling and administrative expense, and incurred 
$0.7 million of outside professional fees and other related 
costs in 2016, as a result of the then anticipated divestiture.

In January 2017, the Company completed this divestiture 
for approximately $12.5 million. The Company recognized 
an additional non-cash loss of $11.6 million in 2017. 

NON-GAAP FINANCIAL MEASURES
Within the following tables, the Company reports certain 
non-GAAP financial measures, including: (1) adjusted 
operating income, adjusted net earnings, and adjusted 
diluted EPS from continuing operations (which exclude 
restructuring and other costs as well as the impact of 
the 2017 Tax Legislation) and (2) percentage changes in 
revenue, operating income, diluted EPS, adjusted operating 
income, and adjusted diluted EPS on a local currency basis 
(which eliminate the effects that result from translating its 
international operations into U.S. dollars). The other costs 
in 2017 and 2016 are divestiture related costs, discussed 
under “Divestiture” above.

The Company has included each of these non-GAAP 
measures in order to provide additional information 
regarding our underlying operating results and comparable 
year-over-year performance. Such information is 
supplemental to information presented in accordance with 
GAAP and is not intended to represent a presentation 
in accordance with GAAP. These non-GAAP measures 
should not be considered in isolation. Rather, they should 
be considered together with GAAP measures and the rest 
of the information included in this report. Management 
internally reviews each of these non-GAAP measures 
to evaluate performance on a comparative period-to-
period basis and to gain additional insight into underlying 
operating and performance trends. The Company believes 
that this information can be beneficial to investors for 
the same purposes. These non-GAAP measures may not 
be comparable to similarly titled measures used by other 
companies.

(in thousands except per share amounts)

2017

2016

Operating Income from continuing operations (GAAP)

$167,806

$185,609

% Change

(9.6%)

Twelve Months Ended December 31,

Restructuring - Cost of products sold

Restructuring - Selling and administrative

Other - Selling and administrative (1)

Adjusted operating income

Net Earnings from continuing operations (GAAP) 

Restructuring & other, before tax

Tax impact of restructuring & other

Impact of the 2017 Tax Legislature

Adjusted net earnings

Diluted EPS from continuing operations (GAAP) 

Restructuring & other, net of tax

2017 Tax Legislation

Adjusted diluted EPS

2,889

33,627

11,555

2,065

12,486

11,535

$215,877

$211,695

   2.0%

$  89,600

   48,071

(5,602)

18,446

$122,913

   26,086

   (4,999)

–

   (27.1%)

$150,515

$144,000

   4.5%

$      2.03

       0.96

0.42

$      2.74

       0.47

–

   (25.9%)

$      3.42

$      3.21

    6.5%

(1)  The other costs in 2017 and 2016 are for the divestiture related costs discussed under “Divestiture” above.

Note: Earnings per share calculations may not foot due to rounding differences

21

The following table summarizes the percentage change in the 2017 results compared to the 2016 results in the respective 
financial measures.

Revenue

Flavors & Fragrances 
Color
Asia Pacific
Total Revenue

Operating Income From Continuing Operations

Flavors & Fragrances
Color
Asia Pacific
Corporate & Other
Operating Income from continuing operations
Diluted EPS from continuing operations

Adjusted operating income (1)
Adjusted diluted EPS (1)

(1) Refer to table above for a reconciliation of these non-GAAP measures.

SEGMENT INFORMATION
The Company determines its operating segments based 
on information utilized by its chief operating decision 
maker to allocate resources and assess performance. 
Segment performance is evaluated on operating income 
before restructuring and other costs (which are reported in 
Corporate & Other), interest expense, and income taxes.

The Company’s reportable segments consist of the 
Flavors & Fragrances, Color, and Asia Pacific segments. 

Beginning in the first quarter of 2017, the results of 
operations for certain of the Company’s cosmetic and 
fragrance businesses in the Asia Pacific segment are now 
reported in the Color segment and Flavors & Fragrances 
segment, respectively. In addition, the Color segment 
reassigned customer accounts and revised cost allocations 
amongst the businesses within their segment resulting 
in changes in the underlying components of segment 
revenue and segment operating income. The results for 
2016 have been restated to reflect these changes. 

The Company’s discussion below regarding its operating 
segments has been updated to reflect the Company’s 
disaggregation of revenue, which was adopted in the first 
quarter of 2018, as summarized in Part IV, Item I, Note 
11, Segment and Geographic Information, of this report.

22

          Twelve Months Ended December 31, 2017

Total

Foreign  
Exchange Rates

Local 
Currency

(6.1%)
4.4%
1.6%
(1.5%)

(7.8%)
7.2%
(12.0%)
18.9%
(9.6%)
(25.9%)

2.0%
6.5%

0.0%        
0.9%
0.8%
0.5%

(0.4%)
0.6%
1.1%
0.1%
0.2%
0.0%

0.2%
0.3%

(6.1%)
3.5%
0.9%
(2.0%)

(7.4%)
6.5%
(13.1%)
18.7%
(9.8%)
(25.9%)

1.8%
6.2%

Flavors & Fragrances
Segment revenue for the Flavors & Fragrances segment 
was $746.9 million in 2017 and $795.8 million in 2016, 
a decrease of approximately 6%. Foreign exchange did 
not have a material impact on revenue. The decrease in 
revenue was primarily due to lower revenue in Flavors 
and Natural Ingredients. The lower segment revenue in 
Flavors was primarily due to the divestiture and lower 
volumes, partially offset by higher selling prices. The 
lower segment revenue in Natural Ingredients was 
primarily due to lower volumes and the divestiture, 
partially offset by higher selling prices.

Segment operating income for the Flavors & Fragrances 
segment was $114.3 million in 2017, and $124.1 million 
in 2016. The lower segment operating income was 
primarily a result of lower segment operating income 
in Flavor and Fragrances. The lower operating income 
in Flavor was primarily due to unfavorable volume 
and product mix, and higher manufacturing and other 
costs, partially offset by higher selling prices. The lower 
operating income in Fragrances was primarily due to 
higher manufacturing and other costs. Segment operating 
margin was 15.3% in 2017 and 15.6% in 2016.

Color
Segment revenue for the Color segment was $526.4 
million in 2017, and $504.1 million in 2016, an increase 

of approximately 4%. The increase in revenue was 
primarily due to higher revenue in non-food colors. The 
higher revenue in non-food colors was primarily due to 
higher volumes, primarily in cosmetic colors, and higher 
selling prices.

Segment operating income for the Color segment was 
$113.4 million in 2017, and $105.8 million in 2016, 
an increase of approximately 7%. The higher segment 
operating income was due to higher segment operating 
income in non-food colors, partially offset by lower 
segment operating income in food and beverage colors. 
The higher operating income for non-food colors was 
primarily due to favorable volume and product mix. The 
lower profit for food and beverage colors was primarily 
due to unfavorable volume and product mix and higher 
manufacturing and other costs, partially offset by higher 
selling prices. Segment operating margin was 21.5% in 
2017 and 21.0% in 2016.

Asia Pacific
Segment revenue for the Asia Pacific segment was 
$123.2 million in 2017, and $121.2 million in 2016, 
an increase of approximately 2%. The higher segment 
revenue was due to higher selling prices, partially offset 
by lower volumes.

Segment operating income for the Asia Pacific segment 
was $20.8 million in 2017, and $23.6 million in 2016, a 
decrease of 12%. The lower segment operating income 
was a result of higher manufacturing and other costs and 
unfavorable volume and product mix, partially offset 
by higher selling prices. Segment operating margin was 
16.9% in 2017 and 19.5% in 2016.

Corporate & Other
The Corporate & Other expenses were $80.7 million 
in 2017 and $67.9 million in 2016, an increase of 
approximately 19%, primarily due to higher restructuring 
and other costs partially offset by lower performance 
based executive compensation and professional services. 
The Company evaluates segment performance before 
restructuring and other costs, and reports all of the 
restructuring and other costs in Corporate & Other. 
Restructuring and other costs were $48.1 million and 
$26.1 million in 2017 and 2016, respectively.

LIQUIDITY AND FINANCIAL POSITION

Financial Condition
The Company’s financial position remains strong. The 
Company is in compliance with its loan covenants calculated 
in accordance with applicable agreements as of December 
31, 2018. In the fourth quarter of 2018, the Company 
amended its accounts receivable securitization program, 
and increased the commitment size from $60 million to $70 
million. See Note 8, Accounts Receivable Securitization, for 
additional information.

The Company expects its cash flow from operations and 
its existing debt capacity can be used to meet anticipated 
future cash requirements for operations, capital expenditures, 
dividend payments, acquisitions, and stock repurchases. The 
impact of inflation on both the Company’s financial position 
and its results of operations has been minimal and is not 
expected to significantly affect 2019 results.

Cash Flows from Operating Activities
Net cash provided by operating activities was $83.5 million 
in 2018; $36.3 million in 2017; and $183.6 million in 
2016. Operating cash flow provided the primary source of 
funds for operating needs, capital expenditures, shareholder 
dividends, acquisitions, and share repurchases. The increase 
in net cash provided by operating activities in 2018 is 
primarily due to the adoption of ASU 2016-15 Statement of 
Cash Flows: Classification of Certain Cash Receipts and 
Cash Payments, which required certain cash receipts related 
to the Company’s accounts receivable securitization (i.e. 
the deferred purchase price) to be classified as investing 
activities. As a result, the Company included $91.1 million, 
$141.5 million, and $35.4 million of cash received as 
deferred purchase price as investing activities, which were 
previously recorded as operating activities, in 2018, 2017, 
and 2016, respectively. The decrease in net cash provided 
by operating activities in 2017 is primarily due to the impact 
of the adoption of ASU 2016-15, higher working capital 
balances, and the timing of tax payments.

Cash Flows from Investing Activities
Net cash provided by (used in) investing activities was 
$14.8 million in 2018; $110.4 million in 2017; and $(36.4) 
million in 2016. Capital expenditures were $50.7 million in 
2018; $56.3 million in 2017; and $81.2 million in 2016. As 
required under ASU 2016-15, the Company included $91.1 
million, $141.5 million and $35.4 million of cash received 
as deferred purchase price under its accounts receivable 
securitization as cash provided by investing activities in 
2018, 2017, and 2016, respectively. In 2018, the Company 
purchased Mazza Innovation Limited, for approximately 
$19.8 million, GlobeNatural for approximately $10.8 
million, and the assets of one other business for an 
immaterial amount. In 2017, the Company sold a facility 
and certain related business lines in Strasbourg, France, 
for approximately $12.5 million, its European Natural 
Ingredients business for a nominal amount, and two other 
production facilities for $10.1 million.   

Cash Flows from Financing Activities
Net cash used in financing activities was $98.7 million in 
2018; $153.4 million in 2017; and $128.0 million in 2016. 
The Company had a net increase in debt of $38.2 million 
in 2018; a net decrease in debt of $8.8 million in 2017; and 
a net decrease in debt of $24.5 million in 2016. Sensient 
purchased $76.7 million, $87.2 million, and $50.1 million 
of Company stock, which settled in 2018, 2017, and 2016, 
respectively.

23

The Company has paid uninterrupted quarterly cash 
dividends since commencing public trading in its stock in 
1962. In the fourth quarter of 2018, the Company increased 
its quarterly dividend from 33 cents per share to 36 cents per 
share. Dividends paid per share were $1.35 in 2018, $1.23 
cents in 2017, and $1.11 cents in 2016. Total dividends paid 
were $57.4 million, $54.0 million, and $49.6 million in 
2018, 2017, and 2016, respectively.

ISSUER PURCHASES OF EQUITY SECURITIES
Sensient purchased 1.1 million shares of Company stock 
in 2018 for a total cost of $76.7 million; 1.1 million shares 
of Company stock in 2017 for a total cost of $87.2 million; 
and 0.7 million shares of Company stock in 2016 for a 
total cost of $47.5 million. In 2014, the Board approved a 
share repurchase program under which the Company was 
authorized to repurchase five million shares of Company 
stock. In October 2017, the Board of Directors authorized 
the repurchase of up to three million additional shares. As of 
December 31, 2018, 2.2 million shares were available to be 
repurchased under existing authorizations. The Company’s 
share repurchase program has no expiration date. These 
authorizations may be modified, suspended, or discontinued 
by the Board of Directors at any time.

CRITICAL ACCOUNTING POLICIES
In preparing the financial statements in accordance with 
accounting principles generally accepted in the U.S., 
management is required to make estimates and assumptions 
that have an impact on the asset, liability, revenue, and 
expense amounts reported. These estimates can also affect 
supplemental information disclosures of the Company, 
including information about contingencies, risk, and 
financial condition. The Company believes, given current 
facts and circumstances, that its estimates and assumptions 
are reasonable, adhere to accounting principles generally 
accepted in the U.S., and are consistently applied. Inherent 
in the nature of an estimate or assumption is the fact that 
actual results may differ from estimates and estimates may 
vary as new facts and circumstances arise. The Company 
makes routine estimates and judgments in determining the 
net realizable value of accounts receivable, inventories, 
and property, plant, and equipment. Management believes 
the Company’s most critical accounting estimates and 
assumptions are in the following areas:

Revenue Recognition 
The Company recognizes revenue as the transfer of control 
of its products to the Company’s customers in an amount 
reflecting the consideration to which the Company expects 
to be entitled. Revenue is recognized when control of the 
product is transferred to the customer, the customer is 
obligated to pay the Company and the Company has no 
remaining obligations, which is typically at shipment. See 

24

Note 1, Summary of Significant Accounting Policies, in the 
Notes to Consolidated Financial Statements included in this 
report for additional details.

Goodwill Valuation 
The Company reviews the carrying value of goodwill 
annually utilizing several valuation methodologies, 
including a discounted cash flow model. The Company 
completed its annual goodwill impairment test under 
Accounting Standards Codification (ASC) 350,  
Intangibles – Goodwill and Other, in the third quarter 
of 2018. In conducting its annual test for impairment, 
the Company performed a qualitative assessment of its 
previously calculated fair values for each of its reporting 
units, as the Company believes it is not more likely than 
not that goodwill is impaired. Fair value is estimated using 
both a discounted cash flow analysis and an analysis of 
comparable company market values. If the fair value of a 
reporting unit exceeds its net book value, no impairment 
exists. The Company’s three reporting units each had 
goodwill recorded and were tested for impairment. 
All three reporting units had fair values that were over 
100% above their respective net book values. Changes 
in estimates of future cash flows caused by items such as 
unforeseen events or changes in market conditions could 
negatively affect the reporting units’ fair value and result  
in an impairment charge.

Income Taxes 
The Company estimates its income tax expense in each of 
the taxing jurisdictions in which it operates. The Company 
is subject to a tax audit in each of these jurisdictions, which 
could result in changes to the estimated tax expense. The 
amount of these changes would vary by jurisdiction and 
would be recorded when probable and estimable. These 
changes could impact the Company’s financial statements. 
Management has recorded valuation allowances to reduce 
the Company’s deferred tax assets to the amount that is 
more likely than not to be realized. Examples of deferred 
tax assets include deductions, net operating losses, and tax 
credits that the Company believes will reduce its future 
tax payments. In assessing the future realization of these 
assets, management has considered future taxable income 
and ongoing tax planning strategies. An adjustment to the 
recorded valuation allowance as a result of changes in facts 
or circumstances could result in a significant change in the 
Company’s tax expense. The Company does not provide for 
deferred taxes on unremitted earnings of foreign subsidiaries, 
which are considered to be invested indefinitely.

Inventories
Inventories are stated at the lower of cost or net realizable 
value. Cost is determined using the first-in, first-out (FIFO) 
method with the exception of certain locations of the Flavors 
& Fragrances segment where cost is determined using a 
weighted average method. Net realizable value is determined 
on the basis of estimated realizable values. Cost includes 
direct materials, direct labor, and manufacturing overhead.

The Company estimates any required write-downs for 
inventory obsolescence by examining inventories on a 
quarterly basis to determine if there are any damaged items 
or slow moving products in which the carrying values could 
exceed net realizable value. Inventory write-downs are 
recorded as the difference between the cost of inventory and 
its estimated market value. While significant judgment is 
involved in determining the net realizable value of inventory, 
the Company believes that inventory is appropriately stated  
at the lower of cost or net realizable value.

Commitments and Contingencies 
The Company is subject to litigation and other legal 
proceedings arising in the ordinary course of its businesses 
or arising under applicable laws and regulations. Estimating 
liabilities and costs associated with these matters requires the 
judgment of management, who rely in part on information 
from Company legal counsel. When it is probable that the 
Company has incurred a liability associated with claims or 

pending or threatened litigation matters and the Company’s 
exposure is reasonably estimable, the Company records a 
charge against earnings. The Company recognizes related 
insurance reimbursement when receipt is deemed probable. 
The Company’s estimate of liabilities and related insurance 
recoveries may change as further facts and circumstances 
become known.

CONTRACTUAL OBLIGATIONS
The Company is subject to certain contractual obligations, 
including long-term debt, operating leases, manufacturing 
purchases, and pension benefit obligations. The Company 
had unrecognized tax benefits of $4.8 million as of December 
31, 2018. However, the Company cannot make a reasonably 
reliable estimate of the period of potential cash settlement of 
the liabilities and, therefore, has not included unrecognized 
tax benefits in the following table of significant contractual 
obligations as of December 31, 2018.

PAYMENTS DUE BY PERIOD

(in thousands)

Long-term debt

Interest payments on long-term debt

Operating lease obligations

Manufacturing purchase commitments

Pension funding obligations

Total contractual obligations

Total

  1 year

   2-3 years

   4-5 years

   > 5 years

$   689,553

 $  10,963 

 $  27,393  

 $464,008 

 $187,189 

85,401

30,535

107,962

23,732

19,069

9,749 

72,375

1,532

36,642

10,604

35,587

3,099

21,736

5,921  

–

5,534

7,954

4,261

–

13,567

 $937,183 

 $113,688

 $113,325 

 $497,199  

 $212,971  

NEW PRONOUNCEMENTS

Recently Adopted Accounting Pronouncements

In February 2018, the Financial Accounting Standards 
Board (FASB) issued ASU 2018-02, Reclassifications of 
Certain Tax Effects from Accumulated Other Comprehensive 
Income. This ASU allows entities the option to reclassify to 
retained earnings tax effects related to the change in federal 
tax rate for all items accounted for in Accumulated Other 
Comprehensive Income (AOCI). The Company adopted this 
standard in the fourth quarter of 2018, and as a result, has 
elected to reclassify $1.4 million from AOCI to Earnings 
Reinvested in the Business on the Consolidated Statements 
of Shareholders’ Equity as of January 1, 2018.

In March 2017, the FASB issued ASU 2017-07, Improving 
the Presentation of Net Periodic Pension Cost and Net 
Periodic Postretirement Benefit Cost. This ASU requires 
employers to present the service cost component of the 
net periodic benefit cost in the same income statement line 
item as the other employee compensation costs arising from 
services rendered during the period. The other components 

of net periodic benefit cost are to be presented outside of 
any subtotal of operating income. This ASU is effective for 
fiscal years and interim periods beginning after December 
15, 2017. The Company adopted this standard in the first 
quarter of 2018, and as a result, the Company’s non-service 
cost portion of its pension expense is now recorded in 
Interest Expense on the Company’s Consolidated Statement 
of Earnings. The Company’s service cost portion of 
pension expense is recorded in Selling and Administrative 
Expenses on the Company’s Consolidated Statements of 
Earnings. This change did not have a material impact on the 
Company’s consolidated financial statements.

In December 2016, the FASB issued ASU 2016-16, 
Accounting for Income Taxes: Intra-Entity Asset Transfers 
of Assets Other than Inventory. Prior to the adoption of 
ASU 2016-16, the tax effects of intra-entity asset transfers 
were deferred until the transferred asset was sold to a third 
party or otherwise recovered through use. ASU 2016-
16 eliminates the exception for all intra-entity sales of 
assets other than inventory. The guidance is effective for 
fiscal years beginning after December 15, 2017, including 
interim periods within those years. The Company adopted 

25

this standard in the first quarter of 2018 resulting in a 
cumulative effect of $0.4 million increase to Earnings 
reinvested in the business; an increase of $3.0 million to 
Deferred Tax Assets; a decrease of $3.7 million to Prepaid 
Expenses and Other Current Assets; and a decrease of 
$1.1 million to Deferred Tax Liabilities on the Company’s 
Consolidated Balance Sheet. 

In August 2016, the FASB issued ASU 2016-15, Statement 
of Cash Flows: Classification of Certain Cash Receipts 
and Cash Payments. This ASU clarifies how certain cash 
receipts and cash payments are presented and classified 
in the statement of cash flows. Among these changes is 
a requirement that a transferor’s receipt of a beneficial 
interest in securitized trade receivables be disclosed as 
an investing transaction. There is also a requirement to 
classify cash receipts received that are related to beneficial 
interests in previously transferred receivables (i.e., deferred 
purchase price) as inflows from investing activities. The 
guidance is effective for fiscal years beginning after 
December 15, 2017, including interim periods within those 
years. The Company adopted this standard in the first 
quarter of 2018 and has included $91.1 million, $141.5 
million, and $35.4 million as cash flows from investing 
activities for the years ended December 31, 2018, 2017, 
and 2016, respectively, related to collections on beneficial 
interests in previously transferred receivables.  

In May 2014, the FASB issued ASU 2014-09, Revenue from 
Contracts with Customers. Under this new standard, revenue 
is recognized when a customer obtains control of promised 
goods or services in an amount that reflects the consideration 
the entity expects to receive in exchange for those goods 
or services. The requirements of the new standard are 
effective for interim and annual periods beginning after 
December 15, 2017. The Company adopted this standard 
in the first quarter of 2018 using the modified retrospective 
method. The adoption of this new standard did not have an 
impact on the revenue recognized by the Company. The 
Company has updated its revenue recognition accounting 
policy, as outlined above, and has included a disclosure 
on its disaggregated revenue in Note 11, Segment and 
Geographic Information. 

Recently Issued Accounting Pronouncements

In February 2016, the FASB issued ASU No. 2016-02, 
Leases, which requires lessees to recognize the lease assets 
and liabilities that arise from leases on the balance sheet and 
to disclose qualitative and quantitative information about 
lease transactions. This guidance is effective for fiscal years 
beginning after December 15, 2018, including interim peri-
ods within those fiscal years. In 2017, the Company created 
a project team within its Corporate Finance Department to 
review the impact that this ASU will have on the Company. 
During 2018, the project team has gathered and reviewed 
existing leases and other relevant documents across all of 

26

the Company’s segments and installed a software solution 
to facilitate the implementation of this new standard. The 
Company believes it has a complete population of leasing 
agreements and has analyzed the agreements. The Company 
has also implemented additional internal controls over the 
evaluation of new leases and the implementation of this ASU 
around leases. The Company has updated its Audit Com-
mittee on the status of the implementation of this ASU. The 
Company’s current estimate of the impact of this ASU on the 
Company’s Consolidated Financial Statements is the recogni-
tion of lease assets and liabilities in the range of $19 million 
to $22 million based on current interest rates and population 
of leases. The Company will continue to evaluate this range 
and the impact on the Company’s Consolidated Financial 
Statements. The Company expects to finalize its implementa-
tion calculations in the first quarter of 2019.

In August 2017, the FASB issued ASU 2017-12, Targeted 
Improvements to Accounting for Hedging Activities, which 
expands an entity’s ability to hedge non-financial and finan-
cial risk components and reduce complexity in fair value 
hedges of interest rate risk. This guidance eliminates the 
requirement to separately measure and report hedge ineffec-
tiveness and generally requires the entire change in the fair 
value of a hedging instrument to be presented in the same 
income statement line item as the hedged item. This ASU is 
effective for fiscal years and interim periods beginning after 
December 15, 2018. The Company is currently evaluating the 
expected impact of this standard.

In June 2016, the FASB issued ASU 2016-13, Financial 
Instruments - Credit Losses (Topic 326): Measurement of 
Credit Losses of Financial Instruments, which replaces the 
current incurred loss impairment model with a methodol-
ogy that reflects expected credit losses. Under the new 
methodology, entities will be required to measure expected 
credit losses on financial instruments held at amortized cost, 
including trade receivables, based on historical experience, 
current conditions, and reasonable forecasts. Adoption of this 
guidance is required for interim and annual periods begin-
ning after December 15, 2019, with early adoption permitted 
for interim and annual periods beginning after December 
15, 2018. The Company is currently evaluating the expected 
impact of this standard.

In January 2017, the FASB issued ASU 2017-04, Intangibles-
Goodwill and Other (Topic 350): Simplifying the Test for 
Goodwill Impairment, which eliminates step two of the good-
will impairment test and specifies that goodwill impairment 
should be measured by comparing the fair value of a reporting 
unit with its carrying amount. This standard will be applied 
prospectively and is effective for annual or interim goodwill 
impairment tests performed in fiscal years beginning after De-
cember 15, 2019. Early adoption is permitted. The Company 
is currently evaluating the expected impact of this standard.

In August 2018, the FASB issued Accounting Standards Up-
date 2018-13, Fair Value Measurement (Topic 820): Disclo-

sure Framework—Changes to the Disclosure Requirements 
for Fair Value Measurement, which changes the requirements 
on fair value measurements by removing, modifying, or add-
ing certain disclosures. Adoption of this guidance is required 
for interim and annual periods beginning after December 15, 
2019 with early adoption permitted. The Company is cur-
rently evaluating the expected impact of this standard.

Other recently issued accounting pronouncements are not 
expected to have a material impact on the Company’s con-
solidated financial statements.

OFF-BALANCE SHEET ARRANGEMENTS

The Company had no off-balance sheet arrangements as of 
December 31, 2018. 

Item 7A. Quantitative and Qualitative Disclosures 
about Market Risk.

The Company is exposed to market risks, including changes 
in interest rates, currency exchange rates, and commodity 
prices. Where possible, the Company nets certain of these 
exposures to take advantage of natural offsets. For certain 
remaining exposures, the Company may enter into various 
derivative transactions pursuant to the Company’s hedging 
policies. The financial impacts of these hedging instruments 
are offset by corresponding changes in the underlying 
exposures being hedged.

The Company does not hold or issue derivative financial 
instruments for trading purposes. Note 1 and Note 5 to the 
Consolidated Financial Statements include discussions of the 
Company’s accounting policies for financial instruments.

Because the Company manufactures and sells its products 
throughout the world, it is exposed to movements in foreign 
currency exchange rates. The major foreign currency 
exposures include the markets in Western Europe, Latin 
America, Canada, and Asia. The primary purpose of the 
Company’s foreign currency hedging activities is to protect 
against the volatility associated with foreign currency sales, 
purchases of materials, and other assets and liabilities 
created during the normal course of business. The Company 
generally utilizes foreign exchange contracts with durations 
of less than 18 months that may or may not be designated as 
cash flow hedges under ASC 815, Derivatives and Hedging. 
The net fair value of these instruments, based on dealer 
quotes, was an asset of $0.1 million and a liability of $0.6 
million as of December 31, 2018 and 2017, respectively. 
At December 31, 2018, the potential gain or loss in the 
fair value of the Company’s outstanding foreign exchange 
contracts, assuming a hypothetical 10% fluctuation in the 
currencies of such contracts, would be approximately $2.1 
million. However, any change in the value of the contracts, 
real or hypothetical, would be significantly offset by a 
corresponding change in the value of the underlying hedged 

items. In addition, this hypothetical calculation assumes 
that each exchange rate would change in the same direction 
relative to the U.S. dollar.

The Company has certain debt denominated in Euros, 
Swiss Francs, and British Pounds. These non-derivative 
debt instruments act as partial hedges of the Company’s 
Euro, Swiss Franc, and British Pound net asset positions. 
The potential increase or decrease in the annual U.S. dollar 
interest expense of the Company’s outstanding foreign 
currency-denominated debt, assuming a hypothetical 
10% fluctuation in the currencies of such debt, would 
be approximately $0.7 million at December 31, 2018. 
However, any change in interest expense from fluctuations 
in currency, real or hypothetical, would be significantly 
offset by a corresponding change in the value of the foreign 
income before interest. In addition, this hypothetical 
calculation assumes that each exchange rate would change 
in the same direction relative to the U.S. dollar.

The Company manages its debt structure and interest rate 
risk through the use of fixed rate and floating rate debt. The 
Company’s primary exposure is to interest rates in the U.S. 
and Western Europe. At December 31, 2018, the potential 
increase or decrease in annual interest expense, assuming a 
hypothetical 10% fluctuation in interest rates of floating rate 
debt, would be approximately $0.8 million.

The Company is the purchaser of certain commodities, 
such as vanilla, corn, sugar, soybean meal, and fruits. The 
Company generally purchases these commodities based 
upon market prices that are established with the vendor 
as part of the purchase process. In general, the Company 
does not use commodity financial instruments to hedge 
commodity prices due to a high correlation between the 
commodity cost and the ultimate selling price of the 
Company’s products. On occasion, the Company may enter 
into non-cancelable forward purchase contracts, as deemed 
appropriate, to reduce the effect of price fluctuations on 
future manufacturing requirements.

Item 8. Financial Statements and Supplementary Data.

The financial statements required by this item are set forth 
below and the supplementary data required by this item are 
set forth in Item 5 above.

Item 9. Changes in and Disagreements with 
Accountants on Accounting and Financial Disclosure.

None.

Item 9A. Controls and Procedures.

Evaluation of Disclosure Controls and Procedures. The 
Company carried out an evaluation, under the supervision 
and with the participation of management, including the 
Company’s Chairman, President and Chief Executive 

27

Officer and its Senior Vice President and Chief Financial 
Officer, of the effectiveness, as of December 31, 2018, 
of the design and operation of the disclosure controls and 
procedures, as defined in Rule 13a-15(e) of the Exchange 
Act. Based upon that evaluation, the Company’s 
Chairman, President and Chief Executive Officer and its 
Senior Vice President and Chief Financial Officer have 
concluded that the disclosure controls and procedures 
were effective as of December 31, 2018.

Management’s Report on Internal Control over 
Financial Reporting. The management of the Company 
is responsible for establishing and maintaining 
adequate internal control over financial reporting, 
as defined in Rule 13a-15(f) under the Exchange 
Act. It is management’s policy to maintain a control-
conscious environment through an effective system 
of internal accounting controls. These controls are 
supported by the careful selection of competent and 
knowledgeable personnel and by the communication 
of standard accounting and reporting policies and 
procedures throughout the Company. The Company’s 
internal control over financial reporting is designed to 
provide reasonable assurance regarding the reliability 
of financial reporting and the preparation of financial 
statements for external purposes in accordance with 
generally accepted accounting principles. Management 
has assessed the effectiveness of the Company’s internal 
control over financial reporting as of December 31, 2018. 
In making its assessment of internal control over financial 
reporting, management used the criteria set forth by the 
Committee of Sponsoring Organizations of the Treadway 
Commission in Internal Control — Integrated Framework 
(2013 Framework). As allowed by Securities and Exchange 
Commission guidance, management excluded from its 
assessment GlobeNatural and Mazza Innovation Limited, 
which were acquired in 2018 and constituted 2.3% 
and 3.4% of total assets and net assets, respectively, as 
of December 31, 2018, and 0.3% of revenues for the 
year then ended. Based on that assessment, management 
has concluded that the Company’s internal control over 
financial reporting was effective as of December 31, 2018.

The Company’s internal control over financial reporting 
as of December 31, 2018, has been audited by Ernst & 
Young LLP, an independent registered public accounting 
firm. Their opinion on the Company’s internal control 
over financial reporting is included in this report.

Because of its inherent limitations, internal control 
over financial reporting may not prevent or detect 
misstatements. Also, projections of any evaluation of 
effectiveness to future periods are subject to the risk that 
controls may become inadequate because of changes in 
conditions, or that the degree of compliance with the 
policies or procedures may deteriorate.

Changes in Internal Control over Financial Reporting. 
There have been no changes in the Company’s internal 
control over financial reporting during the quarter ended 

28

December 31, 2018, that have materially affected, or are 
reasonable likely to materially affect, the Company’s 
internal control over financial reporting.

Item 9B. Other Information.

None.

PART  I II

Item 10. Directors, Executive Officers of the Registrant, 
and Corporate Governance.

Information required by this item regarding directors 
and officers, corporate governance, and other matters 
appearing under “Election of Directors” and “Section 16(a) 
Beneficial Ownership Reporting Compliance” in the Proxy 
Statement for the Annual Meeting of Shareholders of the 
Company to be filed with the Commission within 120 days 
after December 31, 2018 (“2019 Proxy Statement”), is 
incorporated by reference. Additional information required 
by this item regarding executive officers appears at the end of 
Part I above, and information required by this item regarding 
codes of conduct appear at the beginning of Part I above.

Item 11. Executive Compensation.

Information required by this item relating to compensation 
of directors and officers is incorporated by reference from 
the “Election of Directors,” “Executive Compensation,” 
and “Equity Compensation Plan Information” portions 
of the 2019 Proxy Statement. Information required by 
this item relating to the Compensation and Development 
Committee of the Company’s Board of Directors is 
incorporated by reference from the headings “Compensation 
and Development Committee Report” and “Election of 
Directors” in the 2019 Proxy Statement.

Item 12. Security Ownership of Certain Beneficial 
Owners and Management and Related Stockholder 
Matters.

The information required by this item regarding security 
ownership of certain beneficial owners and management 
and related stockholder matters appearing under “Principal 
Shareholders” in the 2019 Proxy Statement is incorporated 
by reference. The information required by this item 
appearing under “Equity Compensation Plan Information” 
in the 2019 Proxy Statement is incorporated by reference.

Item 13. Certain Relationships and Related 
Transactions and Director Independence.

The information required by this item regarding certain 
relationships and related party transactions and director 
independence appearing at the end of “Election of Directors” 
and under “Transactions With Related Persons” in the 2019 
Proxy Statement is incorporated by reference.

 
Item 14. Principal Accountant Fees and Services.

The disclosure regarding principal accountant fees and services appearing under “Audit Committee Report” in  
the 2019 Proxy Statement is incorporated by reference.

PA RT  I V

Item 15. Exhibits and Financial Statement Schedules.

Documents filed:

1 and 2: 

 Financial Statements and Financial Statement Schedule. See below for “List of Financial Statements 
and Financial Statement Schedule.”

3: 

See Exhibit Index following this report.

List of Financial Statements and Financial Statement Schedule

1.  Financial Statements

The following consolidated financial statements of Sensient Technologies Corporation and subsidiaries are included in this 
annual report on Form 10-K:

  Report of Independent Registered Public Accounting Firm

  Consolidated Balance Sheets – December 31, 2018 and 2017

  Consolidated Statements of Earnings – Years ended December 31, 2018, 2017 and 2016

  Consolidated Statements of Comprehensive Income – Years ended December 31, 2018, 2017 and 2016

  Consolidated Statements of Shareholders’ Equity – Years ended December 31, 2018, 2017 and 2016

  Consolidated Statements of Cash Flows – Years ended December 31, 2018, 2017 and 2016

  Notes to Consolidated Financial Statements

2.  Financial Statement Schedule

  Schedule II – Valuation and Qualifying Accounts

57

32

30

31

34

33

35-56

59

All other schedules are omitted because they are inapplicable, not required by the instructions, or the information is included 
in the consolidated financial statements or notes thereto.

Item 16. Form 10-K Summary.

None.

29

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 CONSOLIDATED STATEMENTS OF EARNINGS

(in thousands except per share amounts)   

Revenue

Cost of products sold

Selling and administrative expenses

Operating income

Interest expense

Earnings before income taxes 

Income taxes

Earnings from continuing operations

Gain from discontinued operations, net of tax

Years Ended December 31,

2018

2017

2016

$1,386,815

$1,362,265

$1,383,210

920,686 

262,751

203,378

21,853

181,525

24,165

157,360

–

886,775

307,684

167,806

19,383

148,423

58,823

89,600

–

907,783

289,818

185,609

18,324

167,285

44,372

122,913

3,343

Net earnings

$   157,360

$     89,600

$   126,256

Earnings per common share:

Basic:

  Continuing operations

  Discontinued operations

  Earnings per common share

Diluted:

  Continuing operations

  Discontinued operations

  Earnings per common share

Weighted average number of common shares outstanding

   Basic

   Diluted

See notes to consolidated financial statements.

$        3.71

$        2.05

$        2.76

–

–

0.08

$        3.71

$        2.05

$        2.84

$        3.70

$        2.03

$        2.74

–

–

0.07

$        3.70

$        2.03

$        2.82

42,404

42,499

43,780

44,031

44,523

44,843

30

 
 
 
 
 
 
CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

(in thousands)

Net earnings

Cash flow hedges adjustment, net of tax of $32, $10 and $89, respectively

Pension adjustment, net of tax of $347, $778 and $785, respectively

Foreign currency translation on net investment hedges

Tax effect of current year activity on net investment hedges

Foreign currency translation on long-term intercompany loans

Tax effect of current year activity on intercompany long-term loans

Reclassification of cumulative translation to net earnings 

Other foreign currency translation

Total comprehensive income 

See notes to consolidated financial statements.

Years Ended December 31,

2018

2017

2016

$157,360 

$  89,600 

$126,256

816

1,027

13,661

(3,393)

3,276

(2,498)

–

(27,721)

(584)

2,228

(28,871)

10,812

7,013

–

6,782

66,751

(249)

1,856

6,989

(2,733)

(494)

–

(3,257)

(45,515)

$142,528

$153,731

$  82,853

31

CONSOLIDATED BALANCE SHEETS

(in thousands except share and per share amounts)  
Assets
Current Assets:
   Cash and cash equivalents
   Trade accounts receivable, less allowance for losses of $5,976 and $6,000, respectively
   Inventories
   Prepaid expenses and other current assets
   Assets held for sale
Total current assets
Other assets
Deferred tax assets
Intangible assets – at cost, less accumulated amortization of $20,325 and $17,432, respectively
Goodwill
Property, Plant and Equipment:
   Land
   Buildings
   Machinery and equipment
   Construction in progress

   Less accumulated depreciation

Total assets

Liabilities and Shareholders’ Equity
Current Liabilities:
   Trade accounts payable
   Accrued salaries, wages and withholdings from employees 
   Other accrued expenses
   Income taxes
   Short-term borrowings

Total current liabilities

Deferred tax liabilities
Other liabilities
Accrued employee and retiree benefits
Long-term debt
Shareholders’ Equity:

Common stock, par value $0.10 a share, authorized 100,000,000 shares; issued 
53,954,874 shares
Additional paid-in capital
Earnings reinvested in the business
Treasury stock, 11,731,223 and 10,759,291 shares, respectively, at cost
Accumulated other comprehensive loss

Total liabilities and shareholders’ equity

See notes to consolidated financial statements.

32

   December 31,

2018

2017

$     31,901
255,350
490,757
44,857
–
822,865
66,788
9,189
18,867
416,175

36,787
318,463
688,003
34,772
1,078,025       
(586,969)
491,056
$1,824,940

$   131,812 
23,410
31,198
8,234
20,046

214,700

28,976
8,554
23,210
689,553

$     29,344
195,439
463,517
43,206
1,969
733,475
68,251
7,885
7,211
408,995

35,198
317,464
687,896
40,833
1,081,391
(582,868)
498,523
$1,724,340

$   109,780 
23,613
51,764
11,036
20,130

216,323

18,724
13,539
19,294
604,159

5,396

5,396

101,663
1,516,243
(597,800)
(165,555)
859,947

107,176
1,414,485
(525,422)
(149,334)
852,301

$1,824,940

$1,724,340

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

Cash Flows from Operating Activities

   Net earnings 

   Adjustments to arrive at net cash provided by operating activities:

      Depreciation and amortization

      Share-based compensation 

      Net loss on assets

Loss on divestiture of business

      Liquidation of foreign entity 

      Deferred income taxes

      Changes in operating assets and liabilities:

         Trade accounts receivable

         Inventories

         Prepaid expenses and other assets

         Accounts payable and other accrued expenses

         Accrued salaries, wages and withholdings from employees

         Income taxes

         Other liabilities

Net cash provided by operating activities

Cash Flows from Investing Activities:

   Acquisition of property, plant and equipment

   Cash receipts on sold receivables  

   Proceeds from sale of assets

Proceeds from divesture of business

   Acquisition of new business

   Other investing activities

Net cash provided by (used in) investing activities

Cash Flows from Financing Activities

   Proceeds from additional borrowings

   Debt payments

   Purchase of treasury stock

   Dividends paid

   Other financing activities

Net cash used in financing activities

Effect of exchange rate changes on cash and cash equivalents

Net increase in cash and cash equivalents

Cash and cash equivalents at beginning of year

Cash and cash equivalents at end of year

Cash paid during the year for:

   Interest

   Income taxes

   Capitalized interest 

See notes to consolidated financial statements.

Years Ended December 31,

2018

2017

2016

$157,360 

$89,600

$126,256

53,244

503

63

–

–

9,844 

(96,638) 

(34,114)

(12,544)

7,457

599

(7,335) 

5,081 

83,520

(50,740)

91,142

2,615

–

(31,100) 

2,916

14,833

322,529

(284,332)

(76,734)

(57,410)

(2,777)

(98,724)

2,928

2,557

29,344

48,518

5,855

2,552

33,160

–

17,414 

(130,835)

(47,345)

14,072

4,804

(4,361)

2,846

27

36,307

(56,344)

141,465

10,485

12,457

–

2,319

110,382

231,174

(239,950)

(87,217)

(54,038)

(3,383)

47,019

7,709

9,755

–

(3,257)

10,428

(4,270)

(20,064)

(4,096)

2,332

3,347

5,959

2,521

183,639

(81,216)

35,414

6,254

–

–

3,184

(36,364)

222,562

(247,092)

(50,100)

(49,635)

(3,706)

(153,414)

(127,971)

10,204

3,479

25,865

(5,436)

13,868

11,997

$  31,901

$  29,344

$  25,865

$  21,567

$  19,523

$  18,474

24,089

604

29,261

486

29,217

1,061

33

CONSOLIDATED STATEMENTS OF SHAREHOLDERS’ EQUITY

(in thousands except share  
and per share amounts)

Common 
Stock

Additional 
Paid-in 
Capital

Earnings 
Reinvested in 
the Business

Treasury Stock

Shares

Amount

Accumulated
Other
Comprehensive
(Loss) Income

Balances at December 31, 2015

$5,396

$109,974

$1,302,302

9,174,843

$(402,483)

$(170,062)

Net earnings

Other comprehensive income (loss)

Cash dividends paid – $1.11 per share

Share-based compensation

Stock options exercised

Non-vested stock issued upon vesting

Benefit plans
Purchase of treasury stock

Other

126,256

(49,635)

(43,403)

7,709

(650)

(7,769)

229

(1,807)

(30,500)

(172,147)

(15,839)
702,698

57,449

1,354

7,769

698
(47,534)

(2,603)

Balances at December 31, 2016

5,396

107,686

1,378,923

9,716,504

(442,799)

(213,465)

Net earnings

Other comprehensive income

Cash dividends paid – $1.23 per share

Share-based compensation

Stock options exercised

Non-vested stock issued upon vesting

Benefit plans
Purchase of treasury stock

Other

89,600

(54,038)

64,131

5,855

(202)

(5,478)

445

(1,130)

(10,667)

(114,393)

(12,999)
1,139,734

41,112

499

5,478

596
(87,217)

(1,979)

Balances at December 31, 2017

5,396

107,176

1,414,485

10,759,291

(525,422)

(149,334)

Net earnings

Other comprehensive income (loss)

Cash dividends paid – $1.35 per share

Share-based compensation

Stock options exercised

Non-vested stock issued upon vesting

Benefit plans
Purchase of treasury stock

Other

157,360

(57,410)

503

(80)

(5,454)

350

(4,000)

(111,185)

(15,126)
1,060,000

(832)

1,808

42,243

(14,832)

(1,389)

200

5,454

769
(76,734)

(2,067)

Balances at December 31, 2018

$5,396

$101,663

$1,516,243

11,731,223

$(597,800)

$ (165,555)

See notes to consolidated financial statements.

34

 
NO TE S  TO  CONSOLIDAT ED  FI N A N C IAL  STATEM ENTS

Years ended December 31, 2018, 2017, and 2016

1. Summary of Significant Accounting Policies

• Identification of the contract, or contracts, with a customer

Nature of Operations 
Sensient Technologies Corporation, together with its 
subsidiaries (the Company or Sensient), is a leading 
global manufacturer and marketer of colors, flavors, and 
fragrances. The Company uses advanced technologies at 
facilities around the world to develop specialty food and 
beverage systems; cosmetic, fragrances, pharmaceutical, 
and nutraceutical systems; specialty inks and colors; and 
other specialty and fine chemicals. The Company’s three 
reportable segments are the Flavors & Fragrances Group 
and the Color Group, which are managed on a product line 
basis, and the Asia Pacific Group, which is managed on 
a geographic basis. The Company’s corporate expenses, 
restructuring and other costs, and the results of Mazza 
Innovation Limited (see Note 2, Acquisitions, for further 
information) are included in the “Corporate & Other” 
category.

Principles of Consolidation and Basis of Presentation 
The consolidated financial statements include the accounts 
of the Company and have been prepared in accordance 
with accounting principles generally accepted in the United 
States of America (GAAP). All significant intercompany 
accounts and transactions have been eliminated in 
consolidation.

The results of operations for one of the Company’s 
business units within the Color Group have been reported 
as a discontinued operation for the period ended December 
31, 2016. See Note 14, Discontinued Operations, for 
further information regarding discontinued operations.

Use of Estimates 
The preparation of the consolidated financial statements 
requires the use of management’s estimates and assumptions 
that affect reported amounts of assets, liabilities, revenue, 
and expenses during the reporting period and the disclosure 
of contingent assets and liabilities at the date of the financial 
statements. Actual results could differ from those estimates.

Revenue Recognition 
The Company recognizes revenue as the transfer of 
control of its products to the Company’s customers in 
an amount reflecting the consideration to which the 
Company expects to be entitled. In order to achieve this 
core principle, the Company applies the following five-
step approach: 

• Identification of the performance obligations in the contract

• Determination of the transaction price

•  Allocation of the transaction price to the performance 

obligations in the contract

•  Recognition of revenue when, or as, the Company satisfies 

the performance obligations

The Company considers customer purchase orders, which 
in some cases are governed by master sales agreements, to 
be the contracts with the customer. For each contract, the 
Company considers the identified performance obligation 
to be the promise to transfer products. In determining the 
transaction price, the Company evaluates whether the price 
is subject to refund or adjustment and then determines the 
net consideration to which the Company expects to be 
entitled. In addition, the Company assesses the customer’s 
ability to pay as part of its evaluation of the contract. 
As the Company’s standard payment terms are less than 
one year, the Company elected the practical expedient 
under Accounting Standards Codification (ASC) 606-10-
32-18, and determined that its contracts do not have a 
significant financing component. The Company allocates 
the transaction price to each distinct product based on the 
relative standalone selling price. Revenue is recognized 
when control of the product is transferred to the customer, 
the customer is obligated to pay the Company, and the 
Company has no remaining obligations, which is typically 
at shipment. In certain locations, primarily outside the 
United States, product shipping terms may vary. Thus, in 
such locations, the point at which control of the product 
transfers to the customer and revenue recognition occurs 
will vary accordingly. 

Customer returns of non-conforming products are 
estimated at the time revenue is recognized. In certain 
customer relationships, volume rebates exist, which are 
recognized according to the terms and conditions of the 
contractual relationship. Customer returns, rebates, and 
discounts are not material to the Company’s consolidated 
financial statements. The Company has elected to recognize 
the revenue and cost for freight and shipping when control 
over the products has transferred to the customer. The 
Company has elected to immediately expense contract 
costs related to obtaining a contract as the amortization 
period of the asset the Company otherwise would have 
recognized would have been less than a year. 

In addition to evaluating the Company’s performance 
based on the segments above, revenue is also disaggregated 
and analyzed by product line and geographic market (See 
Note 11, Segment and Geographic Information, for further 
information).

35

Cost of Products Sold 
Cost of products sold includes materials, labor, and overhead 
expenses incurred in the manufacture of our products. Cost 
of products sold also includes charges for obsolete and slow 
moving inventories, as well as costs for quality control, 
purchasing and receiving costs, inspection costs, warehousing 
costs, internal transfer costs, other costs of our internal 
distribution network, and costs incurred for shipping and 
handling. The Company records fees billed to customers for 
shipping and handling as revenue.

Selling and Administrative Expenses 
Selling and administrative expenses primarily include 
the salaries and related costs for executive, finance, 
accounting, human resources, information technology, 
research and development, and legal personnel as 
well as salaries and related costs of salespersons and 
commissions paid to external sales agents.

Cash Equivalents 
The Company considers all highly liquid investments with 
maturities of three months or less at the date of acquisition 
as cash equivalents.

Accounts Receivable 
Receivables are recorded at their face amount, less an 
allowance for doubtful accounts. The allowance for doubtful 
accounts is based on customer-specific analysis and general 
matters such as current assessments of past due balances 
and economic conditions. Specific accounts are written 
off against the allowance for doubtful accounts when it is 
deemed that the receivable is no longer collectible.

Inventories 
Inventories are stated at the lower of cost or net 
realizable value. Net realizable value is determined 
on the basis of estimated realizable values. Cost is 
determined using the first-in, first-out (FIFO) method 
with the exception of certain locations of the Flavors 
& Fragrances Group where cost is determined using a 
weighted average method. Inventories include finished 
and in-process products totaling $320.4 million and 
$310.4 million at December 31, 2018 and 2017, 
respectively, and raw materials and supplies of $170.4 
million and $153.1 million at December 31, 2018 and 
2017, respectively.

Property, Plant and Equipment 
Property, plant, and equipment are recorded at cost reduced 
by accumulated depreciation. Depreciation is provided 
over the estimated useful life of the related asset using the 
straight-line method for financial reporting. The estimated 
useful lives for buildings and leasehold improvements 
range from 5 to 40 years. Machinery and equipment have 
estimated useful lives ranging from 3 to 20 years. Interest 
costs on significant projects constructed or developed for 
the Company’s own use are capitalized as part of the asset.

36

Goodwill and Other Intangible Assets 
The carrying value of goodwill is evaluated for impairment 
on an annual basis or more frequently when an indicator of 
impairment occurs. The impairment assessment includes 
comparing the carrying amount of net assets, including 
goodwill, of each reporting unit to its respective fair value 
as of the date of the assessment. Fair value was estimated 
based upon an evaluation of the reporting unit’s estimated 
future discounted cash flows as well as the public trading 
and private transaction valuation multiples for comparable 
companies. The Company performed such a quantitative 
analysis in 2016, which indicated a substantial premium 
compared to the carrying value of net assets, including 
goodwill. In 2018 and 2017, the Company completed a 
qualitative assessment in comparison to the quantitative 
assessment performed in 2016, noting no indicators 
of impairment. The Company did not record impairment 
charges for any of its reporting units in 2018, 2017, or 2016.

The cost of intangible assets with determinable useful lives 
is amortized on a straight-line basis to reflect the pattern of 
economic benefits consumed, ranging from 5 to 20 years. 
These assets include technological know-how, customer 
relationships, patents, trademarks, and non-compete 
agreements, among others.

Impairment of Long-lived Assets 
The Company reviews long-lived assets for impairment 
whenever events or changes in business circumstances 
indicate that the carrying amount of the assets may not be 
fully recoverable. The Company performs undiscounted cash 
flow analyses to determine if potential impairment exists. If 
impairment is determined to exist, any related impairment 
loss is calculated based on the difference between fair value 
and carrying value. Impairment losses were recorded as a 
result of the Company’s 2014 Restructuring Plan as well as 
the Company’s divestiture of a facility and certain related 
business lines within the Flavors & Fragrances segment in 
Strasbourg, France. See Note 13, Restructuring Charges, and 
Note 15, Divestiture, for additional information.

Derivative Financial Instruments 
The Company selectively uses derivative financial 
instruments to reduce market risk associated with 
changes in foreign currency and interest rate exposures 
which exist as part of ongoing business operations. 
All derivative transactions are authorized and executed 
pursuant to the Company’s risk management policies and 
procedures, which strictly prohibit the use of financial 
instruments for speculative trading purposes.

The primary objectives of the foreign exchange risk 
management activities are to understand and mitigate 
the impact of potential foreign exchange fluctuations on 
the Company’s financial results and its economic well-
being. Changes in the fair value of derivatives that are 
designated as fair value hedges, along with the gain or 
loss on the hedged item, are recorded in current period 

Translation of Foreign Currencies 
For all significant foreign operations, the functional 
currency is the local currency. Assets and liabilities of 
foreign operations are translated into U.S. dollars at 
current exchange rates. Revenue and expense accounts 
are translated into U.S. dollars at average exchange 
rates prevailing during the year. Adjustments resulting 
from the translation of foreign accounts into U.S. dollars 
are recorded in foreign currency translation in OCI. 
Transaction gains and losses that occur as a result of 
transactions denominated in non-functional currencies are 
included in earnings and were not significant during the 
years ended December 31, 2018, 2017, and 2016.

Share-Based Compensation 
Share-based compensation expense is recognized over the 
vesting period of each award based on the fair value of the 
instrument at the time of grant as summarized in Note 6, 
Share-Based Compensation.

Income Taxes 
The Company recognizes a current tax liability or asset for 
the estimated taxes payable or refundable on tax returns 
for the current year and a deferred tax liability or asset for 
the estimated future tax effects attributable to temporary 
differences and carryforwards. The measurement of current 
and deferred tax liabilities and assets is based on provisions 
of enacted tax law. Deferred tax assets are reduced, if 
necessary, by the amount of any tax benefits for which the 
utilization of the asset is not considered likely.

Earnings Per Share 
The difference between basic and diluted earnings per 
share (EPS) is the dilutive effect of stock options and 
non-vested stock. Diluted EPS assumes that non-vested 
stock has vested and all dilutive stock options, for which 
the average market price exceeds the exercise price 
(in-the-money), are exercised. Stock options for which 
the exercise price exceeds the average market price (out-
of-the-money) have an anti-dilutive effect on EPS, and 
accordingly, are excluded from the calculation.

earnings. Generally, these risk management transactions 
involve the use of foreign currency derivatives to protect 
against exposure resulting from recorded accounts 
receivable and payable. The Company may utilize 
forward exchange contracts, generally with maturities of 
less than 18 months, which qualify as cash flow hedges. 
Generally, these foreign exchange contracts are intended 
to offset the effect of exchange rate fluctuations on non-
functional currency denominated sales and purchases. For 
derivative instruments that are designated as cash flow 
hedges, gains and losses are deferred in accumulated 
other comprehensive income (OCI) until the underlying 
transaction is recognized in earnings.

Hedge effectiveness is determined by how closely the 
changes in the fair value of the hedging instrument offset 
the changes in the fair value or cash flows of the hedged 
item. Hedge accounting is permitted only if the hedging 
relationship is expected to be highly effective at the 
inception of the transaction and on an ongoing basis. 

Interest Rate Hedging 
The Company is exposed to interest rate risk through 
its corporate borrowing activities. The objective of the 
Company’s interest rate risk management activities 
is to manage the levels of the Company’s fixed and 
floating interest rate exposure to be consistent with 
the Company’s preferred mix. The interest rate risk 
management program may include entering into interest 
rate swaps, which qualify as fair value hedges, when 
there is a desire to modify the Company’s exposure to 
interest rates. Gains or losses on fair value hedges are 
recognized in earnings, net of gains and losses on the fair 
value of the hedged instruments.

Net Investments Hedging 
The Company may enter into foreign-denominated debt 
to be used as a non-derivative instrument to hedge the 
Company’s net investment in foreign subsidiaries. The 
change in the carrying amount of the foreign-denominated 
debt on the Company’s books, attributable to changes 
in the spot foreign exchange rate, is a hedge of the net 
investment in its foreign subsidiaries. Changes in the fair 
value of debt designated as a net investment hedge are 
recorded in foreign currency translation in OCI.

Commodity Purchases 
The Company purchases certain commodities in the normal 
course of business that result in physical delivery of the 
goods and, hence, are excluded from ASC 815, Derivatives 
and Hedging.

37

The following table sets forth the computation of basic and diluted EPS from continuing operations for the years ended 
December 31:

(in thousands except per share amounts)

Numerator:

   Years Ended December 31,

2018

2017

2016

Net earnings from continuing operations

$157,360

$89,600

$122,913

Denominator:
Denominator for basic EPS - weighted average  
common shares
Effect of dilutive securities
Denominator for diluted EPS - diluted weighted average  
shares outstanding

EPS from continuing operations
Basic
Diluted

The Company has a share-based compensation plan under 
which employees may be granted share-based awards in 
which non-forfeitable dividends are paid on non-vested 
shares for certain awards. As such, these shares are 
considered participating securities under the two-class 
method of calculating EPS as described in ASC 260, 
Earnings per Share. The two-class method of calculating 
EPS did not have a material impact on the Company’s EPS 
calculations as of December 31, 2018, 2017, and 2016.

In 2018, 2017, and 2016, there were no anti-dilutive stock 
options. All EPS amounts are presented on a diluted basis 
unless otherwise noted.

Accumulated Other Comprehensive Income (Loss) 
Accumulated OCI is composed primarily of foreign 
currency translation, pension liability, and unrealized  
gains or losses on cash flow hedges. See Note 9, 
Accumulated Other Comprehensive Income, for 
additional information.

Research and Development 
Research and development costs are recorded in selling 
and administrative expenses in the year they are incurred. 
Research and development costs related to continuing 
operations were $43.0 million during the year ended 
December 31, 2018, and $40.9 million in both years ended 
December 31, 2017 and 2016.

38

42,404

43,780

44,523

95
42,499

251
44,031

320
44,843

$    3.71
$    3.70

$    2.05
$    2.03

$      2.76
$      2.74

Advertising 
Advertising costs are recorded in selling and administrative 
expenses as they are incurred. Advertising costs related to 
continuing operations were $2.5 million, $2.2 million, and 
$2.3 million during the years ended December 31, 2018, 
2017, and 2016, respectively.

Environmental Liabilities 
The Company records liabilities related to environmental 
remediation obligations when estimated future expenditures 
are probable and reasonably estimable. Such accruals 
are adjusted as further information becomes available or 
as circumstances change. Estimated future expenditures 
are discounted to their present value when the timing 
and amount of future cash flows are fixed and readily 
determinable. Recoveries of remediation costs from other 
parties, if any, are recognized as assets when their receipt  
is realizable.

Subsequent Events 
The Company performed an evaluation of subsequent events 
through the date these financial statements were issued and 
no such events were identified.

Recently Adopted Accounting Pronouncements

In February 2018, the Financial Accounting Standards 
Board (FASB) issued ASU 2018-02, Reclassifications of 
Certain Tax Effects from Accumulated Other Comprehensive 
Income. This ASU allows entities the option to reclassify to 
retained earnings tax effects related to the change in federal 
tax rate for all items accounted for in Accumulated Other 
Comprehensive Income (AOCI). The Company adopted this 
standard in the fourth quarter of 2018, and as a result, has 

elected to reclassify $1.4 million from AOCI to Earnings 
Reinvested in the Business on the Consolidated Statements 
of Shareholders’ Equity as of January 1, 2018.

In March 2017, the FASB issued ASU 2017-07, Improving 
the Presentation of Net Periodic Pension Cost and Net 
Periodic Postretirement Benefit Cost. This ASU requires 
employers to present the service cost component of the 
net periodic benefit cost in the same income statement line 
item as the other employee compensation costs arising from 
services rendered during the period. The other components 
of net periodic benefit cost are to be presented outside of 
any subtotal of operating income. This ASU is effective for 
fiscal years and interim periods beginning after December 
15, 2017. The Company adopted this standard in the first 
quarter of 2018, and as a result, the Company’s non-service 
cost portion of its pension expense is now recorded in 
Interest Expense on the Company’s Consolidated Statement 
of Earnings. The Company’s service cost portion of 
pension expense is recorded in Selling and Administrative 
Expenses on the Company’s Consolidated Statements of 
Earnings. This change did not have a material impact on the 
Company’s consolidated financial statements.

In December 2016, the FASB issued ASU 2016-16, 
Accounting for Income Taxes: Intra-Entity Asset Transfers 
of Assets Other than Inventory. Prior to the adoption of ASU 
2016-16, the tax effects of intra-entity asset transfers were 
deferred until the transferred asset was sold to a third party 
or otherwise recovered through use. ASU 2016-16 eliminates 
the exception for all intra-entity sales of assets other than 
inventory. The guidance is effective for fiscal years beginning 
after December 15, 2017, including interim periods within 
those years. The Company adopted this standard in the first 
quarter of 2018 resulting in a cumulative effect of $0.4 
million increase to Earnings reinvested in the business; an 
increase of $3.0 million to Deferred Tax Assets; a decrease of 
$3.7 million to Prepaid Expenses and Other Current Assets; 
and a decrease of $1.1 million to Deferred Tax Liabilities on 
the Company’s Consolidated Balance Sheet. 

In August 2016, the FASB issued ASU 2016-15, Statement 
of Cash Flows: Classification of Certain Cash Receipts 
and Cash Payments. This ASU clarifies how certain cash 
receipts and cash payments are presented and classified 
in the statement of cash flows. Among these changes is a 
requirement that a transferor’s receipt of a beneficial interest 
in securitized trade receivables be disclosed as an investing 
transaction. There is also a requirement to classify cash 
receipts received that are related to beneficial interests in 
previously transferred receivables (i.e., deferred purchase 
price) as inflows from investing activities. The guidance is 
effective for fiscal years beginning after December 15, 2017, 

including interim periods within those years. The Company 
adopted this standard in the first quarter of 2018 and has 
included $91.1 million, $141.5 million, and $35.4 million 
as cash flows from investing activities for the years ended 
December 31, 2018, 2017, and 2016, respectively, related to 
collections on beneficial interests in previously transferred 
receivables.  

In May 2014, the FASB issued ASU 2014-09, Revenue from 
Contracts with Customers. Under this new standard, revenue 
is recognized when a customer obtains control of promised 
goods or services in an amount that reflects the consideration 
the entity expects to receive in exchange for those goods or 
services. The requirements of the new standard are effective 
for interim and annual periods beginning after December 
15, 2017. The Company adopted this standard in the first 
quarter of 2018 using the modified retrospective method. 
The adoption of this new standard did not have an impact 
on the revenue recognized by the Company. The Company 
has updated its revenue recognition accounting policy, 
as outlined above, and has included a disclosure on its 
disaggregated revenue in Note 11, Segment and Geographic 
Information. 

Recently Issued Accounting Pronouncements 

In February 2016, the FASB issued ASU No. 2016-
02, Leases, which requires lessees to recognize the 
lease assets and liabilities that arise from leases on the 
balance sheet and to disclose qualitative and quantitative 
information about lease transactions. This guidance is 
effective for fiscal years beginning after December 15, 
2018, including interim periods within those fiscal years. 
In 2017, the Company created a project team within its 
Corporate Finance Department to review the impact that 
this ASU will have on the Company. During 2018, the 
project team has gathered and reviewed existing leases 
and other relevant documents across all of the Company’s 
segments and installed a software solution to facilitate 
the implementation of this new standard. The Company 
believes it has a complete population of leasing agreements 
and has analyzed the agreements. The Company has also 
implemented additional internal controls over the evaluation 
of new leases and the implementation of this ASU around 
leases. The Company has updated its Audit Committee 
on the status of the implementation of this ASU. The 
Company’s current estimate of the impact of this ASU on 
the Company’s Consolidated Financial Statements is the 
recognition of lease assets and liabilities in the range of $19 
million to $22 million based on current interest rates and 
population of leases. The Company will continue to evaluate 
this range and the impact on the Company’s Consolidated 
Financial Statements. The Company expects to finalize its 
implementation calculations in the first quarter of 2019.

39

In August 2017, the FASB issued ASU 2017-12, Targeted 
Improvements to Accounting for Hedging Activities, which 
expands an entity’s ability to hedge non-financial and 
financial risk components and reduce complexity in fair 
value hedges of interest rate risk. This guidance eliminates 
the requirement to separately measure and report hedge 
ineffectiveness and generally requires the entire change in 
the fair value of a hedging instrument to be presented in 
the same income statement line item as the hedged item. 
This ASU is effective for fiscal years and interim periods 
beginning after December 15, 2018. The Company is 
currently evaluating the expected impact of this standard.

In June 2016, the FASB issued ASU 2016-13, Financial 
Instruments - Credit Losses (Topic 326): Measurement of 
Credit Losses of Financial Instruments, which replaces the 
current incurred loss impairment model with a methodology 
that reflects expected credit losses. Under the new 
methodology, entities will be required to measure expected 
credit losses on financial instruments held at amortized cost, 
including trade receivables, based on historical experience, 
current conditions, and reasonable forecasts. Adoption of 
this guidance is required for interim and annual periods 
beginning after December 15, 2019, with early adoption 
permitted for interim and annual periods beginning after 
December 15, 2018. The Company is currently evaluating 
the expected impact of this standard.

In January 2017, the FASB issued ASU 2017-04, 
Intangibles-Goodwill and Other (Topic 350): Simplifying 
the Test for Goodwill Impairment, which eliminates step two 
of the goodwill impairment test and specifies that goodwill 
impairment should be measured by comparing the fair value 
of a reporting unit with its carrying amount. This standard 
will be applied prospectively and is effective for annual 
or interim goodwill impairment tests performed in fiscal 
years beginning after December 15, 2019. Early adoption is 
permitted. The Company is currently evaluating the expected 
impact of this standard.     

In August 2018, the FASB issued Accounting Standards 
Update 2018-13, Fair Value Measurement (Topic 820): 
Disclosure Framework—Changes to the Disclosure 
Requirements for Fair Value Measurement, which changes 
the requirements on fair value measurements by removing, 
modifying, or adding certain disclosures. Adoption of 
this guidance is required for interim and annual periods 
beginning after December 15, 2019 with early adoption 
permitted. The Company is currently evaluating the expected 
impact of this standard.     

2. Acquisitions

On July 10, 2018, the Company completed the acquisition 
of Mazza Innovation Limited, a botanical extraction business 
with patented solvent-free extraction processes, located in 
Vancouver, Canada. The Company paid $19.8 million of 
cash for this acquisition. The assets acquired and liabilities 
assumed were recorded at their estimated fair values as of 
the acquisition date. The Company acquired net assets of 
$4.0 million and identified intangible assets, principally 
technological know-how, of $6.9 million. The remaining 
$8.9 million was allocated to goodwill. This acquisition 
provides the Company with an umbrella technology, which 
will support applications for both the Flavors & Fragrances 
and Color segments. The Company is still in the process of 
integrating this business, and, therefore, the Company has 
included its results in Corporate & Other. 

On March 9, 2018, the Company completed the acquisition 
of certain net assets and the natural color business of 
GlobeNatural, a natural color company based in Lima, 
Peru. The Company paid $10.8 million of cash for this 
acquisition. The Company acquired net assets of $1.4 
million and identified intangible assets, principally customer 
relationships, of $2.0 million, and allocated the remaining 
$7.4 million to goodwill. These operations are included in 
the Color segment.

40

3. Goodwill and Intangible Assets

At December 31, 2018 and 2017, goodwill is the only intangible asset that is not subject to amortization. The following table 
summarizes intangible assets with determinable useful lives by major category as of December 31, 2018 and 2017:

(In thousands except weighted  
average amortization years)

Technological know-how
Customer relationships
Patents, trademarks,  
non-compete agreements,  
and other
Total finite-lived intangibles

Weighted 
Average 
Amortization 
Years

18.9
17.4 

15.4
17.2

2018

2017

Cost

$  14,570
8,761 

Accumulated 
Amortization

$  (6,768)
(5,673)

Cost

$  7,510
6,869 

Accumulated 
Amortization

$  (6,505)
(5,244)

15,861
$39,192

(7,884)
$(20,325)

10,264
$24,643

(5,683)
$(17,432)

Amortization of intangible assets was $2.3 million in 2018; $1.6 million in 2017; and $1.3 million in 2016. Estimated 
amortization expense, for the five years subsequent to December 31, 2018, is $2.3 million in 2019 and 2020; $2.1 million in 
2021; $2.0 million in 2022; and $1.7 million in 2023.

The changes in goodwill for the years ended December 31, 2018 and 2017, by reportable business segment, were as follows:

(in thousands)

Balance as of December 31, 2016
   Currency translation impact

Balance as of December 31, 2017
Currency translation impact
Acquisitions

Balance as of December 31, 2018

Flavors & 
Fragrances

$109,369
5,624

114,993
(891)
–
$114,102

Color

Asia Pacific

$272,006
18,883

290,889
(8,269)
7,434
$290,054

$2,193
920

3,113
52
–
$3,165

Corporate  
& Other

$       –
–

–
–
8,854
$8,854

Consolidated

 $383,568
25,427       

408,995
(9,108)
  16,288
$416,175

41

 
4. Debt

Long-term Debt  
Long-term debt consisted of the following unsecured obligations at December 31:

(in thousands)

3.66% senior notes due November 2023
3.65% senior notes due May 2024
4.19% senior notes due November 2025

1.27% Euro-denominated senior notes due May 2024
1.71% Euro-denominated senior notes due May 2027
3.06% Euro-denominated senior notes due November 2023
1.85% Euro-denominated senior notes due November 2022
4.47% senior notes due November 2018
2.53% British Pound-denominated notes due November 2023
2.76% British Pound-denominated notes due November 2025
Term loan
Long-term revolving credit facility
Various other notes

Less debt fees
Total long-term debt

2018

$  75,000   
27,000

25,000
57,333
45,866
43,856
76,662
–
31,884
31,884
132,313
142,061
    923
689,782

(229)   

$689,553

2017

$  75,000   
27,000
–
60,024
48,019
45,914
80,260
25,000
–
–
141,375
100,712

1,068    

         604,372 

(213)   

$604,159

In June 2018, the Company amended its accounts receivable 
securitization program with Wells Fargo & Company (Wells 
Fargo). The program was further amended on October 
1, 2018, to increase the amount from $60 million to $70 
million. In connection with the amendments, the Company 
entered into conforming amendments to its revolving credit 
facility and outstanding note purchase agreements. Under 
the amended program, Wells Fargo has extended a secured 
loan (Secured Loan) of up to $70 million to the Company 
secured by Wells Fargo’s undivided interests in certain of 
the Company’s trade accounts receivables. The interest rate 
on the Secured Loan is LIBOR plus 0.75%. The Company 
has the intent and ability either to repay the Secured Loan 
with available funds from the Company’s existing long-term 
revolving credit facility, or to extend its accounts receivable 
program with Wells Fargo when it matures. Accordingly, the 
Secured Loan has been classified as long-term debt on the 
Company’s Consolidated Balance Sheet. As of December 
31, 2018, the amount was fully drawn.

In July 2018, the Company borrowed 50 million British 
Pounds and 45 million Euros under its revolving credit 
facility to act as a partial hedge of the Company’s net 
asset positions in British Pounds and Euros. See Note 
5, Derivatives and Hedging Activity, for additional 
information. The proceeds of these borrowings were used 

to repay the U.S. dollar denominated borrowings under the 
Company’s revolving credit facility.

In November 2018, the Company replaced the 50 million 
British Pounds revolver borrowing with 50 million British 
Pounds of private placement notes. The two notes were 
issued for 25 million British Pounds each, maturing in 
November 2023 and November 2025, and bearing interest 
rates of 2.53% and 2.76%, respectively. At the same time, 
the Company issued $25 million of private placement notes, 
maturing in November 2025, and bearing an interest rate of 
4.19%, the proceeds of which were used to repay maturing 
private placement debt.  

The borrowings under the Term Loan had an average 
interest rate of 3.48% and 2.58% for the years ended 
December 31, 2018 and 2017, respectively. 

The borrowings under the long-term revolving credit facility 
had an average interest rate of 2.08% and 1.77% for the 
years ended December 31, 2018 and 2017, respectively.

The aggregate amounts of contractual maturities on long-
term debt for the five years subsequent to December 31, 
2018, are as follows: 2019, $11.0 million; 2020, $12.8 
million; 2021, $14.6 million; 2022, $313.1 million; and 
2023, $150.9 million.

42

 
The Company has approximately $11.0 million of long-
term debt that matures in 2019. The Company is able and 
intends to refinance these maturities under the long-term 
revolving credit facility. Accordingly, that maturing debt 
has been classified as long-term debt in the Consolidated 
Balance Sheet.

The Company had $264.5 million available under the 
revolving credit facility and $121.8 million available 
under other lines of credit from several banks at 
December 31, 2018.

Substantially all of the senior loan agreements contain 
restrictions concerning interest coverage, borrowings, and 
investments. The Company is in compliance with all of 
these restrictions at December 31, 2018. The following table 
summarizes the Company’s most restrictive loan covenants 
calculated in accordance with the applicable agreements as 
of December 31, 2018:

Actual

Required

Debt to EBITDA(1) (Maximum)
Interest Coverage (Minimum)

2.79     
6.15

<3.50
>2.00

(1)  Debt to EBITDA is defined in the Company’s debt covenants 
as total funded debt divided by the Company’s consolidated 
operating income excluding non-operating gains and losses and 
depreciation and amortization.

The Company had stand-by and trade letters of credit 
outstanding of $6.4 million and $5.9 million as of 
December 31, 2018 and 2017, respectively.

Short-term Borrowings 
The Company’s short-term borrowings consisted of the 
following items at December 31:

(in thousands)

Uncommitted loans
Loans of foreign subsidiaries
Total

2018

$19,768       
278
$20,046

2017

$19,192       
938
$20,130

The weighted average interest rates on short-term 
borrowings were 3.24% and 2.46% at December 31, 
2018 and 2017, respectively.

5. Derivative Instruments and Hedging Activity

The Company may use derivative instruments for the 
purpose of hedging currency, commodity, and interest 
rate exposures, which exist as part of ongoing business 
operations. As a policy, the Company does not engage 
in speculative or leveraged transactions, nor does the 
Company hold or issue financial instruments for trading 
purposes. Hedge effectiveness is determined by how 
closely the changes in the fair value of the hedging 
instrument offset the changes in the fair value or cash 

flows of the hedged transaction. Hedge accounting, which 
generally results in the deferral of derivative gains and 
losses until such time as the underlying transaction is 
recognized in net earnings, is permitted only if the hedging 
relationship is expected to be highly effective at the 
inception of the transaction and on an ongoing basis. 

The Company manages its exposure to foreign exchange 
risk by the use of forward exchange contracts to reduce 
the effect of fluctuating foreign currencies on non-
functional currency sales, purchases, and other known 
foreign currency exposures. These forward exchange 
contracts generally have maturities of less than 18 months. 
The Company also uses certain debt denominated in 
foreign currencies to manage the net asset positions of the 
Company’s foreign subsidiaries. The Company’s primary 
hedging activities and their accounting treatment are 
summarized below:

Forward Exchange Contracts 
Certain forward exchange contracts have been designated 
as cash flow hedges. The Company had $76.0 million and 
$44.9 million of forward exchange contracts, designated 
as cash flow hedges, outstanding as of December 31, 
2018 and 2017, respectively. As of December 31, 
2018, the amount deferred in OCI was $0.8 million. 
For the years ended December 31, 2018 and 2017, the 
amounts reclassified into net earnings in the Company’s 
Consolidated Statement of Earnings that offset the earnings 
impact of the related non-functional asset or liability 
hedged in the same period were not material. In addition, 
the Company utilizes forward exchange contracts that are 
not designated as cash flow hedges and the results of these 
transactions are not material to the financial statements.

Net Investment Hedges 
The Company has certain debt denominated in Euros, 
Swiss Francs and British Pounds. These debt instruments 
have been designated as partial hedges of the Company’s 
Euro, Swiss Franc, and British Pound net asset positions. 
Changes in the fair value of this debt attributable to 
changes in the spot foreign exchange rate are recorded in 
foreign currency translation in OCI. As of December 31, 
2018 and 2017, the total value of the Company’s Euro, 
Swiss Franc and British Pound debt designated as net 
investment hedges was $366.5 million and $261.9 million, 
respectively. The impact of foreign exchange rates on 
these debt instruments has decreased debt by $13.7 million 
and increased debt by $28.9 million for the years ended 
December 31, 2018 and 2017, respectively. These amounts 
have been recorded as foreign currency translation in OCI.

Concentrations of Credit Risk 
Counterparties to forward exchange contracts consist 
of large international financial institutions. While these 
counterparties may expose the Company to potential losses 
due to the credit risk of non-performance, losses are not 
anticipated. Concentrations of credit risk with respect to 

43

trade accounts receivable are limited by the large number 
of customers, generally short payment terms and their 
dispersion across geographic areas.

6. Share-Based Compensation

The Company has various stock plans under which 
employees and directors may be granted non-vested stock 
which vests over a specific time period. The 2007 Stock 
Plan, which expired April 26, 2017, allowed for the granting 
of non-vested stock in the form of restricted stock, restricted 
stock units, non-qualified stock options or incentive stock 
options, and stock appreciation rights. In April 2017, 
the Company’s 2017 Stock Plan was approved, which 
authorized 1.8 million shares to be granted as non-vested 
stock in the form of restricted stock, restricted stock units, 
non-qualified stock options or incentive stock options, and 
stock appreciation rights. As of December 31, 2018, there 
were 1.6 million shares available to be granted as non-vested 
stock under the Company’s existing stock plans.

Expense for shares of non-vested stock is recognized over 
the vesting period with a pro-rata vesting upon retirement. 
The vesting period is three years beginning with awards 
granted in December 2013. During the period of restriction, 
the holder of non-vested stock has voting rights and is 
entitled to receive all dividends and other distributions paid 
with respect to the stock.

The grants issued after December 2013, to elected officers, 
consist of 100% performance stock unit awards which are 
based on a three-year performance and vesting period and 
a pro-rata vesting upon retirement. Three-year performance 
that exceeds the stated performance metrics would result 
in an award up to 150% of the original grant. The holders 
of the performance stock units are not entitled to vote or 
receive dividends and other distributions paid with respect 
to the stock, until the units have vested and the shares of 
stock are issued.

The Company expenses awards for non-vested stock, 
including time-vesting stock and performance stock units, 
based on the fair value of the Company’s common stock  
at the date of the grant.

The following table summarizes the non-vested stock and performance stock unit activity:

Shares

542
119
(172)
(54)
435
115
(114)
(24)
412
142
(111)
(63)
380 

Grant Date Weighted 
Average Fair Value

Aggregate Intrinsic 
Value

$48.94
69.92
43.42
52.41
56.44
74.26
39.75
63.62
65.64
59.45
56.91
64.71
$66.02

$34,063 

          34,184

30,113

$21,239

(In thousands except fair value)

Outstanding at December 31, 2015
Granted 
Vested
Cancelled
Outstanding at December 31, 2016 
Granted 
Vested
Cancelled
Outstanding at December 31, 2017
Granted
Vested
Cancelled
Outstanding at December 31, 2018

44

 
 
The total intrinsic values of shares vested during 2018, 2017, 
and 2016, was $7.7 million, $8.8 million, and $12.8 million, 
respectively.

As of December 31, 2018, total remaining unearned 
compensation, net of expected forfeitures, related to 
non-vested stock and performance stock units was $12.5 
million, which will be amortized over the weighted 
average remaining service period of 1.48 years. 

Total pre-tax share-based compensation recognized in the 
Consolidated Statements of Earnings was $0.5 million, 
$5.9 million, and $7.7 million in 2018, 2017, and 2016, 
respectively. Fluctuations in share-based compensation 
was primarily due to performance based executive stock 
compensation. Tax related (costs) benefits of ($0.3) million, 
$0.5 million, and $2.8 million were also recognized in 
2018, 2017, and 2016, respectively. Cash received from the 
exercise of stock options was $0.1 million, $0.3 million, 
and $0.7 million for 2018, 2017, and 2016, respectively, and 
is reflected in cash flows from financing activities in the 
Consolidated Statements of Cash Flows.

7. Retirement Plans

The Company provides benefits under defined 
contribution plans including a savings plan and an 
employee stock ownership plan (ESOP). The savings 
plan covers substantially all domestic salaried and certain 
non-union hourly employees and provides for matching 
contributions up to 4% of each employee’s salary. The 
ESOP covers substantially all domestic employees and 
provides for contributions based on a percentage of 
each employee’s compensation as determined by the 
Company’s Board of Directors. Total expense for the 
Company’s defined contribution plans was $6.0 million  
in 2018 and 2017, and $6.7 million in 2016.

Although the Company intends for these defined 
contribution plans to be the primary retirement benefit for 
most employees, the Company also has several defined 
benefit plans. The funded status of the defined benefit 
plans was as follows at December 31:

(in thousands)

Benefit obligation at  beginning of year
Service cost
Interest cost
Foreign currency exchange rate changes
Benefits paid
Amendments

Actuarial (gain) loss
Benefit obligation at end of year
Plan assets at beginning of year
Company contributions
Foreign currency exchange rate changes
Benefits paid
Actual (loss) gain on plan assets
Plan assets at end of year 
Funded status
Accumulated benefit obligation

Amounts recognized in the Consolidated Balance Sheets at December 31:

(in thousands)

Accrued employee and retiree benefits
Other accrued expenses
Other assets
Net liability

2018

$37,757
1,465
1,137
(761)
(2,480)
145

(3,111)
34,152
31,768
886 
(1,315)
(2,480)
(560) 

28,299
$ (5,853)   
$33,562   

2018

$(15,245)
     (779)
10,171
$  (5,853)

2017

$41,691
1,939
1,222
1,607
(9,633)
–
931
37,757
36,141
1,195 
2,318
(9,633)
1,747
31,768
$(5,989)   
$36,951   

2017

$(13,304)
     (2,731)
10,046
$  (5,989)

45

Components of annual benefit cost:

(In thousands)

Service cost
Interest cost
Expected return on plan assets
Recognized actuarial (gain) loss
Settlement (income) expense
Defined benefit expense

Weighted average liability assumptions as of December 31:

Discount rate
Expected return on plan assets
Rate of compensation increase

2018

3.80%
3.21%
0.31%

2017

3.16%
3.03%
0.33%

Weighted average cost assumptions for the year ended 
December 31:

Discount rate
Expected return on plan assets
Rate of compensation increase

2018

3.16%
3.03%
  0.33%

2017

3.48%
2.85%
0.43%

In 2017, one of the Company’s defined benefit plans 
was terminated. The plan was associated with two 
facilities which were closed under the Company’s 2014 
Restructuring Plan. As a result, the pension benefit 
obligation was settled by making lump-sum cash 
payments to certain participants and also purchasing 
nonparticipating annuity contracts to cover the remaining 
vested benefits. As a result of the plan’s termination,  

2018
$ 1,465       
1,137
(896)
(141)
(179)
$ 1,386

2017
$ 1,939       
1,222
(892)
(187)
3,796
$ 5,878

2016
$ 2,091
1,669
(1,141)
193
543
$ 3,355

the Company recognized $3.8 million of settlement 
expense in 2017, which has been recorded in the 
Company’s restructuring and other costs. 

The aggregate amounts of benefits expected to be paid 
from defined benefit plans in each of the next five 
years subsequent to December 31, 2018, which include 
employees’ expected future service, are as follows: 2019, 
$1.5 million; 2020, $ 1.5 million; 2021, $1.6 million; 
2022, $3.9 million; 2023, $1.6 million; and $13.6 million 
in total for the years 2024 through 2028.

The Company expects to contribute $1.1 million to 
defined benefit plans in 2019.

Amounts in accumulated other comprehensive income at 
December 31 were as follows:

(In thousands)

Unrecognized net actuarial 
(gain) loss
Prior service cost
Total before tax effects

2018

$(901) 

145
$(756)

2017

$1,112

–
$1,112

The pension adjustments, net of tax, recognized in OCI, were as follows:

(In thousands)

Net actuarial gain arising during the period
Prior service cost
Amortization of actuarial (gain) loss, included in 
defined benefit expense
Pension adjustment, net of tax

2018
$1,257
(127)

(103)
$1,027

2017
$   921
–

1,307
$2,228

2016
$1,312
–

544
$1,856

The estimated actuarial gain for the defined benefit 
plans that will be amortized from accumulated other 
comprehensive loss into periodic benefit cost during 
2019 is $0.1 million.

The investment objectives and target allocations for the 
Company’s pension plans related to the assets of the 
plans are reviewed on a regular basis. The investment 
objectives for the pension assets are to maximize the 

return on assets while maintaining an overall level of 
risk appropriate for a retirement fund and ensuring 
the availability of funds for the payment of retirement 
benefits. The levels of risk assumed by the pension plans 
are determined by market conditions, the rate of return 
expectations, and the liquidity requirements of each 
pension plan. The actual asset allocations of each pension 
plan are reviewed on a regular basis to ensure that they 
are in line with the target allocations.

46

The following table presents the Company’s pension plan assets by asset category as of December 31, 2018 and 2017:

(in thousands)

Equity Funds
Domestic
International

International Fixed 
Income Funds
Other investments
Total assets at fair value

Fair Value
as of  
December 31,
2018

Fair Value Measurements at 
December 31, 2018
Using Fair Value Hierarchy

Level 1

Level 2

Level 3

Fair Value
as of
December 31, 
2017

Fair Value Measurements at
December 31, 2017
Using Fair Value Hierarchy

Level 1

Level 2

Level 3

$  5,385 
83

$5,385
–

$        –
83 

22,703
128 
$28,299 

1,111 
47
$6,543

21,592 
81 
$21,756

$    –
 –

 –
 –
$    –

$  6,226
101

$6,226
–

$        –
101 

25,340
101 
$31,768

934 
44
$7,204

24,406 
57
$24,564

$    –
 –

 –
 –
$    –

The Company is required to categorize pension plan assets based on the following fair value hierarchy:

Level 1: Observable inputs that reflect quoted prices (unadjusted) for identical assets or liabilities in active markets.

Level 2:  Inputs other than quoted prices included in Level 1 that are observable for the asset or liability through corroboration 

with observable market data.

Level 3: Unobservable inputs that reflect the reporting entity’s own assumptions.

8. Accounts Receivable Securitization 

In October 2016, the Company entered into an accounts 
receivable securitization program with Wells Fargo, 
whereby transactions under the program were accounted 
for as sales of trade receivables in accordance with ASC 
Topic 860, Transfers and Servicing, between October 
2016 and June 2018. Sales of trade receivables under 
the program were recorded as a reduction of accounts 
receivable in the Consolidated Balance Sheet. The fair 
value of the receivables sold equaled the carrying cost at 
the time of sale and no gain or loss had been recorded as a 
result of the sales. The sales also resulted in the recording 
of a deferred purchase price amount, which represents 
the retained interest in the sold receivables. This amount 
was adjusted daily based on collections and other activity. 
The Company estimated the fair value of the deferred 
purchase price receivable based on historical performance 
of similar receivables, including an allowance for doubtful 
accounts, as well as estimated cash discounts to be taken 
by customers and potential credits issued to customers. 
The Company deemed the interest rate risk related to 
the deferred purchase price receivable to be de minimis 
primarily due to the short average collection cycle of the 
related receivables. As of December 31, 2017, the net trade 
receivables sold to Wells Fargo totaled $96.4 million, and 
the fair value of the deferred purchase price was $36.4 
million, which was recorded in Trade Accounts Receivable 
in the Company’s Consolidated Balance Sheets.

In June 2018, the Company amended its securitization 
program with Wells Fargo (the “Amendment”). Following 
the Amendment, the Company no longer accounts for the 
sales of the trade receivables in accordance with ASC 
Topic 860 and instead now maintains the trade receivables 
and related debt on its Consolidated Balance Sheet. In 
connection with the Amendment, Wells Fargo’s existing 
ownership interest in the trade receivables was converted 
into undivided interests in the trade receivables to secure a 
loan of up to $60 million to the Company and the deferred 
purchase price was eliminated. 

As a result of the Amendment, the Company’s trade 
account receivables increased by $60 million and the 
Company’s long-term debt increased by $60 million. 
This non-cash transaction did not impact the Company’s 
Consolidated Statement of Cash Flows during the year 
ended December 31, 2018.

In October 2018, the Company further amended the 
accounts receivable securitization program to increase 
the commitment size from $60 million to $70 million and 
extended the expiration date of the program until October 
2019. As of December 31, 2018, $70 million was borrowed 
under this agreement. See Note 4, Debt, for further 
information.

47

9. Accumulated Other Comprehensive Income

The following table summarizes the changes in OCI for 2018, 2017, and 2016:

(In thousands)

Balance as of December 31, 2015

Other comprehensive income (loss) 
before reclassifications
Amounts reclassified from OCI
Balance as of December 31, 2016

Other comprehensive income (loss) 
before reclassifications
Amounts reclassified from OCI

Balance as of December 31, 2017

Other comprehensive income (loss) 
before reclassifications
Amounts reclassified from OCI

Adoption of ASU 2018-02

Cash Flow
Hedges (a)

$     164

(1,094)
845
$     (85)

(768)
    184

$   (669)

667
149

–

Pension
Items (a)

$(4,393)

1,312
544
$(2,537)

    921
1,307

Foreign  
Currency Items

Total

$(165,833)

$(170,062)

(41,753)
(3,257)
$(210,843)

   55,705
     6,782

(41,535)
(1,868)
$(213,465) 

   55,858
     8,273

$   (309)

$(148,356)

$(149,334)

1,130
(103)

(169)

(16,675)
–

(1,220)

(14,878)
46

(1,389)

Balance as of December 31, 2018

$    147

$    549

$(166,251)

$(165,555)

(a) Cash Flow Hedges and Pension Items are net of tax.

In 2018, the Company adopted ASU 2018-02, Reclassifications of Certain Tax Effects from Accumulated Other Comprehensive 
Income,  (See  Note  1,  Summary  of  Significant  Accounting  Policies,  for  additional  information),  resulting  in  the  reclassification  
of OCI into Earnings reinvested in the business. 

10. Income Taxes

The provision for income taxes for continuing operations was as follows:

(In thousands)

Currently (receivable) payable:

Federal (1)
State
Foreign

Deferred expense (benefit):

Federal
State
Foreign

Income taxes

2018

2017

2016

$(9,071)         

$15,513         

205
23,187
14,321

3,977
3,164
2,703
9,844

$24,165

642
25,254
41,409

18,458
215
(1,259)
17,414

$58,823

$12,145               
2,631
19,168
33,944

7,630
1,656
1,142
10,428

$44,372

(1)  In 2018 and 2017, this amount includes $(3.9) million and $7.4 million, respectively, of income tax (benefit) expense related to the one-time 
transition tax on earnings of foreign subsidiaries enacted by the 2017 Tax Legislation (See discussion below). There was no liability for this 
amount recorded as of December 31, 2018. As of December 31, 2017, $5.1 million of this amount was reported in Other liabilities on the 
Consolidated Balance Sheet. 

48

The tax effects of temporary differences that give rise to significant portions of deferred tax assets and liabilities consisted of 
the following:

(in thousands)

Deferred tax assets:
Benefit plans
Liabilities and reserves
Operating loss and credit carryovers
Other
Gross deferred tax assets
Valuation allowance
Deferred tax assets
Deferred tax liabilities:

Property, plant and equipment
Goodwill
Other
Deferred tax liabilities
Net deferred tax liabilities

2018

2017

$    6,788
12,563
65,392
1,404
86,147
(50,702)
35,445

(29,372)
(21,372)
(4,488)
(55,232)
$(19,787)   

$    8,440
11,141
40,164
1,007
60,752
(38,366)
22,386

(12,458)
(20,345)
(422)
(33,225)
$(10,839)   

The Company is subject to current tax on Global Intangible Low-Taxed Income (GILTI) earned by foreign subsidiaries. The 
FASB Staff Q&A Topic No. 5, Accounting for Global Intangible Low-Taxed Income, states that an entity can make an accounting 
policy election either to recognize deferred taxes for temporary differences that are expected to reverse as GILTI in future years 
or provide for the tax expense related to GILTI resulting from those items in the year the tax is incurred. Sensient is electing to 
recognize GILTI as a period expense in the period the tax is incurred.

At December 31, 2018, foreign operating loss carryovers were $122.9 million. Included in the foreign operating loss carryovers 
are losses of $25.2 million that expire through 2033, and $97.7 million that expire after 2033 or do not have an expiration date. 
At December 31, 2018, state operating loss carryovers were $138.4 million, of which $137.3 million expires through 2033. 

The effective tax rate for continuing operations differed from the statutory federal income tax rate as described below:

Taxes at statutory rate
State income taxes, net of federal income tax benefit
Tax credits
Taxes on foreign earnings
Global Intangible Low-Taxed Income
Resolution of prior years’ tax matters
U.S. manufacturing deduction
Valuation allowance adjustments
2017 Tax Legislation
Loss on foreign branch remittances
U.S. tax accounting method changes
Other, net

2018
21.0%               
1.1
(1.5)
(0.4)
0.6
(0.3)
–
0.4
(3.7)
–
(2.9)
(1.0)

2017
35.0%               
0.3
(1.1)
0.2
–
0.1
(1.4)
–
12.4
(5.2)
–
(0.7)

2016
35.0%               
1.4
(1.8)
(4.4)
–
–
(2.0)
(0.3)
–
–
–
(1.4)

Effective tax rate

  13.3%

  39.6%

   26.5%

49

On December 22, 2017, the U.S. enacted the Tax Cuts and 
Jobs Act (Act or 2017 Tax Legislation). The Act significantly 
changed the U.S. corporate income tax laws by reducing 
the U.S. corporate income tax rate to 21% beginning in 
2018 and imposing a one-time mandatory tax on previously 
deferred foreign earnings of U.S. subsidiaries in 2017. Staff 
Accounting Bulletin No. 118 (SAB 118) was issued to address 
the application of U.S. GAAP in situations when a registrant 
does not have the necessary information available, prepared, 
or analyzed (including computations) in reasonable detail to 
complete the accounting for certain income tax effects of the 
Act. In accordance with SAB 118, the Company recorded 
a net charge of $18.4 million during the fourth quarter of 
2017. The amount consists of reassessing the U.S. deferred 
tax assets and liabilities, adjustments to the Company’s 
foreign tax credit carryover, and the one-time mandatory tax 
on previously deferred foreign earnings of U.S. subsidiaries. 
Based on additional guidance, changes in interpretation, 
additional analysis, and assumptions, the Company reduced 
this net charge by $6.6 million in 2018. Sensient considers 
$11.8 million to be the final net charge related to the Act.

During the third and fourth quarters of 2018, the US Treasury 
released numerous proposed regulations related to the 2017 
Tax Legislation. The Company has reviewed and evaluated 
these proposed regulations. These regulations, when finalized, 

could result in adjustments to the Company’s provision for 
income taxes and its realizability of certain deferred tax assets.

The effective tax rate in 2018 was also favorably impacted by 
U.S. tax accounting method changes that were filed with the 
IRS in the second quarter of 2018 and generation of foreign 
tax credits during 2018.

The 2017 loss on remittances is the result of the cumulative 
foreign currency effect related to certain repatriation 
transactions.

Taxes on foreign earnings include the difference between 
the tax rates applied to foreign earnings relative to the 
U.S. statutory tax rate, accruals for foreign unrecognized 
tax benefits, and the impact of the U.S. foreign tax credit, 
not including the impact from GILTI. The impact on the 
Company’s effective tax rate varies from year to year based 
on the mix of earnings, increases in foreign unrecognized 
tax benefits, and the expected realization of U.S. foreign tax 
credits generated each year. The increase of the 2017 effective 
tax rate from taxes on foreign earnings compared to 2016 is 
primarily the result of the non-deductible losses from the sale 
of the European Natural Ingredients business (See Note 13, 
Restructuring Charges), and the sale of the business lines in 
Strasbourg, France (See Note 15, Divestiture).

Earnings from continuing operations before income taxes were as follows:

(in thousands)

United States
Foreign

Total

2018
$  80,641               
100,884

$181,525  

2017
$  88,479               
59,944

$148,423  

2016
$  96,963               
70,322

$167,285  

Federal and state income taxes are provided on international subsidiary income distributed to or taxable in the U.S. during 
the year. At December 31, 2018, no additional income or withholding taxes have been provided for the $553 million of 
undistributed earnings or any additional outside basis differences inherent in these entities, as these amounts are considered 
to be invested indefinitely. If the undistributed earnings were repatriated, Sensient estimates it would have a withholding tax 
liability of $24.9 million. The determination of the tax liability for any outside basis differences is not practicable.

A reconciliation of the change in the liability for unrecognized tax benefits for 2018 and 2017 is as follows:

(in thousands)

Balance at beginning of year
Increases for tax positions taken in the current year
Increases for tax positions taken in prior years
Decreases related to settlements with tax authorities
Decreases as a result of lapse of the applicable statutes of limitations
Foreign currency exchange rate changes
Balance at the end of year

2018

$6,276
834
271
(177)
(920)
(258)
$6,026 

2017

$4,947
871
553
(76)
(607)
588
$6,276 

50

The amount of the unrecognized tax benefits that 
would affect the effective tax rate, if recognized, was 
approximately $4.8 million. The Company recognizes 
interest and penalties related to the unrecognized tax 
benefits in income tax expense. As of December 31, 2018 
and 2017, $0.5 million and $0.5 million, respectively, of 
accrued interest and penalties were reported as an income 
tax liability in each period. The liability for unrecognized 
tax benefits relates to multiple jurisdictions and is reported 
in Other liabilities on the Company’s Consolidated Balance 
Sheet at December 31, 2018.

The Company believes that it is reasonably possible that the 
total amount of liability for unrecognized tax benefits as of 
December 31, 2018, will decrease by approximately $0.9 
million during 2019, of which $0.9 million is estimated to 
impact the effective tax rate. The potential decrease relates 
to various tax matters for which the statute of limitations 
may expire or will be otherwise settled in 2019. The amount 
that is ultimately recognized in the financial statements 
will be dependent upon various factors including potential 
increases or decreases in unrecognized tax benefits as a result 
of examinations, settlements, and other unanticipated items 
that may occur during the year. With limited exceptions, the 
Company is no longer subject to federal, state, and local, or 
non-U.S. income tax examinations by tax authorities for years 
before 2014.

11. Segment and Geographic Information

The accounting policies of the segments are the same as 
those described in the summary of significant accounting 
policies. The Company evaluates performance based on 
operating income before restructuring and other charges, 
interest expense, and income taxes (“segment operating 
income”). Total revenue and segment operating income by 
business segment and geographic region include both sales 
to customers, as reported in the Company’s Consolidated 
Statements of Earnings, and intersegment sales, which are 
accounted for at prices that approximate market prices and 
are eliminated in consolidation.

Assets by business segment and geographic region are 
those assets used in the Company’s operations in each 
segment and geographic region. Segment assets reflect the 
allocation of goodwill to each segment. Corporate & Other 
assets consist primarily of fixed assets and investments.

Segment Information
The Company determines its operating segments based on 
information utilized by its chief operating decision maker 
to allocate resources and assess performance. Segment 
performance is evaluated on operating income of the 
respective business units before restructuring and other 
charges, which are reported in Corporate & Other.

The Company’s three reportable segments are Flavors 
& Fragrances and Color segments, which are both 
managed on a product line basis, and the Asia Pacific 
segment, which is managed on a geographic basis. The 
Company’s Flavors & Fragrances segment produces 
flavor and fragrance products that impart a desired taste, 
texture, aroma, or other characteristic to a broad range of 
consumers and other products. The Color segment produces 
natural and synthetic color systems for foods, beverages, 
pharmaceuticals and nutraceuticals; colors, ingredients 
and systems for cosmetics; specialty inks and technical 
colors for industrial applications. The Asia Pacific segment 
is managed on a geographic basis and produces and 
distributes color, flavor, and fragrance products for the Asia 
Pacific countries. The Company’s corporate expenses and 
restructuring and other costs are included in the “Corporate 
& Other” category.

In July 2018, the Company completed the acquisition 
of Mazza Innovation Limited (See Note 2, Acquisitions, 
for further information). This acquisition provides the 
Company with an umbrella technology, which supports 
applications for both the Flavors & Fragrances and Color 
segments. The Company is in the process of integrating 
this business, and, therefore, the Company has included its 
results in Corporate & Other.

Restructuring and other costs related to continuing 
operations for the years ended December 31, 2017 and 
2016, are further described in Note 13, Restructuring 
Charges, and Note 15, Divestiture, and are included in 
the operating income (loss) results in Corporate & Other 
below. There have been no restructuring and other costs 
in 2018. Consistent with presentation in the Company’s 
Consolidated Balance Sheets and Statements of Cash 
Flows, the below amounts for assets, capital expenditures, 
and depreciation and amortization include discontinued 
operations for the years ended December 31, 2017 and 
2016 and are included in Corporate & Other. In addition, 
the Company’s corporate expenses are included in 
Corporate & Other.

51

(In thousands)

2018:

Revenue from external customers
Intersegment revenue
Total revenue

Operating income (loss)
Interest expense
Earnings (loss) before income 
taxes from continuing operations

Assets
Capital expenditures
Depreciation and amortization

2017:

Revenue from external customers
Intersegment revenue
Total revenue

Operating income (loss)
Interest expense
Earnings (loss) before income 
taxes from continuing operations

Assets
Capital expenditures
Depreciation and amortization

2016:

Revenue from external customers
Intersegment revenue
Total revenue

Operating income (loss)
Interest expense
Earnings (loss) before income 
taxes from continuing operations

Flavors & 
Fragrances

$723,189
23,743
746,932

96,433
–

$539,974
13,505
553,479

114,924
–

Color

Asia Pacific

Corporate
& Other

$        525
–
525

Consolidated

$1,386,815
37,285
1,424,100

$123,127
37
123,164

20,856
–

(28,835)
21,853

203,378
21,853

96,433

114,924

20,856

(50,688)

181,525

784,161
23,679
25,922

$727,026
19,917
746,943

114,343
–

730,644
21,269
21,644

$512,811
13,552
526,363

113,381
–

101,792
2,858
2,451

208,343
2,934
3,227

1,824,940
50,740
53,244

$122,428
765
123,193

$            –     
 –     
 –     

$1,362,265
34,234
1,396,499

20,772
–

(80,690)
19,383

167,806 
19,383

114,343

113,381

20,772

(100,073)

148,423 

773,173
31,989
23,611

$771,434
24,377
795,811

124,059
–

720,328
18,797
19,902

$490,862
13,269
504,131

105,814
–

99,770
3,557
2,303

131,069
2,001
2,702

1,724,340
56,344
48,518

$120,914
282
121,196

$            –     
 –     
 –     

$1,383,210
37,928
1,421,138

23,603
–

(67,867)
18,324

185,609
18,324

124,059

105,814

23,603

(86,191)

167,285

Assets
Capital expenditures
Depreciation and amortization

785,449
57,622
22,897

673,754
15,422
19,421

92,203 
5,199
2,042

116,454
2,973
2,659

1,667,860
81,216
47,019

Geographic Information 

The Company has manufacturing facilities or sales offices in North America, Europe, Asia, Australia, South America, and Africa.

52

Consistent with presentation in the Company’s Consolidated Balance Sheets and Statements of Cash Flows, the below amounts 
for long-lived assets include discontinued operations for the year ended December 31, 2016. The long-lived asset impairment is 
included in Corporate & Other and is further described in Note 15, Divestiture.  

The Company’s annual revenue from continuing operations summarized by geographic location is as follows:

(In thousands)

2018:
Revenue from external customers:

North America

Europe

Asia Pacific 

Other

Flavors & 
Fragrances

Color

Asia Pacific

Corporate
& Other

Consolidated

$477,083

173,562

31,506

41,038

 $245,278 

$          – 

$     371

$   722,732

168,187

59,548

66,961

155

121,975

997

153

–

1

342,057

213,029

108,997

Total revenue from external customers

$723,189

$539,974

$123,127

$525

$1,386,815

Long-lived assets:
North America

Europe

Asia Pacific

Other

  $260,932 

   $209,821 

   $          – 

$97,362

$   568,115

121,372

1,061

277

265,688

3,319

16,387

–

25,856

–

–

–

–

387,060

30,236

16,664 

Total long-lived assets

$383,642

$495,215

$  25,856

$97,362

$1,002,075

2017:
Revenue from external customers:

North America

Europe

Asia Pacific

Other

$487,034

164,641

32,717

42,634

$231,674

159,646

55,108

66,383

$          –

$        –

$   718,708

310

121,110

1,008

–

–

–

324,597

208,935

110,025

Total revenue from external customers

$727,026

$512,811

$122,428

$        –

$1,362,265

Long-lived assets:

North America

Europe

Asia Pacific

Other

$260,802

127,111

1,395

380

$207,746

278,127

3,075

7,196

$          – 

$78,113

$   546,661

– 

26,920

–

–

–

–

405,238

31,390

7,576

Total long-lived assets

$389,688

$496,144

$  26,920

$78,113

$   990,865

2016:
Revenue from external customers:

North America

Europe

Asia Pacific

Other

$515,716

192,185

27,459

36,074

$229,944

150,553

49,580

60,785

$  

      –

$        –

$   745,660

80

119,845

989

–

–

–

342,818

196,884

97,848

Total revenue from external customers

$771,434

$490,862

$120,914

$        –

$1,383,210

Long-lived assets:

North America

Europe

Asia Pacific

Other

$257,661

126,447

1,482

519

$206,078

245,526

3,244

10,571

$          – 

–

25,280

–

$84,935

(10,944)

–

–

$   548,674

361,029

30,006

11,090

Total long-lived assets

$386,109

$465,419

$  25,280

$73,991

$   950,799

53

Sales  in  the  United  States,  based  on  the  final  country  of  destination  of  the  Company’s  products,  were  $586.2  million, 
$574.5 million, and $595.0 million in 2018, 2017, and 2016, respectively. No other country of destination exceeded 10% 
of consolidated sales. Total long-lived assets in the United States amounted to $491.4 million, $491.8 million, and $495.3 
million at December 31, 2018, 2017, and 2016, respectively.

Product Information 
The Company’s revenue from continuing operations summarized by product portfolio is as follows:

(In thousands)

2018:

Flavors

Natural Ingredients

Fragrances

Food & Beverage Colors 

Cosmetics

Other Colors

Asia Pacific
Corporate & Other 

Intersegment Revenue

Total revenue from external customers

2017:
Flavors

Natural Ingredients

Fragrances

Food & Beverage Colors 

Cosmetics

Other Colors

Asia Pacific

Flavors & 
Fragrances

$414,728

224,280

107,924

–

–

–
–

  – 

(23,743)

$723,189

$439,811

219,837

87,295

–

–

–

–

2016:
Flavors

Natural Ingredients

Fragrances

Food & Beverage Colors 

Cosmetics

Other Colors

Asia Pacific

$474,904

237,664

83,243

–

–

–

–

Color

Asia Pacific

Corporate
& Other

Consolidated

$          – 

$          –

$    –

$   414,728

 – 

–

303,386

153,347

96,746
–

   – 

(13,505)

– 

–

–

–

–
123,164

   – 

(37)

$539,974

$123,127

–

–

–

–

–
–

525

–

$525

224,280

107,924

303,386

153,347

96,746
123,164

525

(37,285)

$1,386,815

$          –

$          –

$    –

$   439,811

–

–

279,870

147,637

98,856

–

–

–

–

–

–

123,193

–

–

279,516

123,937

100,678

–

–

–

–

–

–

121,196

–

–

–

–

–

–

–

219,837

87,295

279,870

147,637

98,856

123,193

(34,234) 

–

–

–

–

–

–

–

237,664

83,243

279,516

123,937

100,678

121,196

(37,928)

Intersegment Revenue

(19,917) 

(13,552) 

(765) 

Total revenue from external customers

$727,026

$512,811

$122,428

$    –

$1,362,265

$          –

$          –

   $    –

$   474,904

Intersegment Revenue 

(24,377) 

(13,269) 

 (282) 

Total revenue from external customers

$771,434

$490,862

$120,914

$    –

$1,383,210

54

12. Fair Value Measurements

14. Discontinued Operations

ASC 820, Fair Value Measurements and Disclosures, defines 
fair value for financial assets and liabilities, establishes a 
framework for measuring fair value in GAAP, and expands 
disclosures about fair value measurements. As of December 
31, 2018 and 2017, the Company’s only assets and liabilities 
subject to this standard are forward contracts, investments 
in a money market fund and municipal bonds, and defined 
benefit plan assets (See Note 7, Retirement Plans, for 
additional information on the defined benefit plan assets). 
The net fair value of the forward exchange contracts based on 
current pricing obtained for comparable derivative products 
(Level 2 inputs) was an asset of $0.2 million and a liability of 
$0.6 million as of December 31, 2018 and 2017, respectively. 
The fair value of the investments based on December 31, 
2018 and 2017, market quotes (Level 1 inputs) was an asset 
of $0.1 million in both periods and is reported in Other Assets 
in the Company’s Consolidated Balance Sheets.

The carrying values of the Company’s cash and cash 
equivalents, trade accounts receivable, accounts payable, 
accrued expenses, and short-term borrowings approximated 
fair values as of December 31, 2018 and 2017.

The fair value of the Company’s long-term debt, including 
current maturities, is estimated using discounted cash flows 
based on the Company’s current incremental borrowing 
rates for similar types of borrowing arrangements (Level 
2 inputs). The carrying value of the long-term debt at 
December 31, 2018 and 2017, was $689.6 million and $604.2 
million, respectively. The fair value of the long-term debt 
at December 31, 2018 and 2017, was approximately $695.0 
million and $620.2 million, respectively.

13. Restructuring Charges 

Between March 2014 and 2017, the Company executed a 
restructuring plan (2014 Restructuring Plan) to eliminate 
underperforming operations, consolidate manufacturing 
facilities, and improve efficiencies within the Company. 
In accordance with GAAP, no restructuring costs 
were recorded for the year ended December 31, 2018, 
however, the Company recorded total restructuring 
costs of $36.5 million and $11.1 million for the years 
ended December 31, 2017 and 2016, respectively. The 
restructuring costs incurred in 2017 were primarily due 
to the loss on asset sales of $21.6 million and other costs. 
The restructuring costs incurred in 2016 were primarily 
due to decommissioning costs, professional services, 
moving costs, and other related costs.

In connection with the 2014 Restructuring Plan, the 
Company approved a plan to dispose of a business unit 
within the Color segment, located near Leipzig, Germany. 
Since 2014, the business met the criteria to be presented as 
a discontinued operation as established in ASC Subtopic 
205-20, Discontinued Operations. The results of this 
business have been reported as a discontinued operation 
in the Company’s Consolidated Statements of Earnings 
for the year ended December 31, 2016. During 2016, the 
facility and remaining assets were sold for a gain of $0.2 
million. In addition, the entity was liquidated resulting in a 
reclassification of the cumulative translation adjustment of 
$3.3 million into net earnings.

The following table summarizes the discontinued 
operation’s results, which are included in the gain from 
discontinued operations in the Company’s Consolidated 
Statements of Earnings, for the years ended December 
31, 2018, 2017, and 2016.  

(In thousands)

Net sales

2018
$       –

2017
$       –

2016
$       –

Gain from discontinued 
operations before 
income taxes

Income tax expense 

Gain from discontinued 
operations, net of tax 

       –

       –

 –

    3,410

 –          (67)

$       –

 $       –

$3,343            

15. Divestiture

In 2016, the Company’s Board of Directors authorized 
management to explore strategic alternatives for a facility 
and certain related business lines within the Flavors 
& Fragrances segment in Strasbourg, France. In 2016, 
the Company recorded a non-cash impairment charge 
of $10.8 million, in selling and administrative expense, 
and incurred $0.7 million of outside professional fees 
and other related costs in 2016, as a result of the then 
anticipated divestiture.

In January 2017, the Company completed this divestiture 
for approximately $12.5 million. The Company recognized 
an additional non-cash loss of $11.6 million in 2017. 

55

 
Other Claims
The Company is subject to various claims and litigation 
arising in the normal course of business. The Company 
establishes reserves for claims and proceedings when it is 
probable that liabilities exist and reasonable estimates of 
loss can be made. While it is not possible to predict the 
outcome of these matters, based on our assessment of the 
facts and circumstances now known, we do not believe that 
these matters, individually or in the aggregate, will have a 
material adverse effect on our financial position. However, 
actual outcomes may be different from those expected and 
could have a material effect on our results of operations or 
cash flows in a particular period.

16. Commitments and Contingencies

Leases
The Company leases certain facilities and equipment 
under operating lease arrangements. Aggregate minimum 
rental commitments at December 31, 2018, for all non-
cancelable operating leases with an initial lease term 
greater than one year for the years ending December 31 
are as follows: 2019, $9.7 million; 2020, $6.7 million; 
2021, $3.9 million; 2022, $3.2 million; 2023, $2.7 
million; and $4.3 million thereafter.

Rent expense from continuing operations totaled $13.5 
million, $12.1 million, and $12.4 million during the years 
ended December 31, 2018, 2017, and 2016, respectively.

People of the State of Illinois v. Sensient Flavors LLC

On June 7, 2018, the Attorney General of the State of 
Illinois Office, on her own motion and at the request 
of the Illinois Environmental Protection Agency, filed 
a Complaint in the Lee County Circuit Court against 
Sensient Flavors LLC (“Sensient Flavors”). The 
Complaint alleges that Sensient Flavors’ Amboy, Illinois 
facility improperly discharged wastewater to the City 
of Amboy’s wastewater treatment plant in late 2015 
and early 2016, causing the City to violate its discharge 
permit. The Complaint alleged two counts against 
Sensient Flavors for violations of Illinois state law. 

The Company believes the facility’s discharges in 
question were done with the consent of the City of 
Amboy and in compliance with Illinois state law, and that 
Sensient Flavors complied with its wastewater permit, 
City of Amboy ordinances, and applicable Illinois state 
laws. The Company notes that at all times relevant to 
the matters at issue in the Complaint, the City of Amboy 
accepted Sensient Flavors’ wastewater and, in fact, 
charged Sensient Flavors for treating Sensient Flavors’ 
wastewater. The parties reached a settlement agreement 
in which Sensient Flavors agreed to pay a $100,000 fine 
and enter into a consent decree with the State of Illinois. 
On February 20, 2019, the Lee County Circuit Court 
approved the parties’ settlement agreement.

56

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

The Board of Directors and Shareholders of
Sensient Technologies Corporation 
Milwaukee, Wisconsin

Opinion on the Financial Statements

We have audited the accompanying consolidated 
balance sheets of Sensient Technologies Corporation 
and subsidiaries (the Company) as of December 31, 
2018 and 2017, the related consolidated statements of 
earnings, comprehensive income, shareholders’ equity, 
and cash flows for each of the three years in the period 
ended December 31, 2018, and the related notes and the 
financial statement schedule listed in the Index at Item 
15 (collectively referred to as the “consolidated financial 
statements”). In our opinion, the consolidated financial 
statements present fairly, in all material respects, the 
financial position of the Company at December 31, 2018 
and 2017, and the consolidated results of its operations 
and its cash flows for each of the three years in the 
period ended December 31, 2018, in conformity with 
U.S. generally accepted accounting principles. 

We have also audited, in accordance with the standards of 
the Public Company Accounting Oversight Board (United 
States) (PCAOB), the Company’s internal control over 
financial reporting as of December 31, 2018, based on 
the criteria established in the Internal Control-Integrated 
Framework issued by the Committee of Sponsoring 
Organizations of the Treadway Commission (2013 
framework) and our report dated February 22, 2019 
expressed an unqualified opinion thereon.

Basis for Opinion

These financial statements are the responsibility of the 
Company’s management. Our responsibility is to express 
an opinion on the Company’s financial statements based 
on our audits. We are a public accounting firm registered 
with the PCAOB and are required to be independent 
with respect to the Company in accordance with the 
U.S. federal securities laws and the applicable rules and 
regulations of the Securities and Exchange Commission 
and the PCAOB.

We conducted our audits in accordance with the 
standards of the PCAOB. Those standards require that 
we plan and perform the audit to obtain reasonable 
assurance about whether the financial statements are 
free of material misstatement, whether due to error 
or fraud. Our audits included performing procedures 
to assess the risks of material misstatement of the 
financial statements, whether due to error or fraud, 
and performing procedures that respond to those risks. 
Such procedures included examining, on a test basis, 
evidence regarding the amounts and disclosures in the 
financial statements. Our audits also included evaluating 
the accounting principles used and significant estimates 
made by management, as well as evaluating the overall 
presentation of the financial statements. We believe that 
our audits provide a reasonable basis for our opinion.

/s/ Ernst & Young LLP
We have served as the Company’s auditor since 2006.
Milwaukee, Wisconsin
February 22, 2019

57

REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM 

The Board of Directors and Shareholders of
Sensient Technologies Corporation
Milwaukee, Wisconsin

Opinion on Internal Control over Financial Reporting

We have audited Sensient Technologies Corporation and 
subsidiaries’ internal control over financial reporting as 
of December 31, 2018, based on criteria established in 
Internal Control–Integrated Framework issued by the 
Committee of Sponsoring Organizations of the Treadway 
Commission (2013 framework) (the COSO criteria). 
In our opinion, Sensient Technologies Corporation and 
subsidiaries (the Company) maintained, in all material 
respects, effective internal control over financial reporting 
as of December 31, 2018, based on the COSO criteria. 

As indicated in the accompanying Report on Internal 
Control Over Financial Reporting, management’s 
assessment of and conclusion on the effectiveness of 
internal control over financial reporting did not include the 
internal controls of GlobeNatural and Mazza Innovation 
Limited, which are included in the 2018 consolidated 
financial statements of the Company and constituted 
2.3% and 3.4% of total and net assets, respectively, as of 
December 31, 2018, and 0.3% of revenues for the year then 
ended. Our audit of internal control over financial reporting 
of the Company also did not include an evaluation of the 
internal control over financial reporting of GlobeNatural 
and Mazza Innovation Limited.

We also have audited, in accordance with the standards 
of the Public Company Accounting Oversight Board 
(United States) (PCAOB), the accompanying consolidated 
balance sheets of Sensient Technologies Corporation and 
subsidiaries as of December 31, 2018 and 2017, and the 
related consolidated statements of earnings, comprehensive 
income, shareholders’ equity, and cash flows for each of the 
three years in the period ended December 31, 2018, and the 
related notes and the financial statement schedule listed in 
the Index at Item 15 of the Company and our report dated 
February 22, 2019 expressed an unqualified opinion thereon. 

Basis for Opinion

The Company’s management is responsible for maintaining 
effective internal control over financial reporting and 
for its assessment of the effectiveness of internal control 
over financial reporting included in the accompanying 
Management’s Report on Internal Control over Financial 
Reporting. Our responsibility is to express an opinion on 
the Company’s internal control over financial reporting 
based on our audit. We are a public accounting firm 
registered with the PCAOB and are required to be 

58

independent with respect to the Company in accordance 
with the U.S. federal securities laws and the applicable 
rules and regulations of the Securities and Exchange 
Commission and the PCAOB. 

We conducted our audit in accordance with the standards 
of the PCAOB. Those standards require that we plan and 
perform the audit to obtain reasonable assurance about 
whether effective internal control over financial reporting 
was maintained in all material respects. 

Our audit included obtaining an understanding of internal 
controls over financial reporting, assessing the risk that a 
material weakness exists, testing and evaluating the design 
and operating effectiveness of internal control based on the 
assessed risk, and performing such other procedures as we 
considered necessary in the circumstances. We believe that 
our audit provides a reasonable basis for our opinion.

Definition and Limitations of Internal Control over 
Financial Reporting

A company’s internal control over financial reporting is a 
process designed to provide reasonable assurance regarding 
the reliability of financial reporting and the preparation of 
financial statements for external purposes in accordance 
with generally accepted accounting principles. A company’s 
internal control over financial reporting includes those 
policies and procedures that (1) pertain to the maintenance 
of records that, in reasonable detail, accurately and fairly 
reflect the transactions and dispositions of the assets of the 
company; (2) provide reasonable assurance that transactions 
are recorded as necessary to permit preparation of financial 
statements in accordance with generally accepted accounting 
principles, and that receipts and expenditures of the company 
are being made only in accordance with authorizations 
of management and directors of the company; and (3) 
provide reasonable assurance regarding prevention or timely 
detection of unauthorized acquisition, use, or disposition of 
the company’s assets that could have a material effect on the 
financial statements.

Because of its inherent limitations, internal control 
over financial reporting may not prevent or detect 
misstatements.  Also, projections of any evaluation of 
effectiveness to future periods are subject to the risk that 
controls may become inadequate because of changes in 
conditions, or that the degree of compliance with the 
policies or procedures may deteriorate.

/s/ Ernst & Young LLP
Milwaukee, Wisconsin
February 22, 2019 

SCHEDULE  II

Valuation and Qualifying Accounts (in thousands); Years Ended December 31, 2018, 2017, and 2016

Valuation Accounts Deducted in the 
Balance Sheet From the Assets to  
Which They Apply

Balance
at Beginning
of Period

Additions
Charged to
Costs and
Expenses

Additions
Recorded
During
Acquisitions

Deductions
(A)

Balance  
at End  
of Period

2016
Allowance for losses:

Trade accounts receivable

$3,871

$1,747

$ 0

$   782

$4,836

2017
Allowance for losses:

Trade accounts receivable

$4,836

$1,276

$ 0

$   112

$6,000

2018
Allowance for losses:

Trade accounts receivable

$6,000

$1,004

$ 0

$1,028

$5,976

(A) Accounts written off, net of recoveries.

59

 
  
  
  
  
  
SENSIENT TECHNOLOGIES CORPORATION
EXHIBIT INDEX
2018 ANNUAL REPORT ON FORM 10-K

Exhibit 
Number
3.1

  Description
  Sensient Technologies Corporation 
Amended and Restated Articles of 
Incorporation

Incorporated by Reference from

  Exhibit 3.1 to Current Report on Form 8-K dated 
July 24, 2017 (Commission File No. 1-7626)

Filed 
Herewith

3.2

Sensient Technologies Corporation 
Amended and Restated By-Laws

Exhibit 3.2 to Current Report on Form 8-K 
dated February 8, 2018 (Commission File No. 
1-7626)    

4.1(a)

  Note Purchase Agreement dated as of 

March 22, 2011

  Exhibit 10.1 to Current Report on Form 8-K dated 
March 22, 2011 (Commission File No. 1-7626)

4.1(b)

  First Amendment dated as of 

November 6, 2015 to Note Purchase 
Agreement dated as of March 22, 2011

  Exhibit 10.4 to Current Report on Form 8-K dated 
November 6, 2015 (Commission File No. 1-7626)

4.1(c)

4.1(d)

Second Amendment dated as of May 
3, 2017 to Note Purchase Agreement 
dated as of March 22, 2011

Exhibit 10.5 to Current Report on Form 8-K dated 
May 5, 2017 (Commission File No. 1-7626)

Third Amendment dated as of June 
22, 2018 to Note Purchase Agreement 
dated as of March 22, 2011

Exhibit 4.1(d) to Quarterly Report on Form 10-Q 
for the quarter ended June 30, 2018 (Commission 
File No. 1-7626)

4.2(a)

  Note Purchase Agreement dated as of 

  Exhibit 10.1 to Current Report on Form 8-K dated 

April 5, 2013

April 5, 2013 (Commission File No. 1-7626)

4.2(b)

  First Amendment dated as of 

November 6, 2015 to Note Purchase 
Agreement dated as of April 5, 2013

  Exhibit 10.3 to Current Report on Form 8-K dated 
November 6, 2015 (Commission File No. 1-7626)

4.2(c)

Second Amendment dated as of May 
3, 2017 to Note Purchase Agreement 
dated as of April 5, 2013

Exhibit 10.4 to Current Report on Form 8-K dated 
May 5, 2017 (Commission File No. 1-7626)

4.2(d)

  Third Amendment dated as of June 22, 

2018 to Note Purchase Agreement dated 
as of April 5, 2013

  Exhibit 4.2(d) to Quarterly Report on Form 10-Q 
for the quarter ended June 30, 2018 (Commission 
File No. 1-7626)

4.3(a)

  Note Purchase Agreement dated as of 

November 6, 2015

  Exhibit 10.2 to Current Report on Form 8-K dated 
November 6, 2015 (Commission File No. 1-7626)

First Amendment dated as of May 3, 
2017 to Note Purchase Agreement dated 
as of November 6, 2015

Exhibit 10.3 to Current Report on Form 8-K dated 
May 5, 2017 (Commission File No. 1-7626)

  Second Amendment dated as of June 
22, 2018 to Note Purchase Agreement 
dated as of November 6, 2015

  Exhibit 4.3(c) to Quarterly Report on Form 10-Q 
for the quarter ended June 30, 2018 (Commission 
File No. 1-7626)

4.3(b)

4.3(c)

E-1

 
 
 
 
 
 
 
 
 
 
 
 
 
 
SENSIENT TECHNOLOGIES CORPORATION
EXHIBIT INDEX
2018 ANNUAL REPORT ON FORM 10-K

Exhibit 
Number
4.4(a)

Description

Incorporated by Reference from

  Note Purchase Agreement dated as of 

  Exhibit 10.2 to Current Report on Form 8-K dated 

May 3, 2017

May 5, 2017 (Commission File No. 1-7626)

Filed 
Herewith

4.4(b)

  First Amendment dated as of June 22, 

2018 to Note Purchase Agreement dated 
as of May 3, 2017

  Exhibit 4.4(b) to Quarterly Report on Form 10-Q 
for the quarter ended June 30, 2018 (Commission 
File No. 1-7626)

4.5

  Note Purchase Agreement dated as of 

November 1, 2018

  Exhibit 10.1 to Current Report on Form 8-K dated 
November 1, 2018 (Commission File No. 1-7626)

10

  Material Contracts

10.1

  Management Contracts or Compensatory 

Plans

10.1(a)

  Executive Employment Contract 

dated as of February 9, 2017, between 
Sensient Technologies Corporation and 
Paul Manning

  Exhibit 10.1 to Current Report on Form 8-K dated 
February 9, 2017 (Commission File No. 1-7626)

10.1(b)

Form of Change of Control Employment 
and Severance Agreement

Exhibit 10.1(b)(3) to Annual Report on Form 
10-K for the fiscal year ended December 31, 2011 
(Commission File No. 1-7626)

10.1(c)(1)

  Sensient Technologies Corporation 

  Appendix C to Definitive Proxy Statement filed 

2002 Non-Employee Directors Stock 
Plan (superseded)

on Schedule 14A on March 15, 2004 (Commission 
File No. 1-7626)

10.1(c)(2)   Sensient Technologies Corporation 

  Exhibit 10.1(c)(2) to Annual Report on Form 

2012 Non-Employee Directors  
Stock Plan

10-K for the fiscal year ended December 31, 2014 
(Commission File No. 1-7626)

10.1(d)

  Universal Foods Corporation 1994 

Employee Stock Plan

  Exhibit 10.2(f) to Annual Report on Form 10-K 
for the fiscal year ended September 30, 1998 
(Commission File No. 1-7626)

10.1(d)(1)   Amendment of Universal Foods 

  Exhibit 10.1(e)(1) to Annual Report on Form 

Corporation 1994 Employee Stock Plan

10-K for the fiscal year ended December 31, 2000 
(Commission File No. 1-7626)

10.1(e)

  Universal Foods Corporation 1998 

Stock Option Plan

  Exhibit 10.2(h) to Annual Report on Form 10-K 
for the fiscal year ended September 30, 1998 
(Commission File No. 1-7626)

10.1(e)(1)   Amendment of Universal Foods 

  Exhibit 10.1(f)(1) to Annual Report on Form 

Corporation 1998 Stock Option Plan

10-K for the fiscal year ended December 31, 2000 
(Commission File No. 1-7626)

E-2

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SENSIENT TECHNOLOGIES CORPORATION
EXHIBIT INDEX
2018 ANNUAL REPORT ON FORM 10-K

Exhibit 
Number
10.1(f)

Description

Incorporated by Reference from

  Universal Foods Corporation 1999 
Non-Employee Director Stock  
Option Plan

  Appendix A to Definitive Proxy Statement 

filed on Schedule 14A on December 17, 1999 
(Commission File No. 1-7626)

Filed 
Herewith

10.1(f)(1)

  Amendment of Universal Foods 

  Exhibit 10.1(g)(1) to Annual Report on Form 

Corporation 1999 Non-Employee 
Director Stock Option Plan

10-K for the fiscal year ended December 31, 2000 
(Commission File No. 1-7626)

10.1(g)

  Sensient Technologies Corporation 2002 

  Appendix B to Definitive Proxy Statement filed 

Stock Option Plan

on Schedule 14A on March 22, 2002 (Commission 
File No. 1-7626)

10.1(g)(1)

Amendment No. 1 to the Sensient 
Technologies Corporation 2002 Stock 
Option Plan

Exhibit 10.11 to Quarterly Report on Form 
10-Q for the quarter ended September 30, 2008 
(Commission File No. 1-7626)

10.1(g)(2)   Form of Sensient Technologies 

Corporation 2002 Stock Option Plan 
Restricted Stock Agreement

  Exhibit 10.1 to Current Report on Form 8-K dated 
December 1, 2005 (Commission File No. 1-7626)

10.1(h)

  Sensient Technologies Corporation 

  Appendix B to Definitive Proxy Statement filed on 

2007 Stock Plan

Schedule 14A on March 15, 2013 (Commission File 
No. 1-7626)

10.1(i)

Sensient Technologies Corporation 
Directors’ Deferred Compensation Plan

Exhibit 10.1 to Current Report on Form 8-K dated 
May 28, 2014 (Commission File No. 1-7626)

10.1(i)(1)

  Sensient Technologies Corporation 

  Exhibit 10.2 to Current Report on Form 8-K dated 

Non-Employee Directors’  
Retirement Plan

July 25, 2013 (Commission File No. 1-7626)

10.1(j)(1)

  Sensient Technologies Corporation 
Frozen Management Income  
Deferral Plan

  Exhibit 10.5(a) to Quarterly Report on Form 

10-Q for the quarter ended September 30, 2008 
(Commission File No. 1-7626)

10.1(j)(2)

  Sensient Technologies Corporation 
Management Income Deferral Plan

  Exhibit 10.5(b) to Quarterly Report on Form 

10-Q for the quarter ended September 30, 2008 
(Commission File No. 1-7626)

10.1(k)(1)

  Sensient Technologies Corporation 

  Exhibit 10.4(a) to Quarterly Report on Form 

Frozen Executive Income Deferral Plan

10-Q for the quarter ended September 30, 2008 
(Commission File No. 1-7626)

E-3

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SENSIENT TECHNOLOGIES CORPORATION
EXHIBIT INDEX
2018 ANNUAL REPORT ON FORM 10-K

Exhibit 
Number
10.1(k)(2)

Description

Incorporated by Reference from

  Sensient Technologies Corporation 
Executive Income Deferral Plan

  Exhibit 10.4(b) to Quarterly Report on Form 

10-Q for the quarter ended September 30, 2008 
(Commission File No. 1-7626)

Filed 
Herewith

10.1(l)

  Amended and Restated Sensient 

Technologies Corporation Rabbi Trust 
“A” Agreement dated November 30, 
2009, between Sensient Technologies 
Corporation and Wells Fargo Bank, N.A.

10.1(m)(1)   Amended and Restated Sensient 

Technologies Corporation Rabbi Trust 
“B” Agreement dated November 30, 
2009, between Sensient Technologies 
Corporation and Wells Fargo Bank, N.A.

  Exhibit 10.1(l) to Annual Report on Form 10-K 
for the fiscal year ended December 31, 2009 
(Commission File No. 1-7626)

  Exhibit 10.1(m) to Annual Report on Form 10-K 
for the fiscal year ended December 31, 2009 
(Commission File No. 1-7626)

10.1(m)(2)

  Amendment No. 1 to the Amended 
and Restated Sensient Technologies 
Corporation Rabbi Trust “B” 
Agreement

  Exhibit 10.1(m)(2) to Quarterly Report on 

Form 10-Q for the quarter ended June 30, 2017 
(Commission File No. 1-7626)

10.1(n)

  Amended and Restated Sensient 

Technologies Corporation Rabbi Trust 
“C” Agreement dated November 30, 
2009, between Sensient Technologies 
Corporation and Wells Fargo Bank, N.A.

  Exhibit 10.1(n) to Annual Report on Form 10-K 
for the fiscal year ended December 31, 2009 
(Commission File No. 1-7626)

10.1(o)

  Sensient Technologies Corporation 
Incentive Compensation Plan for 
Elected Corporate Officers

  Appendix B to Definitive Proxy Statement filed on 

Schedule 14A on March 17, 2014 (Commission File 
No. 1-7626)

10.1(p)

  Sensient Technologies Corporation 

Management Incentive Plan for Group 
Presidents

  Exhibit 10.9 to Quarterly Report on Form 10-Q for 
the quarter ended September 30, 2008 (Commission 
File No. 1-7626)

10.1(q)

Sensient Technologies Corporation 
Management Incentive Plan for 
Corporate Management

Exhibit 10.7 to Quarterly Report on Form 
10-Q for the quarter ended September 30, 2008 
(Commission File No. 1-7626)

10.1(r)

  Sensient Technologies Corporation 

  Exhibit 10.8 to Quarterly Report on Form 

Management Incentive Plan for Group/
Division Management

10-Q for the quarter ended September 30, 2008 
(Commission File No. 1-7626)

10.1(s)(1)

  Sensient Technologies Corporation Form 
of Supplemental Executive Retirement 
Plan A Agreement

  Exhibit 10.1(s) to Annual Report on Form 10-K 
for the fiscal year ended December 31, 2008 
(Commission File No. 1-7626)

E-4

 
 
 
 
 
 
 
 
 
 
 
 
SENSIENT TECHNOLOGIES CORPORATION
EXHIBIT INDEX
2018 ANNUAL REPORT ON FORM 10-K

Exhibit 
Number
10.1(s)(2)

Description

Incorporated by Reference from

  Form of Amendment No. 1 to the 

  Exhibit 10.1(s)(2) to Annual Report on Form 

Sensient Technologies Corporation 
Amended and Restated Supplemental 
Executive Retirement Plan A

10-K for the fiscal year ended December 31, 2010 
(Commission file No. 1-7626)

Filed 
Herewith

10.1(s)(3)

  Form of Amendment No. 2 to the 

Sensient Technologies Corporation 
Amended and Restated Supplemental 
Executive Retirement Plan A

  Exhibit 10.1 to Current Report on Form 8-K dated 
April 22, 2010 (Commission File No. 1-7626)

10.1(t)(1)

  Sensient Technologies Corporation 
Form of Supplemental Executive 
Retirement Plan B Agreement

  Exhibit 10.1(t) to Annual Report on Form 10-K 
for the fiscal year ended December 31, 2008 
(Commission File No. 1-7626)

10.1(t)(2)

  Form of Amendment No. 1 to the 

  Exhibit 10.1(t)(2) to Annual Report on Form 

Sensient Technologies Corporation 
Amended and Restated Supplemental 
Executive Retirement Plan B

10-K for the fiscal year ended December 31, 2010 
(Commission File No. 1-7626)

10.1(t)(3)

  Form of Amendment No. 2 to the 

Sensient Technologies Corporation 
Amended and Restated Supplemental 
Executive Retirement Plan B

  Exhibit 10.2 to Current Report on Form 8-K dated 
April 22, 2010 (Commission File No. 1-7626)

10.1(u)(1)   Sensient Technologies Frozen 

  Exhibit 10.6(a) to Quarterly Report on Form 

Supplemental Benefit Plan

10-Q for the quarter ended September 30, 2008 
(Commission File No. 1-7626)

10.1(u)(2)   Sensient Technologies Supplemental 

  Exhibit 10.6(b) to Quarterly Report on Form 

Benefit Plan

10-Q for the quarter ended September 30, 2008 
(Commission File No. 1-7626)

10.1(v)

  Sensient Technologies Corporation Policy 
on Recovery of Incentive Compensation 
from Executives

  Exhibit 10.1 to Current Report on Form 8-K dated 
December 8, 2011 (Commission File No. 1-7626)

10.1(w)

  Form of Performance Stock Unit 

  Exhibit 10.3 to Current Report on Form 8-K dated 

Agreement

May 28, 2014 (Commission File No. 1-7626

10.1(x)

  Sensient Technologies Corporation 2017 

  Appendix B to Definitive Proxy Statement filed 

Stock Plan

on Schedule 14A on March 10, 2017 (Commission 
File No. 1-7626)

10.2(a)

  Amended and Restated Credit 

Agreement dated as of October 24, 2014

  Exhibit 10.1 to Current Report on Form 8-K dated 
October 24, 2014 (Commission File No. 1-7626)

E-5

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
SENSIENT TECHNOLOGIES CORPORATION
EXHIBIT INDEX
2018 ANNUAL REPORT ON FORM 10-K

Exhibit 
Number
10.2(b)

Description
First Amendment dated as of 
November 6, 2015 to Amended and 
Restated Credit Agreement dated as of 
October 24, 2014

Incorporated by Reference from
Exhibit 10.1 to Current Report on Form 8-K dated 
November 6, 2015 (Commission File No. 1-7626)

Filed 
Herewith

10.2(c)

  Second Amended and Restated Credit 
Agreement dated as of May 3, 2017

  Exhibit 10.1 to Current Report on Form 8-K dated 

May 5, 2017 (Commission File No. 1-7626)

10.2(d)

First Amendment to Second Amended 
and Restated Credit Agreement dated as 
of June 22, 2018

Exhibit 10.2(d) to Quarterly Report on Form 10-Q 
for the quarter ended June 30, 2018 (Commission 
File No. 1-7626)

10.3

Credit Agreement dated as of October 
7, 2008

Exhibit 10.1 to Current Report on Form 8-K dated 
October 7, 2008 (Commission File No. 1-7626)

10.4(a)

  Receivables Sale Agreement dated as 

of October 3, 2016

  Exhibit 10.1 to Current Report on Form 8-K dated 
October 3, 2016 (Commission File No. 1-7626)

10.4(b)

  Amendment No. 1 to the Receivables 

Sale Agreement, dated as of 
October 2, 2017

  Exhibit 10.1 to Current Report on Form 8-K dated 
October 2, 2017 (Commission File No. 1-7626)

10.5(a)

Receivables Purchase Agreement dated 
as of October 3, 2016

Exhibit 10.2 to Current Report on Form 8-K dated 
October 3, 2016 (Commission File No. 1-7626)

10.5(b)

10.5(c)

10.5(d)

Amendment No. 1 to the Receivables 
Purchase Agreement and Performance 
Undertaking, dated as of October 2, 2017

Exhibit 10.2 to Current Report on Form 8-K dated 
October 2, 2017 (Commission File No. 1-7626)

Amendment No. 2 to Receivables 
Purchase Agreement, dated as of  
June 26, 2018

Exhibit 10.5(c) to Quarterly Report on Form 10-Q 
for the quarter ended June 30, 2018 (Commission 
File No. 1-7626)

  Amendment No. 3 to Receivables 
Purchase Agreement, dated as of 
October 1, 2018

  Exhibit 10.1 to Current Report on Form 8-K dated 
October 1, 2018 (Commission File No. 1-7626)

10.6

  Performance Undertaking made as of 

October 3, 2016

  Exhibit 10.3 to Current Report on Form 8-K dated 
October 3, 2016 (Commission File No. 1-7626)

21

  Subsidiaries of the Registrant

23.1

  Consent of Ernst & Young LLP

X

X

E-6

 
 
 
 
 
 
 
 
 
 
 
SENSIENT TECHNOLOGIES CORPORATION
EXHIBIT INDEX
2018 ANNUAL REPORT ON FORM 10-K

Exhibit 
Number
31

Description

Incorporated by Reference from

  Certifications of Sensient’s President 

and Chief Executive Officer and Senior 
Vice President and Chief Financial 
Officer, pursuant to Rule 13a-14(a) of 
the Exchange Act

Filed 
Herewith
X

32

  Certifications of Sensient’s President 

and Chief Executive Officer and Senior 
Vice President and Chief Financial 
Officer, pursuant to 18 United States 
Code § 1350

101.INS*

Instance Document

101.SCH*

XBRL Taxonomy Extension Schema 
Document

101.CAL*

XBRL Taxonomy Extension 
Calculation Linkbase Document

101.DEF*

XBRL Taxonomy Extension Definition 
Linkbase Document

101.LAB*

XBRL Taxonomy Extension Label 
Linkbase Document

101.PRE*

XBRL Taxonomy Extension 
Presentation Linkbase Document

X

X

X

X

X

X

X

*The following financial information is formatted in XBRL (eXtensible Business Reporting Language) and furnished 
electronically herewith: (i) Consolidated Statements of Earnings for the twelve months ended December 31, 2018, 2017, and 
2016; (ii) Consolidated Statements of Comprehensive Income for the twelve months ended December 31, 2018, 2017, and 
2016; (iii) Consolidated Balance Sheets as of December 31, 2018 and 2017; (iv) Consolidated Statements of Shareholders’ 
Equity for the twelve months ended December 31, 2018, 2017, and 2016; (v) Consolidated Statements of Cash Flow for the 
twelve months ended December 31, 2018, 2017, and 2016; and (vi) Notes to Consolidated Financial Statements.

E-7

 
 
 
 
 
 
SIGNATURES

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the Registrant has duly caused 
this report to be signed on its behalf by the undersigned, thereunto duly authorized.

SENSIENT TECHNOLOGIES CORPORATION

/s/ John J. Manning
John J. Manning
Vice President, General Counsel and Secretary

Dated: February 22, 2019 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below as of February 22, 
2019, by the following persons on behalf of the Registrant and in the capacities indicated.

/s/ Paul Manning
Paul Manning
Chairman of the Board, President and
Chief Executive Officer

/s/ Stephen J. Rolfs
Stephen J. Rolfs
Senior Vice President and
Chief Financial Officer

/s/ Tobin Tornehl
Tobin Tornehl
Vice President, Controller and
Chief Accounting Officer

/s/ Hank Brown
Hank Brown
Director

/s/ Joseph Carleone
Joseph Carleone
Director

/s/ Edward H. Cichurski
Edward H. Cichurski
Director

/s/ Mario Ferruzzi
Mario Ferruzzi
Director

/s/ Donald W. Landry
Donald W. Landry
Director

/s/ Scott C. Morrison
Scott C. Morrison
Director

/s/ Deborah McKeithan-Gebhardt
Deborah McKeithan-Gebhardt
Director

/s/ Elaine R. Wedral
Elaine R. Wedral
Director

/s/ Essie Whitelaw
Essie Whitelaw
Director

S-1